<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">48705</article-id><article-id pub-id-type="doi">10.7554/eLife.48705</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Neuroscience</subject></subj-group></article-categories><title-group><article-title><italic>Stxbp1/Munc18-1</italic> haploinsufficiency impairs inhibition and mediates key neurological features of <italic>STXBP1</italic> encephalopathy</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-58077"><name><surname>Chen</surname><given-names>Wu</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-7400-0519</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund5"/><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-113765"><name><surname>Cai</surname><given-names>Zhao-Lin</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0003-4034-2884</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-58090"><name><surname>Chao</surname><given-names>Eugene S</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-113707"><name><surname>Chen</surname><given-names>Hongmei</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-173763"><name><surname>Longley</surname><given-names>Colleen M</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0001-8326-6143</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="fund6"/><xref ref-type="other" rid="fund7"/><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-102554"><name><surname>Hao</surname><given-names>Shuang</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-143691"><name><surname>Chao</surname><given-names>Hsiao-Tuan</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-2854-5470</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-143692"><name><surname>Kim</surname><given-names>Joo Hyun</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-143693"><name><surname>Messier</surname><given-names>Jessica E</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-5865-7043</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund6"/><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-1029"><name><surname>Zoghbi</surname><given-names>Huda Y</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-0700-3349</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="aff" rid="aff8">8</xref><xref ref-type="other" rid="fund4"/><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-134612"><name><surname>Tang</surname><given-names>Jianrong</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="con11"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-100380"><name><surname>Swann</surname><given-names>John W</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0001-8995-5812</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con12"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-58092"><name><surname>Xue</surname><given-names>Mingshan</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-1463-8884</contrib-id><email>Mingshan.Xue@bcm.edu</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund3"/><xref ref-type="fn" rid="con13"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution>Department of Neuroscience, Baylor College of Medicine</institution><addr-line><named-content content-type="city">Houston</named-content></addr-line><country>United States</country></aff><aff id="aff2"><label>2</label><institution>The Cain Foundation Laboratories, Jan and Dan Duncan Neurological Research Institute at Texas Children’s Hospital</institution><addr-line><named-content content-type="city">Houston</named-content></addr-line><country>United States</country></aff><aff id="aff3"><label>3</label><institution>Program in Developmental Biology, Baylor College of Medicine</institution><addr-line><named-content content-type="city">Houston</named-content></addr-line><country>United States</country></aff><aff id="aff4"><label>4</label><institution>Department of Pediatrics, Division of Neurology and Developmental Neuroscience, Baylor College of Medicine</institution><addr-line><named-content content-type="city">Houston</named-content></addr-line><country>United States</country></aff><aff id="aff5"><label>5</label><institution>Jan and Dan Duncan Neurological Research Institute at Texas Children’s Hospital</institution><addr-line><named-content content-type="city">Houston</named-content></addr-line><country>United States</country></aff><aff id="aff6"><label>6</label><institution>Department of Molecular and Human Genetics, Baylor College of Medicine</institution><addr-line><named-content content-type="city">Houston</named-content></addr-line><country>United States</country></aff><aff id="aff7"><label>7</label><institution>McNair Medical Institute, The Robert and Janice McNair Foundation</institution><addr-line><named-content content-type="city">Houston</named-content></addr-line><country>United States</country></aff><aff id="aff8"><label>8</label><institution>Howard Hughes Medical Institute, Baylor College of Medicine</institution><addr-line><named-content content-type="city">Houston</named-content></addr-line><country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Monteggia</surname><given-names>Lisa M</given-names></name><role>Reviewing Editor</role><aff><institution>Vanderbilt University</institution><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Dulac</surname><given-names>Catherine</given-names></name><role>Senior Editor</role><aff><institution>Harvard University</institution><country>United States</country></aff></contrib></contrib-group><pub-date date-type="publication" publication-format="electronic"><day>19</day><month>02</month><year>2020</year></pub-date><pub-date pub-type="collection"><year>2020</year></pub-date><volume>9</volume><elocation-id>e48705</elocation-id><history><date date-type="received" iso-8601-date="2019-05-23"><day>23</day><month>05</month><year>2019</year></date><date date-type="accepted" iso-8601-date="2020-02-18"><day>18</day><month>02</month><year>2020</year></date></history><permissions><copyright-statement>© 2020, Chen et al</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>Chen et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-48705-v2.pdf"/><abstract><p>Mutations in genes encoding synaptic proteins cause many neurodevelopmental disorders, with the majority affecting postsynaptic apparatuses and much fewer in presynaptic proteins. Syntaxin-binding protein 1 (STXBP1, also known as MUNC18-1) is an essential component of the presynaptic neurotransmitter release machinery. De novo heterozygous pathogenic variants in <italic>STXBP1</italic> are among the most frequent causes of neurodevelopmental disorders including intellectual disabilities and epilepsies. These disorders, collectively referred to as <italic>STXBP1</italic> encephalopathy, encompass a broad spectrum of neurologic and psychiatric features, but the pathogenesis remains elusive. Here we modeled <italic>STXBP1</italic> encephalopathy in mice and found that <italic>Stxbp1</italic> haploinsufficiency caused cognitive, psychiatric, and motor dysfunctions, as well as cortical hyperexcitability and seizures. Furthermore, <italic>Stxbp1</italic> haploinsufficiency reduced cortical inhibitory neurotransmission via distinct mechanisms from parvalbumin-expressing and somatostatin-expressing interneurons. These results demonstrate that <italic>Stxbp1</italic> haploinsufficient mice recapitulate cardinal features of <italic>STXBP1</italic> encephalopathy and indicate that GABAergic synaptic dysfunction is likely a crucial contributor to disease pathogenesis.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>neurobehaviors</kwd><kwd>intellectual disability</kwd><kwd>epilepsy</kwd><kwd>neuropsychiatric dysfunctions</kwd><kwd>cortical inhibitory interneurons</kwd><kwd>synaptic transmission</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100002736</institution-id><institution>Citizens United for Research in Epilepsy</institution></institution-wrap></funding-source><award-id>CURE Epilepsy Award</award-id><principal-award-recipient><name><surname>Xue</surname><given-names>Mingshan</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000065</institution-id><institution>National Institute of Neurological Disorders and Stroke</institution></institution-wrap></funding-source><award-id>R01NS100893</award-id><principal-award-recipient><name><surname>Xue</surname><given-names>Mingshan</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000025</institution-id><institution>National Institute of Mental Health</institution></institution-wrap></funding-source><award-id>R01MH117089</award-id><principal-award-recipient><name><surname>Xue</surname><given-names>Mingshan</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100009633</institution-id><institution>Eunice Kennedy Shriver National Institute of Child Health and Human Development</institution></institution-wrap></funding-source><award-id>U54HD083092</award-id><principal-award-recipient><name><surname>Zoghbi</surname><given-names>Huda Y</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100001454</institution-id><institution>American Epilepsy Society</institution></institution-wrap></funding-source><award-id>Postdoctoral Research Fellowship</award-id><principal-award-recipient><name><surname>Chen</surname><given-names>Wu</given-names></name></principal-award-recipient></award-group><award-group id="fund6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100001234</institution-id><institution>Robert and Janice McNair Foundation</institution></institution-wrap></funding-source><award-id>McNair MD/PhD Student Scholars</award-id><principal-award-recipient><name><surname>Longley</surname><given-names>Colleen M</given-names></name><name><surname>Messier</surname><given-names>Jessica E</given-names></name></principal-award-recipient></award-group><award-group id="fund7"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000025</institution-id><institution>National Institute of Mental Health</institution></institution-wrap></funding-source><award-id>F30MH118804</award-id><principal-award-recipient><name><surname>Longley</surname><given-names>Colleen M</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Two genetically distinct <italic>Stxbp1</italic> haploinsufficiency mouse models exhibit seizures and impairments in cognitive, psychiatric, and motor functions, representing robust preclinical models of <italic>STXBP1</italic> encephalopathy with both construct and face validity.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Human genetic studies of neurodevelopmental disorders continue to uncover pathogenic variants in genes encoding synaptic proteins (<xref ref-type="bibr" rid="bib34">Hoischen et al., 2014</xref>; <xref ref-type="bibr" rid="bib88">Zhu et al., 2014</xref>; <xref ref-type="bibr" rid="bib17">Deciphering Developmental Disorders Study, 2015</xref>; <xref ref-type="bibr" rid="bib18">Deciphering Developmental Disorders Study, 2017</xref>; <xref ref-type="bibr" rid="bib74">Stessman et al., 2017</xref>; <xref ref-type="bibr" rid="bib42">Lindy et al., 2018</xref>), demonstrating the importance of these proteins for neurologic and psychiatric features. The molecular and cellular functions of many of these synaptic proteins have been extensively studied. However, to understand the pathological mechanisms underlying these synaptic disorders, in-depth neurological and behavioral studies in animal models are necessary. While it is difficult to perform such studies for all disorders, this knowledge gap can be significantly narrowed by studying a few prioritized genes that are highly penetrant and affect a broad spectrum of neurologic and psychiatric features common among neurodevelopmental disorders (<xref ref-type="bibr" rid="bib34">Hoischen et al., 2014</xref>; <xref ref-type="bibr" rid="bib55">Ogden et al., 2016</xref>). Syntaxin-binding protein 1 (STXBP1, also known as MUNC18-1) is one such example because its molecular and cellular functions are well understood (<xref ref-type="bibr" rid="bib64">Rizo and Xu, 2015</xref>), its pathogenic variants are emerging as prevalent causes of multiple neurodevelopmental disorders (<xref ref-type="bibr" rid="bib73">Stamberger et al., 2016</xref>), and yet it remains unclear how its dysfunction causes disease.</p><p>Stxbp1/Munc18-1 is involved in synaptic vesicle docking, priming, and fusion through multiple interactions with the neuronal soluble <italic>N</italic>-ethylmaleimide-sensitive factor-attachment protein receptors (SNAREs) (<xref ref-type="bibr" rid="bib64">Rizo and Xu, 2015</xref>). Genetic deletion of Stxbp1 in worms, flies, mice, and fish abolishes neurotransmitter release and leads to lethality and cell-intrinsic degeneration of neurons (<xref ref-type="bibr" rid="bib30">Harrison et al., 1994</xref>; <xref ref-type="bibr" rid="bib81">Verhage, 2000</xref>; <xref ref-type="bibr" rid="bib83">Weimer et al., 2003</xref>; <xref ref-type="bibr" rid="bib32">Heeroma et al., 2004</xref>; <xref ref-type="bibr" rid="bib23">Grone et al., 2016</xref>). In humans, <italic>STXBP1</italic> de novo heterozygous mutations cause several of the most severe forms of epileptic encephalopathies including Ohtahara syndrome (<xref ref-type="bibr" rid="bib67">Saitsu et al., 2008</xref>; <xref ref-type="bibr" rid="bib68">Saitsu et al., 2010</xref>), West syndrome (<xref ref-type="bibr" rid="bib20">Deprez et al., 2010</xref>; <xref ref-type="bibr" rid="bib57">Otsuka et al., 2010</xref>), Lennox-Gastaut syndrome (<xref ref-type="bibr" rid="bib11">Carvill et al., 2013</xref>; <xref ref-type="bibr" rid="bib1">Allen et al., 2013</xref>), Dravet syndrome (<xref ref-type="bibr" rid="bib12">Carvill et al., 2014</xref>), and other types of early-onset epileptic encephalopathies (<xref ref-type="bibr" rid="bib20">Deprez et al., 2010</xref>; <xref ref-type="bibr" rid="bib49">Mignot et al., 2011</xref>; <xref ref-type="bibr" rid="bib73">Stamberger et al., 2016</xref>). Furthermore, <italic>STXBP1</italic> is one of the most frequently mutated genes in sporadic intellectual disabilities and developmental disorders (<xref ref-type="bibr" rid="bib27">Hamdan et al., 2009</xref>; <xref ref-type="bibr" rid="bib28">Hamdan et al., 2011</xref>; <xref ref-type="bibr" rid="bib62">Rauch et al., 2012</xref>; <xref ref-type="bibr" rid="bib17">Deciphering Developmental Disorders Study, 2015</xref>; <xref ref-type="bibr" rid="bib18">Deciphering Developmental Disorders Study, 2017</xref>; <xref ref-type="bibr" rid="bib75">Suri et al., 2017</xref>). All <italic>STXBP1</italic> encephalopathy patients show intellectual disability, mostly severe to profound, and 95% of patients have epilepsy (<xref ref-type="bibr" rid="bib73">Stamberger et al., 2016</xref>). More than 90% of patients have motor deficits, such as dystonia, spasticity, ataxia, hypotonia, and tremor. Other clinical features in subsets of patients include developmental delay, hyperactivity, anxiety, stereotypies, aggressive behaviors, and autistic features (<xref ref-type="bibr" rid="bib27">Hamdan et al., 2009</xref>; <xref ref-type="bibr" rid="bib20">Deprez et al., 2010</xref>; <xref ref-type="bibr" rid="bib49">Mignot et al., 2011</xref>; <xref ref-type="bibr" rid="bib50">Milh et al., 2011</xref>; <xref ref-type="bibr" rid="bib10">Campbell et al., 2012</xref>; <xref ref-type="bibr" rid="bib62">Rauch et al., 2012</xref>; <xref ref-type="bibr" rid="bib82">Weckhuysen et al., 2013</xref>; <xref ref-type="bibr" rid="bib8">Boutry-Kryza et al., 2015</xref>; <xref ref-type="bibr" rid="bib73">Stamberger et al., 2016</xref>; <xref ref-type="bibr" rid="bib75">Suri et al., 2017</xref>).</p><p><italic>STXBP1</italic> encephalopathy is mostly caused by haploinsufficiency because more than 60% of the reported mutations are either deletions, nonsense, frameshift, or splice site variants (<xref ref-type="bibr" rid="bib73">Stamberger et al., 2016</xref>). A subset of missense variants were shown to destabilize the protein (<xref ref-type="bibr" rid="bib67">Saitsu et al., 2008</xref>; <xref ref-type="bibr" rid="bib68">Saitsu et al., 2010</xref>; <xref ref-type="bibr" rid="bib24">Guiberson et al., 2018</xref>; <xref ref-type="bibr" rid="bib36">Kovacevic et al., 2018</xref>) and cause aggregation to further reduce the wild type (WT) protein levels (<xref ref-type="bibr" rid="bib24">Guiberson et al., 2018</xref>). Thus, partial loss-of-function of <italic>Stxbp1</italic> in vivo would offer opportunities to model <italic>STXBP1</italic> encephalopathy and study its pathogenesis. Indeed, removing <italic>stxbp1b</italic>, one of the two <italic>STXBP1</italic> homologs in zebrafish, caused spontaneous electrographic seizures (<xref ref-type="bibr" rid="bib23">Grone et al., 2016</xref>). Three different <italic>Stxbp1</italic> null alleles have been generated in mice (<xref ref-type="bibr" rid="bib81">Verhage, 2000</xref>; <xref ref-type="bibr" rid="bib51">Miyamoto et al., 2017</xref>; <xref ref-type="bibr" rid="bib36">Kovacevic et al., 2018</xref>). However, previous characterization of the corresponding heterozygous knockout mice was limited in scope, used relatively small cohorts, and yielded inconsistent results. For example, the reported cognitive phenotypes in mutant mice are mild or inconsistent between studies (<xref ref-type="bibr" rid="bib51">Miyamoto et al., 2017</xref>; <xref ref-type="bibr" rid="bib36">Kovacevic et al., 2018</xref>; <xref ref-type="bibr" rid="bib56">Orock et al., 2018</xref>). Motor dysfunctions and several psychiatric deficits were not reported in previous studies (<xref ref-type="bibr" rid="bib25">Hager et al., 2014</xref>; <xref ref-type="bibr" rid="bib51">Miyamoto et al., 2017</xref>; <xref ref-type="bibr" rid="bib36">Kovacevic et al., 2018</xref>; <xref ref-type="bibr" rid="bib56">Orock et al., 2018</xref>). Thus, a comprehensive neurological and behavioral study of <italic>Stxbp1</italic> haploinsufficiency models is still lacking. Interestingly, Stxbp1 protein levels were reduced by only 25% in the brain of one line of previous <italic>Stxbp1</italic> heterozygous knockout mice (<xref ref-type="bibr" rid="bib56">Orock et al., 2018</xref>) and 25% in the cortex and 50% in the hippocampus of another line (<xref ref-type="bibr" rid="bib51">Miyamoto et al., 2017</xref>). Although STXBP1 levels in human patients are unknown, mouse models with a stronger reduction in Stxbp1 levels are desirable to determine to what extent <italic>Stxbp1</italic> haploinsufficient mice can recapitulate the neurological phenotypes of <italic>STXBP1</italic> encephalopathy. Furthermore, it remains elusive how <italic>STXBP1</italic> haploinsufficiency in vivo leads to hyperexcitable neural circuits and neurological deficits.</p><p>To address these questions and enhance the robustness and reproducibility of preclinical models of <italic>STXBP1</italic> haploinsufficiency, we developed two new genetically distinct <italic>Stxbp1</italic> haploinsufficiency mouse models and performed parallel studies on both of them. These mutant mice showed a 40–50% reduction of Stxbp1 protein levels in most brain regions and recapitulated all key phenotypes observed in the human condition including seizures and impairments in cognitive, psychiatric, and motor functions. Electrophysiological and optogenetic experiments revealed that <italic>Stxbp1</italic> haploinsufficiency reduced cortical inhibition through two distinct mechanisms from two main classes of GABAergic neurons: reducing the synaptic strength of parvalbumin-expressing (Pv) interneurons and decreasing the connectivity of somatostatin-expressing (Sst) interneurons. Thus, these results demonstrate a crucial role of <italic>Stxbp1</italic> in neurologic and psychiatric functions and indicate that <italic>Stxbp1</italic> haploinsufficient mice are construct- and face-valid models of <italic>STXBP1</italic> encephalopathy. Furthermore, the reduced inhibition is likely a major contributor to the cortical hyperexcitability and neurobehavioral phenotypes. The differential effects on Pv and Sst interneuron-mediated inhibition suggest synapse-specific functions of <italic>Stxbp1</italic> and also highlight the necessity of studying synaptic specificity and diversity in neural circuits of synaptopathies.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Generation of two new genetically distinct <italic>Stxbp1</italic> haploinsufficiency mouse models</title><p>To model <italic>STXBP1</italic> haploinsufficiency in mice, we first generated a knockout-first (KO-first) allele (<italic>tm1a</italic>), in which the <italic>Stxbp1</italic> genomic locus was targeted with a multipurpose cassette (<xref ref-type="bibr" rid="bib77">Testa et al., 2004</xref>; <xref ref-type="bibr" rid="bib72">Skarnes et al., 2011</xref>). The targeted allele contains a splice acceptor site from <italic>Engrailed 2</italic> (<italic>En2SA</italic>), an encephalomyocarditis virus internal ribosomal entry site (<italic>IRES</italic>), <italic>lacZ</italic>, and SV40 polyadenylation element (pA) that trap the transcripts after exon 6, thereby truncating the <italic>Stxbp1</italic> mRNA. The trapping cassette (<italic>En2SA-IRES-lacZ-pA</italic>) and exon 7 are flanked by two <italic>FRT</italic> sites and two <italic>loxP</italic> sites, respectively (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A</xref>). By sequentially crossing with Flp and Cre germline deleter mice, we removed both the trapping cassette and exon 7 from the heterozygous KO-first mice, which leads to a premature stop codon in exon 8 and generates a conventional knockout (KO) allele (<italic>tm1d</italic>) (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). Heterozygous KO (<italic>Stxbp1<sup>tm1d/+</sup></italic>) and KO-first (<italic>Stxbp1<sup>tm1a/+</sup></italic>) mice are maintained on the C57BL/6J isogenic background for all experiments.</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title><italic>Stxbp1</italic> haploinsufficient mice exhibit reduced Stxbp1 levels, survival, and body weights and develop hindlimb clasping.</title><p>(<bold>A</bold>) Genomic structures of <italic>Stxbp1</italic> WT, <italic>tm1a</italic> (KO-first), and <italic>tm1d</italic> (KO) alleles. In the <italic>tm1a</italic> allele, the STOP including the <italic>En2SA-IRES-lacZ-pA</italic> trapping cassette (see <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A</xref>) truncates the <italic>Stxbp1</italic> mRNA after exon 6. In the <italic>tm1d</italic> allele, exon 7 is deleted, resulting in a premature stop codon in exon 8. E, exon; <italic>FRT</italic>, Flp recombination site; <italic>loxP</italic>, Cre recombination site. (<bold>B</bold>) Representative Western blots of proteins from different brain regions of 3-month-old WT, <italic>Stxbp1<sup>tm1d/+</sup></italic>, and <italic>Stxbp1<sup>tm1a/+</sup></italic> mice. Gapdh, a housekeeping protein as loading control. The brain regions are labeled by the same abbreviations as in (<bold>C</bold>). (<bold>C</bold>) Summary data of normalized Stxbp1 expression levels from different brain regions. Stxbp1 levels were first normalized by the Gapdh levels and then by the average Stxbp1 levels of all WT mice from the same blot. Each filled (male) or open (female) circle represents one mouse. (<bold>D</bold>) <italic>Stxbp1<sup>tm1d/+</sup></italic> and <italic>Stxbp1<sup>tm1a/+</sup></italic> male mice were crossed with WT female mice. Pie charts show the observed genotypes of the offspring at weaning (i.e., around the age of 3 weeks). <italic>Stxbp1<sup>tm1d/+</sup></italic> and <italic>Stxbp1<sup>tm1a/+</sup></italic> mice were significantly less than Mendelian expectations. (<bold>E</bold>) <italic>Stxbp1<sup>tm1d/+</sup></italic> and <italic>Stxbp1<sup>tm1a/+</sup></italic> mice were smaller and showed hindlimb clasping (arrows). (<bold>F</bold>) Body weights as a function of age. M, male; F, female. (<bold>G</bold>) The fraction of mice with hindlimb clasping as a function of age. Bar graphs are mean ± s.e.m. **, p&lt;0.01; ***, p&lt;0.001; ****, p&lt;0.0001.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-48705-fig1-v2.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>Generation of two new <italic>Stxbp1</italic> null alleles.</title><p>(<bold>A</bold>) The <italic>Stxbp1</italic> WT genomic region was targeted by a multipurpose cassette that contains an <italic>Engrailed two</italic> splice acceptor site (<italic>En2SA</italic>), an encephalomyocarditis virus internal ribosomal entry site (<italic>IRES</italic>), <italic>lacZ</italic>, SV40 polyadenylation element (pA), and floxed exon 7, resulting in the KO-first allele (<italic>tm1a</italic>). The restriction enzymes and probes used in the Southern blots are indicated in the diagrams. The KO-first allele was converted to the KO allele (<italic>tm1d</italic>) by crossing <italic>Stxbp1<sup>tm1a/+</sup></italic> mice with <italic>Rosa26-Flpo</italic> and <italic>Sox2-Cre</italic> mice sequentially. (<bold>B</bold>) Representative Western blots of Stxbp1 and Gapdh proteins extracted from the brains at embryonic day 17.5. Stxbp1 was detected by an antibody recognizing the C terminus (left two blots) or the N terminus (right two blots). The genotypes are indicated above the samples. Note that Stxbp1 was reduced in heterozygous mutants and absent in homozygous mutants. (<bold>C</bold>) Summary data of normalized Stxbp1 expression levels. Stxbp1 levels were first normalized by the Gapdh levels and then by the average Stxbp1 levels of all WT mice from the same blot. The data obtained by both Stxbp1 antibodies are combined. Each triangle represents one mouse. Bar graphs are mean ± s.e.m. **, p&lt;0.01; ***, p&lt;0.001; ****, p&lt;0.0001.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-48705-fig1-figsupp1-v2.tif"/></fig><fig id="fig1s2" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 2.</label><caption><title>Reduced survival of <italic>Stxbp1</italic> haploinsufficient mice.</title><p>(<bold>A</bold>) <italic>Stxbp1<sup>tm1d/+</sup></italic> and <italic>Stxbp1<sup>tm1a/+</sup></italic> male mice were crossed with WT female mice. The observed genotypes of the offspring at weaning (i.e., around the age of 3 weeks) are shown in the pie charts. The male and female <italic>Stxbp1<sup>tm1d/+</sup></italic> and <italic>Stxbp1<sup>tm1a/+</sup></italic> mice were significantly less than Mendelian expectations. Note that the genotypes of some female mice were not determined and therefore, they were not included in this analysis. (<bold>B</bold>) Survival curves of a subset of <italic>Stxbp1<sup>tm1d/+</sup></italic>, <italic>Stxbp1<sup>tm1a/+</sup></italic>, and WT mice that were monitored for 80 weeks. The numbers of observed mice are indicated in the figures. n.s., p&gt;0.05; *, p&lt;0.05; **, p&lt;0.01; ****, p&lt;0.0001.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-48705-fig1-figsupp2-v2.tif"/></fig></fig-group><p>Homozygous mutants (<italic>Stxbp1<sup>tm1d/tm1d</sup></italic> and <italic>Stxbp1<sup>tm1a/tm1a</sup></italic>) died immediately after birth because they were completely paralyzed and could not breathe, consistent with the previous <italic>Stxbp1</italic> null alleles (<xref ref-type="bibr" rid="bib81">Verhage, 2000</xref>; <xref ref-type="bibr" rid="bib51">Miyamoto et al., 2017</xref>). Western blots with antibodies recognizing either the N- or C-terminus of Stxbp1 showed that at embryonic day 17.5, Stxbp1 protein was absent in <italic>Stxbp1<sup>tm1d/tm1d</sup></italic> and <italic>Stxbp1<sup>tm1a/tm1a</sup></italic> mice, and reduced by 50% in <italic>Stxbp1<sup>tm1d/+</sup></italic> and <italic>Stxbp1<sup>tm1a/+</sup></italic> mice (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1B,C</xref>), indicating that both <italic>tm1d</italic> and <italic>tm1a</italic> are null alleles. We surveyed the Stxbp1 protein levels in different brain regions of <italic>Stxbp1<sup>tm1d/+</sup></italic> and <italic>Stxbp1<sup>tm1a/+</sup></italic> mice at 3 months of age. Stxbp1 was reduced by 40–50% in most brain areas except the cerebellum and olfactory bulb where the reduction was 20–30% (<xref ref-type="fig" rid="fig1">Figure 1B,C</xref>). These results demonstrate that <italic>Stxbp1<sup>tm1d/+</sup></italic> and <italic>Stxbp1<sup>tm1a/+</sup></italic> are indeed <italic>Stxbp1</italic> haploinsufficient mice. In theory, the <italic>tm1d</italic> and <italic>tm1a</italic> alleles could produce a truncated Stxbp1 protein of 18 kD and 16 kD, respectively. However, no such truncated proteins were observed in either heterozygous or homozygous mutants (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1B</xref>), most likely because the truncated <italic>Stxbp1</italic> transcripts were degraded due to nonsense-mediated mRNA decay (<xref ref-type="bibr" rid="bib13">Chang et al., 2007</xref>).</p></sec><sec id="s2-2"><title><italic>Stxbp1</italic> haploinsufficient mice show a reduction in survival and body weights, and developed hindlimb clasping</title><p>We bred <italic>Stxbp1<sup>tm1d/+</sup></italic> and <italic>Stxbp1<sup>tm1a/+</sup></italic> mice with WT mice and found that at the time of genotyping (i.e., around postnatal week 3) <italic>Stxbp1<sup>tm1d/+</sup></italic> and <italic>Stxbp1<sup>tm1a/+</sup></italic> mice are 40% and 43% of the total offspring, respectively (<xref ref-type="fig" rid="fig1">Figure 1D</xref> and <xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2A</xref>), indicating a postnatal lethality phenotype. However, the lifespans of many mutant mice that survived through weaning were similar to those of WT littermates (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2B</xref>). Thus, <italic>Stxbp1</italic> haploinsufficient mice show reduced survival, but this phenotype is not fully penetrant. <italic>Stxbp1<sup>tm1d/+</sup></italic> and <italic>Stxbp1<sup>tm1a/+</sup></italic> mice appeared smaller and their body weights were consistently about 20% less than their sex- and age-matched WT littermates (<xref ref-type="fig" rid="fig1">Figure 1E,F</xref>). At 4 weeks of age, <italic>Stxbp1<sup>tm1d/+</sup></italic> and <italic>Stxbp1<sup>tm1a/+</sup></italic> mice began to exhibit abnormal hindlimb clasping, indicative of dystonia or spasticity (<xref ref-type="fig" rid="fig1">Figure 1E</xref>). By the age of 3 months, almost all mutant mice developed hindlimb clasping (<xref ref-type="fig" rid="fig1">Figure 1G</xref>). Thus, these observations indicate neurological deficits in <italic>Stxbp1</italic> haploinsufficient mice.</p><p>Guided by the symptoms of <italic>STXBP1</italic> encephalopathy human patients, we sought to perform behavioral and physiological assays to further examine the neurologic and psychiatric functions in male and female <italic>Stxbp1</italic> haploinsufficient mice and their sex- and age-matched WT littermates.</p></sec><sec id="s2-3"><title>Impaired motor and normal sensory functions in <italic>Stxbp1</italic> haploinsufficient mice</title><p>Motor impairments including dystonia, spasticity, ataxia, hypotonia, and tremor are frequently observed in <italic>STXBP1</italic> encephalopathy patients. Thus, we first assessed general locomotion by the open-field test where a mouse is allowed to freely explore an arena (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). The locomotion of <italic>Stxbp1<sup>tm1d/+</sup></italic> and <italic>Stxbp1<sup>tm1a/+</sup></italic> mice was largely normal, but they traveled longer distances and faster than WT mice, indicating that <italic>Stxbp1</italic> haploinsufficient mice are hyperactive (<xref ref-type="fig" rid="fig2">Figure 2B,C</xref>). Both <italic>Stxbp1<sup>tm1d/+</sup></italic> and <italic>Stxbp1<sup>tm1a/+</sup></italic> mice explored the center region of the arena less than WT mice (<xref ref-type="fig" rid="fig2">Figure 2D</xref>) and made less vertical movements (<xref ref-type="fig" rid="fig2">Figure 2E</xref>), indicating that the mutant mice are more anxious. This anxiety phenotype was later confirmed by two other assays that specifically assess anxiety (see below). We used a variety of assays to further evaluate motor functions. <italic>Stxbp1</italic> haploinsufficient mice performed similarly to WT mice in the rotarod test, dowel test, inverted screen test, and wire hang test (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>). However, the forelimb grip strength of <italic>Stxbp1</italic> haploinsufficient mice was weaker (<xref ref-type="fig" rid="fig2">Figure 2F</xref>). Furthermore, in the foot slip test where a mouse is allowed to walk on a wire grid, both <italic>Stxbp1<sup>tm1d/+</sup></italic> and <italic>Stxbp1<sup>tm1a/+</sup></italic> mice were not able to place their paws precisely on the wire to hold themselves and made many more foot slips than WT mice (<xref ref-type="fig" rid="fig2">Figure 2G</xref>). To assess the agility of mice, we performed the vertical pole test, which is often used to measure the bradykinesia of parkinsonism. When mice were placed head-up on the top of a vertical pole, it took mutant mice longer to orient themselves downward and descend the pole than WT mice (<xref ref-type="fig" rid="fig2">Figure 2H</xref>). Together, these results indicate that <italic>Stxbp1</italic> haploinsufficient mice do not develop ataxia, but their fine motor coordination and muscle strength are reduced.</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Motor dysfunctions of <italic>Stxbp1</italic> haploinsufficient mice.</title><p>(<bold>A</bold>) Representative tracking plots of the mouse positions in the open-field test. Note that <italic>Stxbp1<sup>tm1d/+</sup></italic> and <italic>Stxbp1<sup>tm1a/+</sup></italic> mice traveled less in the center (dashed box) than WT mice. (<bold>B–E</bold>) Summary data showing hyperactivity and anxiety-like behaviors of <italic>Stxbp1<sup>tm1d/+</sup></italic> and <italic>Stxbp1<sup>tm1a/+</sup></italic> mice in the open-field test. <italic>Stxbp1<sup>tm1d/+</sup></italic> and <italic>Stxbp1<sup>tm1a/+</sup></italic> mice showed an increase in the total moving distance (<bold>B</bold>) and speed (<bold>C</bold>), and a decrease in the ratio of center moving distances over total moving distance (<bold>D</bold>) and vertical activity (<bold>E</bold>). (<bold>F–H</bold>) <italic>Stxbp1<sup>tm1d/+</sup></italic> and <italic>Stxbp1<sup>tm1a/+</sup></italic> mice had weaker forelimb grip strength (<bold>F</bold>), made more foot slips per travel distance on a wire grid (<bold>G</bold>), and took more time to get down from a vertical pole (<bold>H</bold>). The numbers and ages of tested mice are indicated in the figures. Each filled (male) or open (female) circle represents one mouse. Bar graphs are mean ± s.e.m. *, p&lt;0.05; **, p&lt;0.01; ***, p&lt;0.001; ****, p&lt;0.0001.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-48705-fig2-v2.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>Normal performance of <italic>Stxbp1<sup>tm1d/+</sup></italic> mice in rotarod, dowel, inverted screen, and wire hang tests.</title><p>(<bold>A</bold>) In the 2 day rotarod test, 6–7 week old <italic>Stxbp1<sup>tm1d/+</sup></italic> mice performed better than WT mice, as they were able to walk (left panel) and stay (right panel) on the rotating rod for longer time, probably due to their lower body weights or hyperactivity. (<bold>B,C</bold>) Similar to (<bold>A</bold>), but for the ages of 26–27 weeks (<bold>B</bold>) and 61–69 weeks (<bold>C</bold>). <italic>Stxbp1<sup>tm1d/+</sup></italic> mice performed similar to WT mice. (<bold>D</bold>) In the 4 day rotarod test, <italic>Stxbp1<sup>tm1d/+</sup></italic> mice performed similar to WT mice at the age of 10–11 weeks. (<bold>E,F</bold>) <italic>Stxbp1<sup>tm1d/+</sup></italic> mice could stay on the dowel (6.5- or 9.5 mm diameter) for similar amount of time as WT mice. (<bold>G,H</bold>) <italic>Stxbp1<sup>tm1d/+</sup></italic> mice could hang on the screen (<bold>G</bold>) or wire (<bold>H</bold>) for similar amount of time as WT mice. The numbers and ages of tested mice are indicated in the figures. Each filled (male) or open (female) circle represents one mouse. Bar graphs are mean ± s.e.m. n.s., p&gt;0.05; *, p&lt;0.05; **, p&lt;0.01.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-48705-fig2-figsupp1-v2.tif"/></fig><fig id="fig2s2" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 2.</label><caption><title><italic>Stxbp1</italic> haploinsufficient mice have normal sensory functions.</title><p>(<bold>A</bold>) <italic>Stxbp1<sup>tm1d/+</sup></italic> and <italic>Stxbp1<sup>tm1a/+</sup></italic> mice showed similar acoustic startle responses as WT mice at different sound levels. (<bold>B</bold>) In the pre-pulse inhibition test, when a weak sound (74, 78, or 82 dB) preceded a loud sound (120 dB), <italic>Stxbp1<sup>tm1d/+</sup></italic> and <italic>Stxbp1<sup>tm1a/+</sup></italic> mice showed a similar reduction in the startle responses to the loud sound as WT mice. (<bold>C</bold>) In the hot plate test, <italic>Stxbp1<sup>tm1d/+</sup></italic> and <italic>Stxbp1<sup>tm1a/+</sup></italic> mice showed similar latencies in response to the high temperature as WT mice. The numbers and ages of tested mice are indicated in the figures. Each filled (male) or open (female) circle represents one mouse. Bar graphs are mean ± s.e.m. n.s., p&gt;0.05.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-48705-fig2-figsupp2-v2.tif"/></fig></fig-group><p>We next examined the acoustic sensory function and found that <italic>Stxbp1<sup>tm1d/+</sup></italic> and <italic>Stxbp1<sup>tm1a/+</sup></italic> mice showed normal startle responses to different levels of sound (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2A</xref>). To test sensorimotor gating, we measured the pre-pulse inhibition where the startle response to a strong sound is reduced by a preceding weaker sound. <italic>Stxbp1<sup>tm1d/+</sup></italic> and <italic>Stxbp1<sup>tm1a/+</sup></italic> mice displayed similar pre-pulse inhibition as WT mice (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2B</xref>). They also had normal nociception as measured by the hot plate test (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2C</xref>). Thus, the sensory functions and sensorimotor gating of <italic>Stxbp1</italic> haploinsufficient mice are normal.</p></sec><sec id="s2-4"><title>Cognitive functions of <italic>Stxbp1</italic> haploinsufficient mice are severely impaired</title><p>Intellectual disability is a core feature of <italic>STXBP1</italic> encephalopathy, as the vast majority of patients have severe to profound intellectual disability (<xref ref-type="bibr" rid="bib73">Stamberger et al., 2016</xref>). However, the learning and memory deficits described in the previous <italic>Stxbp1</italic> heterozygous knockout mice are mild and inconsistent (<xref ref-type="bibr" rid="bib51">Miyamoto et al., 2017</xref>; <xref ref-type="bibr" rid="bib36">Kovacevic et al., 2018</xref>; <xref ref-type="bibr" rid="bib56">Orock et al., 2018</xref>). To assess cognitive functions, we tested <italic>Stxbp1</italic> haploinsufficient mice in three different paradigms, object recognition, associative learning and memory, and working memory. First, we performed the novel object recognition test that exploits the natural tendency of mice to explore novel objects to evaluate their memories. This task is thought to depend on the hippocampus and cortex (<xref ref-type="bibr" rid="bib2">Antunes and Biala, 2012</xref>; <xref ref-type="bibr" rid="bib14">Cohen and Stackman, 2015</xref>). When tested with an inter-trial interval of 24 hr, WT mice interacted more with the novel object than the familiar object, whereas <italic>Stxbp1<sup>tm1d/+</sup></italic> and <italic>Stxbp1<sup>tm1a/+</sup></italic> mice interacted equally between the familiar and novel objects (<xref ref-type="fig" rid="fig3">Figure 3A</xref>). We also evaluated <italic>Stxbp1<sup>tm1d/+</sup></italic> mice with an inter-trial interval of 5 min and observed a similar deficit (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1A</xref>). We noticed that mutant mice overall spent less time interacting with the objects than WT mice during the trials (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1B</xref>), which might reduce their ‘memory load’ of the objects. We hence allowed <italic>Stxbp1<sup>tm1d/+</sup></italic> mice to spend twice as much time as WT mice in each trial to increase their interaction time with the objects (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1C</xref>), but they still showed a similar deficit in recognition memory (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1D</xref>). Thus, both long-term and short-term recognition memories are impaired in <italic>Stxbp1</italic> haploinsufficient mice.</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Impaired cognition of <italic>Stxbp1</italic> haploinsufficient mice.</title><p>(<bold>A</bold>) In the novel object recognition test with 24 hr testing intervals, the ability of a mouse to recognize the novel object was assessed by the preference index (see Materials and methods). On days 1, 2, 3, and 5, mice were presented with the same two identical objects. In contrast to WT mice, <italic>Stxbp1<sup>tm1d/+</sup></italic> and <italic>Stxbp1<sup>tm1a/+</sup></italic> mice did not show a preference for the novel object on day 4 when they were presented with the familiar object and a novel object. (<bold>B–E</bold>) In the fear conditioning test, <italic>Stxbp1<sup>tm1d/+</sup></italic> and <italic>Stxbp1<sup>tm1a/+</sup></italic> mice at two different ages showed a reduction in both context-induced (<bold>B,D</bold>) and cue-induced (<bold>C,E</bold>) freezing behaviors 24 hr after training. The numbers and ages of tested mice are indicated in the figures. Each filled (male) or open (female) circle represents one mouse. Bar graphs are mean ± s.e.m. ***, p&lt;0.001; ****, p&lt;0.0001.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-48705-fig3-v2.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title><italic>Stxbp1</italic> haploinsufficient mice show an impairment in object recognition and fear memory, but not working memory.</title><p>(<bold>A</bold>) In the novel object recognition test with 5 min testing intervals, <italic>Stxbp1<sup>tm1d/+</sup></italic> mice did not show a preference for the novel object on trial four when they were presented with the familiar and novel objects. (<bold>B</bold>) In the novel object recognition test with 24 hr testing intervals (same as <xref ref-type="fig" rid="fig3">Figure 3A</xref>), <italic>Stxbp1<sup>tm1d/+</sup></italic> mice spent less time interacting with the familiar and novel objects. (<bold>C,D</bold>) In the modified novel object recognition test with 24 hr testing intervals, <italic>Stxbp1<sup>tm1d/+</sup></italic> mice spent similar amount of time interacting with the familiar and novel objects as WT mice (<bold>C</bold>), but they still failed to show a preference for the novel object on day 4 (<bold>D</bold>). (<bold>E</bold>) <italic>Stxbp1<sup>tm1d/+</sup></italic> mice showed a reduction in both contextual (left panel) and cued (right panel) fear memories 1 hr after training. (<bold>F</bold>) In the Y maze spontaneous alternation test that evaluates working memory, <italic>Stxbp1<sup>tm1d/+</sup></italic> mice made similar numbers of choices (left panel) and alternations (right panel) as WT mice. The numbers and ages of tested mice are indicated in the figures. Each filled (male) or open (female) circle represents one mouse. Bar graphs are mean ± s.e.m. n.s., p&gt;0.05; *, p&lt;0.05; **, p&lt;0.01; ***, p&lt;0.001; ****, p&lt;0.0001.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-48705-fig3-figsupp1-v2.tif"/></fig></fig-group><p>Second, we used the Pavlovian fear conditioning paradigm to evaluate associative learning and memory, in which a mouse learns to associate a specific environment (i.e., the context) and a sound (i.e., the cue) with electric foot shocks. The fear memory is manifested by the mouse freezing when it is subsequently exposed to this specific context or cue without electric shocks. At two tested ages, <italic>Stxbp1<sup>tm1d/+</sup></italic> and <italic>Stxbp1<sup>tm1a/+</sup></italic> mice displayed a profound reduction in both context- and cue-induced freezing behaviors when tested 24 hr after the conditioning paradigm (<xref ref-type="fig" rid="fig3">Figure 3B–E</xref>). We also tested <italic>Stxbp1<sup>tm1d/+</sup></italic> mice 1 hr after the conditioning paradigm and observed similar deficits (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1E</xref>). Since the acoustic startle response and nociception are intact in <italic>Stxbp1</italic> haploinsufficient mice (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2A,C</xref>), these results indicate that <italic>Stxbp1</italic> haploinsufficiency impairs both hippocampus-dependent contextual and hippocampus-independent cued fear memories.</p><p>Finally, we used the Y maze spontaneous alternation test to examine working memory, but did not observe significant difference between <italic>Stxbp1<sup>tm1d/+</sup></italic> and WT mice (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1F</xref>). Taken together, our results indicate that both long-term and short-term forms of recognition and associative memories are severely impaired in <italic>Stxbp1</italic> haploinsufficiency mice, but their working memory is intact.</p></sec><sec id="s2-5"><title><italic>Stxbp1</italic> haploinsufficient mice exhibit an increase in anxiety-like and repetitive behaviors</title><p>A number of psychiatric phenotypes including hyperactivity, anxiety, stereotypies, aggression, and autistic features were reported in subsets of <italic>STXBP1</italic> encephalopathy patients. We used a battery of behavioral assays to characterize each of these features in <italic>Stxbp1</italic> haploinsufficiency mice. The open-field test indicates that <italic>Stxbp1</italic> haploinsufficiency mice are hyperactive and more anxious than WT mice (<xref ref-type="fig" rid="fig2">Figure 2A–E</xref>). To specifically assess anxiety-like behaviors, we tested <italic>Stxbp1<sup>tm1d/+</sup></italic> and <italic>Stxbp1<sup>tm1a/+</sup></italic> mice in the elevated plus maze and light-dark chamber tests where a mouse is allowed to explore the open or closed arms of the maze and the clear or black chamber of the box, respectively. <italic>Stxbp1<sup>tm1d/+</sup></italic> and <italic>Stxbp1<sup>tm1a/+</sup></italic> mice entered the open arms and clear chamber less frequently and traveled shorter distance in the open arms and clear chamber than WT mice (<xref ref-type="fig" rid="fig4">Figure 4A–D</xref>; <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1A–D</xref>). Hence, these results confirm the heightened anxiety in <italic>Stxbp1</italic> haploinsufficient mice and are consistent with the previous studies (<xref ref-type="bibr" rid="bib25">Hager et al., 2014</xref>; <xref ref-type="bibr" rid="bib51">Miyamoto et al., 2017</xref>; <xref ref-type="bibr" rid="bib36">Kovacevic et al., 2018</xref>).</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title><italic>Stxbp1</italic> haploinsufficient mice show increased anxiety-like and repetitive behaviors.</title><p>(<bold>A,B</bold>) In the elevated plus maze test, <italic>Stxbp1<sup>tm1d/+</sup></italic> and <italic>Stxbp1<sup>tm1a/+</sup></italic> mice entered the open arms less frequently (<bold>A</bold>) and traveled shorter distance in the open arms (<bold>B</bold>). (<bold>C,D</bold>) In the light-dark chamber test, <italic>Stxbp1<sup>tm1d/+</sup></italic> and <italic>Stxbp1<sup>tm1a/+</sup></italic> mice made less transitions between the light and dark chambers (<bold>C</bold>) and traveled shorter distance in the light chamber (<bold>D</bold>). (<bold>E–G</bold>) In the hole-board test, <italic>Stxbp1<sup>tm1d/+</sup></italic> and <italic>Stxbp1<sup>tm1a/+</sup></italic> mice poked similar numbers of holes as WT mice (<bold>E</bold>) and made similar or more total nose pokes (<bold>F</bold>). They made more repetitive nose pokes (i.e.,≥2 consecutive pokes) than WT mice across different holes (<bold>G</bold>). The numbers and ages of tested mice are indicated in the figures. Each filled (male) or open (female) circle represents one mouse. Bar graphs are mean ± s.e.m. n.s., p&gt;0.05; *, p&lt;0.05; **, p&lt;0.01; ***, p&lt;0.001.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-48705-fig4-v2.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>The movements of <italic>Stxbp1</italic> haploinsufficient mice in elevated plus maze and light-dark chamber tests.</title><p>(<bold>A,B</bold>) In the elevated plus maze test, the total travel distances (<bold>A</bold>) and travel distances in the closed arms (<bold>B</bold>) of <italic>Stxbp1<sup>tm1d/+</sup></italic> and <italic>Stxbp1<sup>tm1a/+</sup></italic> mice were similar or slightly longer than those of WT mice. (<bold>C,D</bold>) In the light-dark chamber test, the total travel distances of <italic>Stxbp1<sup>tm1d/+</sup></italic> mice were reduced (<bold>C</bold>) due to the reduction of their travel distances in the light chamber and normal travel distances in the dark chamber (<bold>D</bold>). The total travel distances of <italic>Stxbp1<sup>tm1a/+</sup></italic> mice were normal (<bold>C</bold>) and their travel distances in the dark chamber was slightly increased as compared to WT mice (<bold>D</bold>). The numbers and ages of tested mice are indicated in the figures. Each filled (male) or open (female) circle represents one mouse. Bar graphs are mean ± s.e.m. n.s., p&gt;0.05; *, p&lt;0.05; **, p&lt;0.01.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-48705-fig4-figsupp1-v2.tif"/></fig></fig-group><p>To assess the stereotyped and repetitive behaviors, we used the hole-board test to measure the pattern of mouse exploratory nose poke (also called head dipping) behavior. As compared to WT mice, <italic>Stxbp1</italic> haploinsufficient mice explored similar numbers of holes (<xref ref-type="fig" rid="fig4">Figure 4E</xref>) and made similar or larger numbers of nose pokes (<xref ref-type="fig" rid="fig4">Figure 4F</xref>). We analyzed the repetitive nose pokes (i.e.,≥2 consecutive pokes) into the same hole as a measure of repetitive behaviors. The mutant mice made more repetitive nose pokes than WT mice across many holes (<xref ref-type="fig" rid="fig4">Figure 4G</xref>), indicating that <italic>Stxbp1</italic> haploinsufficiency in mice causes abnormal stereotypy and repetitive behaviors, a psychiatric feature observed in about 20% of the <italic>STXBP1</italic> encephalopathy patients (<xref ref-type="bibr" rid="bib73">Stamberger et al., 2016</xref>).</p></sec><sec id="s2-6"><title>Social aggression of <italic>Stxbp1</italic> haploinsufficient mice are elevated</title><p>During daily mouse husbandry, we noticed incidences of fighting and injuries of WT and <italic>Stxbp1</italic> haploinsufficient mice in their home cages, but no injuries were observed when <italic>Stxbp1</italic> haploinsufficient mice were singly housed, suggesting that the injuries likely resulted from fighting instead of self-injury. To formally examine aggressive behaviors, we first performed the resident-intruder test, in which a male intruder mouse is introduced into the home cage of a male resident mouse, and the aggressive behaviors of the resident towards the intruder were scored. As compared to WT mice, male resident <italic>Stxbp1<sup>tm1d/+</sup></italic> and <italic>Stxbp1<sup>tm1a/+</sup></italic> mice were more likely to attack and spent more time attacking the intruders (<xref ref-type="fig" rid="fig5">Figure 5A–C</xref>). Another paradigm to assess aggression and social dominance is the tube test, in which two mice are released into the opposite ends of a tube, and the more dominant and aggressive mouse will win the competition by pushing its opponent out of the tube. When <italic>Stxbp1<sup>tm1d/+</sup></italic> and <italic>Stxbp1<sup>tm1a/+</sup></italic> mice were placed against their sex- and age-matched WT littermates, <italic>Stxbp1</italic> haploinsufficient mice won more competitions despite their smaller body sizes (<xref ref-type="fig" rid="fig5">Figure 5D</xref>). Thus, <italic>Stxbp1</italic> haploinsufficiency elevates innate aggression in mice.</p><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title><italic>Stxbp1</italic> haploinsufficient mice show increased aggressive behaviors and reduced nest building and digging behaviors.</title><p>(<bold>A–C</bold>) In the resident-intruder test, male <italic>Stxbp1<sup>tm1d/+</sup></italic> and <italic>Stxbp1<sup>tm1a/+</sup></italic> mice showed a reduction in the latency to attack the male intruder mice (<bold>A</bold>). The total duration (<bold>B</bold>) and number (<bold>C</bold>) of their attacks were increased as compared to WT mice. (<bold>D</bold>) In the tube test, <italic>Stxbp1<sup>tm1d/+</sup></italic> and <italic>Stxbp1<sup>tm1a/+</sup></italic> mice won more competitions against their WT littermates. (<bold>E</bold>) In the three-chamber test, <italic>Stxbp1<sup>tm1d/+</sup></italic> and <italic>Stxbp1<sup>tm1a/+</sup></italic> mice showed a preference in interacting with the partner mouse over the object. (<bold>F,G</bold>) <italic>Stxbp1<sup>tm1d/+</sup></italic> and <italic>Stxbp1<sup>tm1a/+</sup></italic> mice built poor quality nests. The quality of the nests was scored according to the criteria in (<bold>F</bold>) for three consecutive days (<bold>G</bold>). (<bold>H</bold>) <italic>Stxbp1<sup>tm1d/+</sup></italic> and <italic>Stxbp1<sup>tm1a/+</sup></italic> mice buried fewer marbles than WT mice. The numbers and ages of tested mice are indicated in the figures. Each filled (male) or open (female) circle represents one mouse. Bar graphs are mean ± s.e.m. *, p&lt;0.05; **, p&lt;0.01; ***, p&lt;0.001; ****, p&lt;0.0001.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-48705-fig5-v2.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 1.</label><caption><title><italic>Stxbp1</italic> haploinsufficient mice show normal social interactions.</title><p>(<bold>A</bold>) In the partition test, <italic>Stxbp1<sup>tm1d/+</sup></italic> and WT mice showed a similar preference for the novel partner mouse over the familiar partner mouse. The numbers and ages of tested mice are indicated in the figures. Each filled (male) or open (female) circle represents one mouse. Bar graphs are mean ± s.e.m. n.s., p&gt;0.05; **, p&lt;0.01; ***, p&lt;0.001; ****, p&lt;0.0001.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-48705-fig5-figsupp1-v2.tif"/></fig></fig-group><p>To further evaluate social interaction, we performed the three-chamber test where a mouse is allowed to interact with an object or a sex- and age-matched partner mouse. Like WT mice, <italic>Stxbp1<sup>tm1d/+</sup></italic> and <italic>Stxbp1<sup>tm1a/+</sup></italic> mice preferred to interact with the partner mice rather than the objects (<xref ref-type="fig" rid="fig5">Figure 5E</xref>), indicating that <italic>Stxbp1</italic> haploinsufficiency does not compromise general sociability. Interestingly, the mutant mice in fact spent significantly more time than WT mice interacting with the partner mice (p&lt;0.0001 for <italic>Stxbp1<sup>tm1d/+</sup></italic> vs. WT and p=0.0015 for <italic>Stxbp1<sup>tm1a/+</sup></italic> vs. WT), which might be due to the increased aggression of the mutant mice. Furthermore, we used the partition test to examine the preference for social novelty, in which a mouse is allowed to interact with a familiar or novel partner mouse. Both WT and <italic>Stxbp1<sup>tm1d/+</sup></italic> mice preferentially interacted more with the novel partner mice (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1A</xref>). These results indicate that the general sociability and interest in social novelty are normal in <italic>Stxbp1</italic> haploinsufficient mice.</p></sec><sec id="s2-7"><title>Reduced nest building and digging behaviors in <italic>Stxbp1</italic> haploinsufficient mice</title><p>To further assess the well-being and psychiatric phenotypes of <italic>Stxbp1</italic> haploinsufficient mice, we performed the Nestlet shredding test and marble burying test to examine two innate behaviors, nest building and digging, respectively. We provided a Nestlet (pressed cotton square) to each mouse in the home cage and scored the degree of shredding and nest quality after 24, 48, and 72 hr (<xref ref-type="fig" rid="fig5">Figure 5F</xref>). <italic>Stxbp1<sup>tm1d/+</sup></italic> and <italic>Stxbp1<sup>tm1a/+</sup></italic> mice consistently scored lower than WT mice at all time points (<xref ref-type="fig" rid="fig5">Figure 5G</xref>). In the marble burying test, the <italic>Stxbp1<sup>tm1d/+</sup></italic> and <italic>Stxbp1<sup>tm1a/+</sup></italic> mice buried fewer marbles than WT mice (<xref ref-type="fig" rid="fig5">Figure 5H</xref>). The interpretation of marble burying remains controversial, as it may measure anxiety, compulsive-like behavior, or simply digging behavior (<xref ref-type="bibr" rid="bib16">Deacon, 2006</xref>; <xref ref-type="bibr" rid="bib78">Thomas et al., 2009</xref>; <xref ref-type="bibr" rid="bib85">Wolmarans et al., 2016</xref>). Since <italic>Stxbp1</italic> haploinsufficient mice show elevated anxiety and repetitive behaviors, the reduced marble burying likely reflects an impairment of digging behavior, possibly due to the motor deficits. Likewise, the motor deficits may also contribute to the reduced nest building behavior.</p></sec><sec id="s2-8"><title>Cortical hyperexcitability and epileptic seizures in <italic>Stxbp1</italic> haploinsufficient mice</title><p>Another core feature of <italic>STXBP1</italic> encephalopathy is epilepsy with a broad spectrum of seizure types, such as epileptic spasm, focal, tonic, clonic, myoclonic, and absence seizures (<xref ref-type="bibr" rid="bib73">Stamberger et al., 2016</xref>; <xref ref-type="bibr" rid="bib75">Suri et al., 2017</xref>). To investigate if <italic>Stxbp1</italic> haploinsufficient mice have abnormal cortical activity and epileptic seizures, we performed chronic video-electroencephalography (EEG) and electromyography (EMG) recordings in freely moving <italic>Stxbp1<sup>tm1d/+</sup></italic> mice and their sex- and age-matched WT littermates. We implanted three EEG electrodes in the frontal and somatosensory cortices and an EMG electrode in the neck muscles to record intracranial EEG and EMG, respectively, for at least 72 hr (<xref ref-type="fig" rid="fig6">Figure 6A</xref>). The phenotypes of each mouse are summarized in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>. <italic>Stxbp1<sup>tm1d/+</sup></italic> mice exhibited cortical hyperexcitability and several epileptiform activities. First, they had numerous spike-wave discharges (SWDs) that typically were 3–6 Hz and lasted 1–2 s (<xref ref-type="fig" rid="fig6">Figure 6C,E,F</xref>). These oscillations showed similar characteristics to those generalized spike-wave discharges observed in animal models of absence seizures (<xref ref-type="bibr" rid="bib46">Maheshwari and Noebels, 2014</xref>; <xref ref-type="bibr" rid="bib19">Depaulis and Charpier, 2018</xref>). A much smaller number of SWDs with similar characteristics were also observed in WT mice (<xref ref-type="fig" rid="fig6">Figure 6B,E</xref>), consistent with previous studies (<xref ref-type="bibr" rid="bib3">Arain et al., 2012</xref>; <xref ref-type="bibr" rid="bib40">Letts et al., 2014</xref>). On average, the frequency of SWD episodes in <italic>Stxbp1<sup>tm1d/+</sup></italic> mice was more than 40-fold higher than that in WT mice (<xref ref-type="fig" rid="fig6">Figure 6E,F</xref>). Importantly, SWDs frequently occurred in a cluster manner (i.e.,≥5 episodes with an inter-episode-interval of ≤60 s) in <italic>Stxbp1<sup>tm1d/+</sup></italic> mice, which never occurred in WT mice (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1</xref>; <xref ref-type="video" rid="video1">Video 1</xref>). Furthermore, 56 episodes of SWDs from 10 out of 13 <italic>Stxbp1<sup>tm1d/+</sup></italic> mice lasted more than 4 s, among which 54 episodes occurred during rapid eye movement (REM) sleep (<xref ref-type="fig" rid="fig6">Figure 6D</xref>; <xref ref-type="video" rid="video2">Video 2</xref>) and the other two episodes occurred when mice were awake. In contrast, only 1 out of 11 WT mice had 3 episodes of such long SWDs, all of which occurred when mice were awake (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>). In <italic>Stxbp1<sup>tm1d/+</sup></italic> mice, SWDs were most frequent during the night, but occurred throughout the day and night (<xref ref-type="fig" rid="fig6">Figure 6F</xref>), indicating a general cortical hyperexcitability and abnormal synchrony in <italic>Stxbp1</italic> haploinsufficient mice.</p><fig-group><fig id="fig6" position="float"><label>Figure 6.</label><caption><title><italic>Stxbp1<sup>tm1d/+</sup></italic> mice exhibit cortical hyperexcitability and epileptic seizures.</title><p>(<bold>A–D</bold>) Representative EEG traces of the left frontal cortex (L-FC), left somatosensory cortex (L-SC), and right somatosensory cortex (R-SC), and EMG traces of the neck muscle from WT (<bold>A,B</bold>) and <italic>Stxbp1<sup>tm1d/+</sup></italic> mice (<bold>C,D</bold>). Spike-wave discharges (SWDs, indicated by the blue arrows) occurred frequently and often in a cluster manner in <italic>Stxbp1<sup>tm1d/+</sup></italic> mice (see <xref ref-type="video" rid="video1">Video 1</xref>). The gray line-highlighted SWDs from WT and <italic>Stxbp1<sup>tm1d/+</sup></italic> mice were expanded to show the details of the oscillations (<bold>B,C</bold>). A long SWD (i.e.,&gt;4 s) during REM sleep from a <italic>Stxbp1<sup>tm1d/+</sup></italic> mouse is shown in (<bold>D</bold>) (see <xref ref-type="video" rid="video2">Video 2</xref>). (<bold>E</bold>) Summary data showing the overall SWD frequency (left panel), duration (middle panel), and average spike rate (right panel). (<bold>F</bold>) The numbers of SWDs per hour in WT (left Y axis) and <italic>Stxbp1<sup>tm1d/+</sup></italic> (right Y axis) mice are plotted as a function of time of day and averaged over 3 days. (<bold>G</bold>) Video frames showing a myoclonic jump from a <italic>Stxbp1<sup>tm1d/+</sup></italic> mouse (see <xref ref-type="video" rid="video3">Video 3</xref>). The mouse was in REM sleep before the jump. (<bold>H</bold>) Representative EEG and EMG traces showing myoclonic jerks (indicated by the blue arrows) from a <italic>Stxbp1<sup>tm1d/+</sup></italic> mouse (see <xref ref-type="video" rid="video4">Video 4</xref>). Two episodes of myoclonic jerks highlighted by the gray lines were expanded to show that the EEG discharges occurred prior to (the first episode) or simultaneously with (the second episode) the EMG discharges. (<bold>I,J</bold>) Summary data showing the frequencies of two types of myoclonic seizures in different behavioral states. The numbers and ages of recorded mice are indicated in the figures. Each filled (male) or open (female) circle represents one mouse. Bar graphs are mean ± s.e.m. n.s., p&gt;0.05; **, p&lt;0.01; ***, p&lt;0.001; ****, p&lt;0.0001.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-48705-fig6-v2.tif"/></fig><fig id="fig6s1" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 1.</label><caption><title>The clustering of SWDs in <italic>Stxbp1<sup>tm1d/+</sup></italic> mice does not result from a random distribution of frequent SWD episodes.</title><p>(<bold>A–C</bold>) In <italic>Stxbp1<sup>tm1d/+</sup></italic> mice, many SWDs occurred in a cluster manner. A SWD cluster is defined as five or more episodes of SWDs that occur with an inter-episode-interval of 60 s or less. For each <italic>Stxbp1<sup>tm1d/+</sup></italic> mouse, simulations were performed to determine if the clustering of SWD episodes was simply due to the overall high frequencies of episodes. The recorded episodes of SWDs from a <italic>Stxbp1<sup>tm1d/+</sup></italic> mouse were randomly distributed in the same period of time for 10<sup>6</sup> times. The number of SWD clusters was determined from each simulated distribution, and the results of the 10<sup>6</sup> simulations are shown as the probability distribution of the number of SWD clusters for each mouse. The vertical lines with the same color as the probability distribution curves represent the numbers of the recorded SWD clusters in each mouse. The numbers of simulated SWD clusters are all smaller than that of recorded SWD clusters for each <italic>Stxbp1<sup>tm1d/+</sup></italic> mouse (p&lt;10<sup>−6</sup>), demonstrating that a random distribution of the same number of SWD episodes does not result in the same clustering of SWDs in <italic>Stxbp1<sup>tm1d/+</sup></italic> mice.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-48705-fig6-figsupp1-v2.tif"/></fig></fig-group><media id="video1" mime-subtype="mp4" mimetype="video" xlink:href="elife-48705-video1.mp4"><label>Video 1.</label><caption><title><italic>Stxbp1<sup>tm1d/+</sup></italic> mice show clusters of SWDs.</title><p>A representative video showing a SWD cluster in a <italic>Stxbp1<sup>tm1d/+</sup></italic> mouse. The top three traces are EEG signals from the left frontal cortex, right somatosensory cortex, and left somatosensory cortex. The bottom trace is the EMG signal from the neck muscle. The vertical line indicates the time of the current video frame. Note that the EEG signal from the left somatosensory cortex (the third channel) is inverted.</p></caption></media><media id="video2" mime-subtype="mp4" mimetype="video" xlink:href="elife-48705-video2.mp4"><label>Video 2.</label><caption><title><italic>Stxbp1<sup>tm1d/+</sup></italic> mice show long SWDs.</title><p>A representative video showing a long SWD during REM sleep in a <italic>Stxbp1<sup>tm1d/+</sup></italic> mouse. The top three traces are EEG signals from the left frontal cortex, right somatosensory cortex, and left somatosensory cortex. The bottom trace is the EMG signal from the neck muscle. The vertical line indicates the time of the current video frame. Note that the EEG signal from the left somatosensory cortex (the third channel) is inverted.</p></caption></media><p>Second, <italic>Stxbp1<sup>tm1d/+</sup></italic> mice experienced frequent myoclonic seizures that manifested as sudden jumps or more subtle, involuntary muscle jerks associated with EEG discharges (<xref ref-type="fig" rid="fig6">Figure 6G,H</xref>). The large movement artifacts associated with the myoclonic jumps precluded proper interpretation of EEG signals, but this type of myoclonic seizures was observed in all 13 recorded <italic>Stxbp1<sup>tm1d/+</sup></italic> mice and the majority of episodes occurred during REM or non-rapid eye movement (NREM) sleep (<xref ref-type="fig" rid="fig6">Figure 6I</xref>; <xref ref-type="video" rid="video3">Video 3</xref>). There were three similar jumps in 2 out of 11 WT mice that were indistinguishable from those in <italic>Stxbp1<sup>tm1d/+</sup></italic> mice, but all of them occurred when mice were awake (<xref ref-type="fig" rid="fig6">Figure 6I</xref>). Moreover, the more subtle myoclonic jerks occurred frequently and often in clusters in <italic>Stxbp1<sup>tm1d/+</sup></italic> mice, whereas only isolated events were observed in WT mice at a much lower frequency (<xref ref-type="fig" rid="fig6">Figure 6H,J</xref>; <xref ref-type="video" rid="video4">Video 4</xref>). EEG and EMG recordings showed that the cortical EEG spikes associated with the myoclonic jerks occurred before or simultaneously with the neck muscle EMG discharges (<xref ref-type="fig" rid="fig6">Figure 6H</xref>), consistent with the cortical or subcortical origins of myoclonuses, respectively (<xref ref-type="bibr" rid="bib4">Avanzini et al., 2016</xref>).</p><media id="video3" mime-subtype="mp4" mimetype="video" xlink:href="elife-48705-video3.mp4"><label>Video 3.</label><caption><title><italic>Stxbp1<sup>tm1d/+</sup></italic> mice show myoclonic jumps.</title><p>A representative video showing a myoclonic jump of a <italic>Stxbp1<sup>tm1d/+</sup></italic> mouse. The top three traces are EEG signals from the left frontal cortex, right somatosensory cortex, and left somatosensory cortex. The bottom trace is the EMG signal from the neck muscle. The vertical line indicates the time of the current video frame. Note that the EEG signal from the left somatosensory cortex (the third channel) is inverted.</p></caption></media><media id="video4" mime-subtype="mp4" mimetype="video" xlink:href="elife-48705-video4.mp4"><label>Video 4.</label><caption><title><italic>Stxbp1<sup>tm1d/+</sup></italic> mice show myoclonic jerks.</title><p>A representative video showing a myoclonic jerk of a <italic>Stxbp1<sup>tm1d/+</sup></italic> mouse. The top three traces are EEG signals from the left frontal cortex, right somatosensory cortex, and left somatosensory cortex. The bottom trace is the EMG signal from the neck muscle. The vertical line indicates the time of the current video frame. Note that the EEG signal from the left somatosensory cortex (the third channel) is inverted.</p></caption></media></sec><sec id="s2-9"><title>Normal cortical neuron densities in <italic>Stxbp1</italic> haploinsufficient mice</title><p>To identify cellular mechanisms that may underlie the cortical hyperexcitability and neurological deficits in <italic>Stxbp1</italic> haploinsufficient mice, we first examined the general cytoarchitecture and neuronal densities in the somatosensory cortex, as Stxbp1 affects neuronal survival and migration (<xref ref-type="bibr" rid="bib81">Verhage, 2000</xref>; <xref ref-type="bibr" rid="bib26">Hamada et al., 2017</xref>). Immunostaining of a pan-neuronal marker NeuN revealed a grossly normal cytoarchitecture and cortical lamination in adult <italic>Stxbp1<sup>tm1d/+</sup></italic> mice (<xref ref-type="fig" rid="fig7">Figure 7A,B</xref>). The densities of cortical neurons and two major classes of inhibitory neurons, Pv and Sst interneurons, were similar between <italic>Stxbp1<sup>tm1d/+</sup></italic> and WT mice (<xref ref-type="fig" rid="fig7">Figure 7B–D</xref>). Thus, <italic>Stxbp1</italic> haploinsufficiency does not appear to affect cortical neuron survival and migration.</p><fig id="fig7" position="float"><label>Figure 7.</label><caption><title>Cortical neuron densities are unaltered in <italic>Stxbp1<sup>tm1d/+</sup></italic> mice.</title><p>(<bold>A</bold>) Representative fluorescent images of coronal sections stained by antibodies against NeuN (blue), Pv (green), and Sst (magenta). Note the similar cytoarchitecture between WT (upper panel) and <italic>Stxbp1<sup>tm1d/+</sup></italic> (lower panel) mice. (<bold>B</bold>) Representative fluorescent images of the somatosensory cortices within the boxed regions in (<bold>A</bold>) for WT (upper panels) and <italic>Stxbp1<sup>tm1d/+</sup></italic> (lower panels) mice. (<bold>C</bold>) Summary data showing similar densities of neurons (i.e., NeuN positive cells), Pv, and Sst interneurons in the somatosensory cortices of WT and <italic>Stxbp1<sup>tm1d/+</sup></italic> mice. (<bold>D</bold>) Summary data showing that the ratios of Pv and Sst interneurons to all somatosensory cortical neurons are similar between WT and <italic>Stxbp1<sup>tm1d/+</sup></italic> mice. The numbers and ages of mice are indicated in the figures. Each filled (male) or open (female) circle represents one mouse. Bar graphs are mean ± s.e.m. n.s., p&gt;0.05.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-48705-fig7-v2.tif"/></fig></sec><sec id="s2-10"><title><italic>Stxbp1</italic> haploinsufficiency reduces cortical inhibition in a synapse-specific manner</title><p>We next examined neuronal excitability and synaptic transmission in the somatosensory cortex. Whole-cell current clamp recordings of layer 2/3 pyramidal neurons in acute brain slices revealed only a small increase in the input resistances of <italic>Stxbp1<sup>tm1d/+</sup></italic> neurons as compared to WT neurons (<xref ref-type="fig" rid="fig8s1">Figure 8—figure supplement 1</xref>). Previous studies showed that synaptic transmission was reduced in the cultured hippocampal neurons from heterozygous <italic>Stxbp1</italic> knockout mice and human neurons derived from heterozygous <italic>STXBP1</italic> knockout embryonic stem cells (<xref ref-type="bibr" rid="bib79">Toonen et al., 2006</xref>; <xref ref-type="bibr" rid="bib58">Patzke et al., 2015</xref>; <xref ref-type="bibr" rid="bib56">Orock et al., 2018</xref>). However, such a decrease in excitatory transmission onto excitatory neurons is probably inadequate to explain how <italic>Stxbp1</italic> haploinsufficiency in vivo leads to cortical hyperexcitability. Genetic deletion of one copy of <italic>Stxbp1</italic> from GABAergic neurons led to early lethality in a subset of mice, suggesting a crucial role of Stxbp1 in GABAergic neurons <xref ref-type="bibr" rid="bib36">Kovacevic et al. (2018)</xref>, but see <xref ref-type="bibr" rid="bib51">Miyamoto et al. (2017)</xref> and <xref ref-type="bibr" rid="bib52">Miyamoto et al. (2019)</xref>. Thus, we focused on the inhibitory synaptic transmission originating from Pv and Sst interneurons. A Cre-dependent tdTomato reporter line, <italic>Rosa26-CAG-LSL-tdTomato</italic> (<xref ref-type="bibr" rid="bib45">Madisen et al., 2010</xref>), and <italic>Pv-ires-Cre</italic> (<xref ref-type="bibr" rid="bib33">Hippenmeyer et al., 2005</xref>) or <italic>Sst-ires-Cre</italic> (<xref ref-type="bibr" rid="bib76">Taniguchi et al., 2011</xref>) were used to identify Pv or Sst interneurons, respectively. We used whole-cell current clamp to stimulate a single Pv or Sst interneuron in layer 2/3 with a brief train of action potentials and whole-cell voltage clamp to record the resulting unitary inhibitory postsynaptic currents (uIPSCs) in a nearby pyramidal neuron (<xref ref-type="fig" rid="fig8">Figure 8A,E</xref>). The connectivity rate of Pv interneurons to pyramidal neurons was unaltered in <italic>Stxbp1<sup>tm1d/+</sup>;Rosa26<sup>tdTomato/+</sup>;Pv<sup>Cre/+</sup></italic> mice (<xref ref-type="fig" rid="fig8">Figure 8B</xref>), but the unitary connection strength was reduced by 45% as compared to <italic>Stxbp1<sup>+/+</sup>;Rosa26<sup>tdTomato/+</sup>;Pv<sup>Cre/+</sup></italic> mice (<xref ref-type="fig" rid="fig8">Figure 8C</xref>). In contrast, <italic>Stxbp1<sup>tm1d/+</sup>;Rosa26<sup>tdTomato/+</sup>;Sst<sup>Cre/+</sup></italic> mice showed a 26% reduction in the connectivity rate of Sst interneurons to pyramidal neurons (<xref ref-type="fig" rid="fig8">Figure 8F</xref>), but the unitary connection strength was normal (<xref ref-type="fig" rid="fig8">Figure 8G</xref>). The short-term synaptic depression of both inhibitory connections during the train of stimulations was normal (<xref ref-type="fig" rid="fig8">Figure 8D,H</xref>). The inter-soma distances of interneurons and pyramidal neurons were similar between WT and mutant mice (Pv: WT 35.2 ± 2.4 μm, <italic>n</italic> = 33, mutant 33.2 ± 2.5 μm, <italic>n</italic> = 31, p=0.69; Sst: WT 31.4 ± 2.4 μm, <italic>n</italic> = 36, mutant 32.0 ± 2.1 μm, <italic>n</italic> = 36, p=0.65). Furthermore, we recorded the spontaneous excitatory postsynaptic currents (sEPSCs) in Pv and Sst interneurons and did not observe any significant changes of either amplitude or frequency in the mutant mice (<xref ref-type="fig" rid="fig8s2">Figure 8—figure supplement 2</xref>), suggesting that the excitatory drive onto interneurons is normal in <italic>Stxbp1</italic> haploinsufficient mice.</p><fig-group><fig id="fig8" position="float"><label>Figure 8.</label><caption><title>Inhibitory synapses from Pv and Sst interneurons are differentially impaired in <italic>Stxbp1<sup>tm1d/+</sup></italic> mice.</title><p>(<bold>A</bold>) uIPSCs of a layer 2/3 pyramidal neuron (<italic>V<sub>m</sub></italic> = + 10 mV) in the somatosensory cortex (upper panels) evoked by a train of 10 Hz action potentials in a nearby Pv interneuron (lower panels) from WT and <italic>Stxbp1<sup>tm1d/+</sup></italic> mice. 50 individual traces (lighter color) and the average trace (darker color) are superimposed. Note smaller uIPSCs in the <italic>Stxbp1<sup>tm1d/+</sup></italic> neuron. (<bold>B</bold>) Unitary connectivity rates from Pv interneurons to pyramidal neurons were similar between WT (27 connections out of 33 pairs) and <italic>Stxbp1<sup>tm1d/+</sup></italic> (26 connections out of 32 pairs) mice. (<bold>C</bold>) Cumulative frequencies of uIPSC amplitudes evoked by the first action potentials in the trains (median: WT, 217.3 pA; <italic>Stxbp1<sup>tm1d/+</sup></italic>, 127.1 pA). Inset, each filled (male) or open (female) circle represents the uIPSC amplitude of one synaptic connection. (<bold>D</bold>) uIPSC amplitudes during the trains of action potentials were normalized by the amplitudes of the first uIPSCs. Note the similar synaptic depression between WT and <italic>Stxbp1<sup>tm1d/+</sup></italic> neurons. (<bold>E–H</bold>) Similar to (A–D), but for Sst interneurons. Unitary connectivity rates from Sst interneurons to pyramidal neurons (<bold>F</bold>) in <italic>Stxbp1<sup>tm1d/+</sup></italic> mice (25 connections out of 36 pairs) were less than WT mice (34 connections out of 36 pairs). The uIPSC amplitudes evoked by the first action potentials in the trains (G, median: 83.5 pA and 68.0 pA, respectively) and synaptic depression (<bold>H</bold>) were similar between WT and <italic>Stxbp1<sup>tm1d/+</sup></italic> mice. The ages of mice are indicated in the figures. Bar graphs are mean ± s.e.m. n.s., p&gt;0.05; *, p&lt;0.05; **, p&lt;0.01.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-48705-fig8-v2.tif"/></fig><fig id="fig8s1" position="float" specific-use="child-fig"><label>Figure 8—figure supplement 1.</label><caption><title>Intrinsic neuronal excitability of <italic>Stxbp1<sup>tm1d/+</sup></italic> mice is slightly increased.</title><p>(<bold>A</bold>) Membrane potentials (upper panels) in response to current injections (lower panels) in layer 2/3 pyramidal neurons of the somatosensory cortex from WT and <italic>Stxbp1<sup>tm1d/+</sup></italic> mice. (<bold>B–D</bold>) Summary data showing that <italic>Stxbp1<sup>tm1d/+</sup></italic> neurons had similar resting membrane potentials and rheobase currents as WT neurons, but their input resistances were 19% larger than WT neurons. The numbers and ages of recorded neurons are indicated in the figures. Each filled (male) or open (female) circle represents one neuron. Bar graphs are mean ± s.e.m. n.s., p&gt;0.05; *, p&lt;0.05.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-48705-fig8-figsupp1-v2.tif"/></fig><fig id="fig8s2" position="float" specific-use="child-fig"><label>Figure 8—figure supplement 2.</label><caption><title>Spontaneous excitatory inputs onto Pv and Sst interneurons are unaltered in <italic>Stxbp1<sup>tm1d/+</sup></italic> mice.</title><p>(<bold>A,B</bold>) sEPSCs of a Pv (<bold>A</bold>) or Sst (<bold>B</bold>) interneuron (<italic>V<sub>m</sub></italic> = –70 mV) in the layer 2/3 of the somatosensory cortex from WT or <italic>Stxbp1<sup>tm1d/+</sup></italic> mice. (<bold>C,D</bold>) Summary data showing that the frequency and amplitude of sEPSCs in Pv (<bold>C</bold>) and Sst (<bold>D</bold>) interneurons are similar between WT and <italic>Stxbp1<sup>tm1d/+</sup></italic> mice. The numbers and ages of recorded neurons are indicated in the figures. Each filled (male) or open (female) circle represents one neuron. Bar graphs are mean ± s.e.m. n.s., p&gt;0.05.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-48705-fig8-figsupp2-v2.tif"/></fig></fig-group><p>To determine the properties of quantal inhibitory transmission, we developed a new optogenetic method to isolate quantal IPSCs mediated by the GABA release specifically from Pv or Sst interneurons. We expressed a blue light-gated cation channel, channelrhodopsin-2 (ChR2) (<xref ref-type="bibr" rid="bib53">Nagel et al., 2003</xref>; <xref ref-type="bibr" rid="bib9">Boyden et al., 2005</xref>; <xref ref-type="bibr" rid="bib41">Li et al., 2005</xref>), in Pv interneurons by injecting a Cre recombinase-dependent adeno-associated virus (AAV) into the somatosensory cortices of <italic>Stxbp1<sup>tm1d/+</sup>;Pv<sup>Cre/+</sup></italic> and <italic>Stxbp1<sup>+/+</sup>;Pv<sup>Cre/+</sup></italic> mice (<xref ref-type="fig" rid="fig9">Figure 9A</xref>). We recorded miniature IPSCs (mIPSCs) from layer 2/3 pyramidal neurons in the presence of voltage-gated sodium channel blocker, tetrodotoxin (TTX), but without any voltage-gated potassium channel blockers. Under such conditions light activation of ChR2 did not evoke synchronous neurotransmitter release, but could enhance asynchronous exocytosis of synaptic vesicles from Pv interneurons, resulting in an increase in the frequency of mIPSCs (<xref ref-type="fig" rid="fig9">Figure 9B</xref>). We also replaced the extracellular Ca<sup>2+</sup> with Sr<sup>2+</sup> to further reduce the likelihood of synchronous release. Instead of using a constant light intensity, we gradually decreased the photostimulation strength to minimize the tonic currents (<xref ref-type="fig" rid="fig9s1">Figure 9—figure supplement 1</xref>). We mathematically subtracted the mIPSCs recorded during the baseline period (i.e., before blue light stimulation) from those recorded during blue light stimulation to obtain the average amplitude, charge, and decay time constant of Pv interneurons-mediated quantal IPSCs (<xref ref-type="fig" rid="fig9">Figure 9B</xref>), which were all similar between <italic>Stxbp1<sup>tm1d/+</sup>;Pv<sup>Cre/+</sup></italic> and <italic>Stxbp1<sup>+/+</sup>;Pv<sup>Cre/+</sup></italic> mice (<xref ref-type="fig" rid="fig9">Figure 9E</xref>). Using this optogenetic method, we also found that the average amplitude, charge, and decay time constant of quantal IPSCs mediated by Sst interneurons were normal in <italic>Stxbp1<sup>tm1d/+</sup>;Sst<sup>Cre/+</sup></italic> mice (<xref ref-type="fig" rid="fig9">Figure 9C,D,F</xref>). Thus, <italic>Stxbp1</italic> haploinsufficiency does not affect the postsynaptic properties of inhibitory transmission.</p><fig-group><fig id="fig9" position="float"><label>Figure 9.</label><caption><title>Pv and Sst interneurons-mediated quantal IPSCs are isolated by a novel optogenetic method and are unaltered in <italic>Stxbp1<sup>tm1d/+</sup></italic> mice.</title><p>(<bold>A</bold>) Schematic of slice experiments in (<bold>B</bold>). ChR2 in Pv interneurons. (<bold>B</bold>) mIPSCs in a layer 2/3 pyramidal neuron (<italic>V<sub>m</sub></italic> = + 10 mV) from the somatosensory cortex of WT or <italic>Stxbp1<sup>tm1d/+</sup></italic> mice. The intensity of blue light is indicated above the mIPSC traces. Note the increase of mIPSC frequency during blue light stimulation. The quantal IPSC trace was computed by subtracting the average mIPSC trace of the baseline period from that of the light stimulation period (bottom row). (<bold>C,D</bold>) As in (<bold>A,B</bold>), but for ChR2 in Sst interneurons. (<bold>E,F</bold>) Summary data showing that the average amplitude, charge, and decay time constant of Pv (<bold>E</bold>) or Sst (<bold>F</bold>) interneuron-mediated quantal IPSCs are similar between WT and <italic>Stxbp1<sup>tm1d/+</sup></italic> mice. The numbers and ages of recorded neurons are indicated in the figures. Each filled (male) or open (female) circle represents one neuron. Bar graphs are mean ± s.e.m. n.s., p&gt;0.05.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-48705-fig9-v2.tif"/></fig><fig id="fig9s1" position="float" specific-use="child-fig"><label>Figure 9—figure supplement 1.</label><caption><title>Ramping down blue light intensity minimizes the tonic currents during optogenetic activation of interneurons.</title><p>(<bold>A</bold>) Schematic of slice experiments in (<bold>B,C</bold>). ChR2 in Pv interneurons. (<bold>B,C</bold>) mIPSCs of the same layer 2/3 pyramidal neuron (<italic>V<sub>m</sub></italic> = + 10 mV) from the somatosensory cortex of a WT mouse. The intensity of blue light is indicated above the mIPSC traces. Note the increase of tonic currents (i.e., the increase of holding currents) caused by the constant blue light stimulation (<bold>B</bold>), which was reduced by gradually decreasing the blue light intensity (<bold>C</bold>).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-48705-fig9-figsupp1-v2.tif"/></fig></fig-group><p>Altogether, our results indicate that the reduction in the strength of Pv interneuron synapses is most likely due to a decrease in the number of readily releasable vesicles or release probability because the quantal amplitude and connectivity are unaltered in <italic>Stxbp1<sup>tm1d/+</sup></italic> mice. Since Sst interneuron density and overall neuron density are normal in <italic>Stxbp1<sup>tm1d/+</sup></italic> mice (<xref ref-type="fig" rid="fig7">Figure 7</xref>), a reduction in the connectivity rate of Sst interneurons to pyramidal neurons suggests a decrease in the number of inhibitory inputs onto pyramidal neurons. Thus, cortical inhibition mediated by both Pv and Sst interneurons is impaired in <italic>Stxbp1</italic> haploinsufficient mice, representing a likely cellular mechanism for the cortical hyperexcitability, seizures, and neurobehavioral deficits.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>Extensive biochemical and structural studies of Stxbp1/Munc18-1 have elucidated its crucial role in synaptic vesicle exocytosis (<xref ref-type="bibr" rid="bib64">Rizo and Xu, 2015</xref>), but provided little insight into its functional role at the organism level. Hence, apart from being an essential gene, the significance of <italic>STXBP1</italic> dysfunction in vivo was not appreciated until its de novo heterozygous mutations were discovered first in epileptic encephalopathies (<xref ref-type="bibr" rid="bib67">Saitsu et al., 2008</xref>) and later in other neurodevelopmental disorders (<xref ref-type="bibr" rid="bib27">Hamdan et al., 2009</xref>; <xref ref-type="bibr" rid="bib28">Hamdan et al., 2011</xref>; <xref ref-type="bibr" rid="bib62">Rauch et al., 2012</xref>; <xref ref-type="bibr" rid="bib17">Deciphering Developmental Disorders Study, 2015</xref>). In this study, we generated two new lines of <italic>Stxbp1</italic> haploinsufficient mice (<italic>Stxbp1<sup>tm1d/+</sup></italic> and <italic>Stxbp1<sup>tm1a/+</sup></italic>) and systematically characterized them in all of the neurologic and psychiatric domains affected by <italic>STXBP1</italic> encephalopathy. These mice exhibit reduced survival, hindlimb clasping, impaired motor coordination, learning and memory deficits, hyperactivity, increased anxiety-like and repetitive behaviors, aggression, and epileptic seizures. Sensory abnormality has not been documented in <italic>STXBP1</italic> encephalopathy patients (<xref ref-type="bibr" rid="bib73">Stamberger et al., 2016</xref>) and we also did not observe any sensory dysfunctions in <italic>Stxbp1</italic> haploinsufficient mice. Thus, despite the large phenotypic spectrum of <italic>STXBP1</italic> encephalopathy in humans, our <italic>Stxbp1</italic> haploinsufficient mice recapitulate all key features of this neurodevelopmental disorder and are construct and face valid models of <italic>STXBP1</italic> encephalopathy. Importantly, the identical phenotypes of <italic>Stxbp1<sup>tm1d/+</sup></italic> and <italic>Stxbp1<sup>tm1a/+</sup></italic> mice demonstrate the robustness and reproducibility of these preclinical models, providing a foundation to further study the disease pathogenesis and explore therapeutic strategies. About 17% of the <italic>STXBP1</italic> encephalopathy patients showed autistic traits (<xref ref-type="bibr" rid="bib73">Stamberger et al., 2016</xref>), but we and others (<xref ref-type="bibr" rid="bib51">Miyamoto et al., 2017</xref>; <xref ref-type="bibr" rid="bib36">Kovacevic et al., 2018</xref>) did not observe an impairment of social interaction in mutant mice using the three-chamber and partition tests. Perhaps the elevated aggression in <italic>Stxbp1</italic> haploinsufficient mice confounds these tests, or new mouse models that more precisely mimic the genetic alterations in the subset of <italic>STXBP1</italic> encephalopathy patients with autistic features are required to recapitulate this social behavioral phenotype.</p><p>Prior studies using the other three lines of <italic>Stxbp1</italic> heterozygous knockout mouse models reported only a subset of the neurologic and psychiatric deficits that we observed here (<xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>). For example, the reduced survival, hindlimb clasping, motor dysfunction, and increased repetitive behavior were not documented in the previous models. The previously reported cognitive phenotypes were much milder than what we observed. Both <italic>Stxbp1<sup>tm1d/+</sup></italic> and <italic>Stxbp1<sup>tm1a/+</sup></italic> mice showed severe impairments in the novel objection recognition and fear conditioning tests. In contrast, another line of <italic>Stxbp1</italic> heterozygous knockout mice showed normal spatial learning in the Morris water maze and Barnes maze (a dry version of the spatial maze) in one study (<xref ref-type="bibr" rid="bib36">Kovacevic et al., 2018</xref>), but reduced spatial learning and memory in the radial arm water maze in another study (<xref ref-type="bibr" rid="bib56">Orock et al., 2018</xref>). Different behavioral tests could have contributed to such differences among studies. However, a subtle but perhaps key difference is the Stxbp1 protein levels in different lines of heterozygous mutant mice. Stxbp1 is reduced by 40–50% in most brain regions of our <italic>Stxbp1<sup>tm1d/+</sup></italic> and <italic>Stxbp1<sup>tm1a/+</sup></italic> mice, but only by 25–50% in previous heterozygous knockout mice (<xref ref-type="bibr" rid="bib51">Miyamoto et al., 2017</xref>; <xref ref-type="bibr" rid="bib56">Orock et al., 2018</xref>), which may lead to fewer or less severe phenotypes. Furthermore, our study utilized much larger cohorts of mice for phenotypic characterization than previous studies, which allowed us to more comprehensively detect neurologic and psychiatric deficits in <italic>Stxbp1<sup>tm1d/+</sup></italic> and <italic>Stxbp1<sup>tm1a/+</sup></italic> mice.</p><p>Dysfunction of cortical GABAergic inhibition has been widely considered as a primary defect in animal models of autism spectrum disorder, schizophrenia, Down syndrome, and epilepsy among other neurological disorders (<xref ref-type="bibr" rid="bib61">Ramamoorthi and Lin, 2011</xref>; <xref ref-type="bibr" rid="bib47">Marín, 2012</xref>; <xref ref-type="bibr" rid="bib54">Nelson and Valakh, 2015</xref>; <xref ref-type="bibr" rid="bib59">Paz and Huguenard, 2015</xref>; <xref ref-type="bibr" rid="bib15">Contestabile et al., 2017</xref>; <xref ref-type="bibr" rid="bib39">Lee et al., 2017</xref>). In many cases, the origins of GABAergic dysfunction were either unidentified or attributed to Pv interneurons. Sst interneurons have only been directly implicated in a few disease models (<xref ref-type="bibr" rid="bib35">Ito-Ishida et al., 2015</xref>; <xref ref-type="bibr" rid="bib66">Rubinstein et al., 2015</xref>) despite their important physiological functions. Here we identified distinct deficits at Pv and Sst interneuron synapses in <italic>Stxbp1</italic> haploinsufficient mice, suggesting that Stxbp1 may have diverse functions at distinct synapses. The reduction in the strength of Pv interneuron synapses is consistent with the previous results that basal synaptic transmission is reduced at the neuromuscular junctions of <italic>Stxbp1</italic> heterozygous null flies and mice (<xref ref-type="bibr" rid="bib86">Wu et al., 1998</xref>; <xref ref-type="bibr" rid="bib79">Toonen et al., 2006</xref>) and the glutamatergic synapses of human <italic>STXBP1</italic> heterozygous knockout neurons (<xref ref-type="bibr" rid="bib58">Patzke et al., 2015</xref>). The reduced synaptic strength is likely due to a decrease in the number of readily releasable vesicles or release probability given the crucial role of Stxbp1 in synaptic vesicle priming and fusion (<xref ref-type="bibr" rid="bib64">Rizo and Xu, 2015</xref>) and the fact that the quantal amplitude and connectivity are normal in <italic>Stxbp1<sup>tm1d/+</sup></italic> mice. Although the short-term synaptic depression is unaltered in <italic>Stxbp1<sup>tm1d/+</sup></italic> mice, a change in release probability is still possible because at the Pv interneuron synapses the short-term synaptic plasticity during a short train of action potentials is not sensitive to the release probability (<xref ref-type="bibr" rid="bib37">Kraushaar and Jonas, 2000</xref>; <xref ref-type="bibr" rid="bib44">Luthi et al., 2001</xref>). On the other hand, the reduction in the connectivity of Sst interneuron synapses is unexpected, as Stxbp1 has not yet been implicated in the formation or maintenance of synapses. Complete loss of Stxbp1 in mice does not appear to affect the initial formation of neural circuits, but causes cell-autonomous neurodegeneration and protein trafficking defects (<xref ref-type="bibr" rid="bib81">Verhage, 2000</xref>; <xref ref-type="bibr" rid="bib32">Heeroma et al., 2004</xref>; <xref ref-type="bibr" rid="bib38">Law et al., 2016</xref>). Since Munc13-1/2 double knockout mice also lack synaptic exocytosis, but do not show neurodegeneration (<xref ref-type="bibr" rid="bib80">Varoqueaux et al., 2002</xref>), the degeneration phenotype in Stxbp1 null mice is unlikely the result of total arrest of synaptic exocytosis. Thus, Stxbp1 may regulate other intracellular processes in addition to presynaptic transmitter release, and we speculate that it may be involved in a protein trafficking process important for the formation or maintenance of Sst interneuron synapses. Future morphological and structural analyses of Sst interneuron synapses will be necessary to further confirm the involvement of Stxbp1 in synapse formation or maintenance. Nevertheless, the impairment of Pv and Sst interneuron-mediated inhibition likely constitutes a key mechanism underlying the cortical hyperexcitability and neurobehavioral phenotypes of <italic>Stxbp1</italic> haploinsufficient mice. Future studies using cell-type specific <italic>Stxbp1</italic> haploinsufficient mouse models will help determine the role of specific GABAergic interneurons in the disease pathogenesis.</p><p>There are over one hundred developmental brain disorders that arise from mutations in postsynaptic proteins (<xref ref-type="bibr" rid="bib7">Bayés et al., 2011</xref>; <xref ref-type="bibr" rid="bib18">Deciphering Developmental Disorders Study, 2017</xref>), whereas few neurodevelopmental disorders have been diagnosed with mutations in presynaptic proteins until recently. In addition to <italic>STXBP1</italic>, pathogenic variants in genes encoding other key components of the presynaptic neurotransmitter release machinery have been increasingly discovered in neurodevelopmental disorders. These include Ca<sup>2+</sup>-sensor synaptotagmin 1 (<italic>SYT1</italic>), vesicle priming factor unc-13 homolog A (<italic>UNC13A</italic>), and all three components of the neuronal SNAREs, syntaxin 1B (<italic>STX1B</italic>), synaptosome associated protein 25 (<italic>SNAP25</italic>), and vesicle associated membrane protein 2 (<italic>VAMP2</italic>) (<xref ref-type="bibr" rid="bib65">Rohena et al., 2013</xref>; <xref ref-type="bibr" rid="bib70">Schubert et al., 2014</xref>; <xref ref-type="bibr" rid="bib71">Shen et al., 2014</xref>; <xref ref-type="bibr" rid="bib5">Baker et al., 2015</xref>; <xref ref-type="bibr" rid="bib21">Engel et al., 2016</xref>; <xref ref-type="bibr" rid="bib29">Hamdan et al., 2017</xref>; <xref ref-type="bibr" rid="bib43">Lipstein et al., 2017</xref>; <xref ref-type="bibr" rid="bib6">Baker et al., 2018</xref>; <xref ref-type="bibr" rid="bib22">Fukuda et al., 2018</xref>; <xref ref-type="bibr" rid="bib69">Salpietro et al., 2019</xref>; <xref ref-type="bibr" rid="bib84">Wolking et al., 2019</xref>). Haploinsufficiency of these synaptic proteins is likely the leading disease mechanism because the majority of the cases were caused by heterozygous loss-of-function mutations. The clinical features of these disorders are diverse, but significantly overlap with those of <italic>STXBP1</italic> encephalopathy. The most common phenotypes are intellectual disability and epilepsy (or cortical hyperexcitability), which can be considered as the core features of these genetic synaptopathies. Thus, <italic>Stxbp1</italic> haploinsufficient mice are a valuable model to understand the cellular and circuit origins of these complex disorders and provide mechanistic insights into the growing list of neurodevelopmental disorders caused by synaptic dysfunction.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th valign="top">Reagent type <break/>(species) or resource</th><th valign="top">Designation</th><th valign="top">Source or reference</th><th valign="top">Identifiers</th><th valign="top">Additional <break/>information</th></tr></thead><tbody><tr><td valign="top">Cell line <break/>(<italic>M. musculus</italic>)</td><td valign="top"><italic>Stxbp1<sup>tm1a(EUCOMM)Hmgu</sup></italic> embryonic stem cell clones (C57BL/6N strain)</td><td valign="top">European Conditional Mouse Mutagenesis Program (EUCOMM)</td><td valign="top">HEPD0510_5_A09, HEPD0510_5_B10</td><td valign="top"/></tr><tr><td valign="top">Genetic reagent (<italic>M. musculus</italic>)</td><td valign="top"><italic>Stxbp1<sup>tm1a</sup></italic> (C57BL/6J strain)</td><td valign="top">This paper</td><td valign="top"/><td valign="top"/></tr><tr><td valign="top">Genetic reagent <break/>(<italic>M. musculus</italic>)</td><td valign="top"><italic>Stxbp1<sup>tm1d</sup></italic> (C57BL/6J strain)</td><td valign="top">This paper</td><td valign="top"/><td valign="top"/></tr><tr><td valign="top">Genetic reagent (<italic>M. musculus</italic>)</td><td valign="top">B6(Cg)-<italic>Tyr<sup>c-2J</sup></italic>/J</td><td valign="top">The Jackson Laboratory</td><td valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/IMSR_JAX:000058">IMSR_JAX:000058</ext-link></td><td valign="top"/></tr><tr><td valign="top">Genetic reagent <break/>(<italic>M. musculus</italic>)</td><td valign="top"><italic>Rosa26-Flpo</italic> (C57BL/6J strain)</td><td valign="top">The Jackson Laboratory</td><td valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/IMSR_JAX:012930">IMSR_JAX:012930</ext-link></td><td valign="top"/></tr><tr><td valign="top">Genetic reagent (<italic>M. musculus</italic>)</td><td valign="top"><italic>Sox2-Cre</italic> (C57BL/6J strain)</td><td valign="top">The Jackson Laboratory</td><td valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/IMSR_JAX:008454">IMSR_JAX:008454</ext-link></td><td valign="top"/></tr><tr><td valign="top">Genetic reagent (<italic>M. musculus</italic>)</td><td valign="top">C57BL/6J</td><td valign="top">The Jackson Laboratory</td><td valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/IMSR_JAX:000664">IMSR_JAX:000664</ext-link></td><td valign="top"/></tr><tr><td valign="top">Genetic reagent (<italic>M. musculus</italic>)</td><td valign="top"><italic>Pv-ires-Cre</italic> (C57BL/6J strain)</td><td valign="top">The Jackson <break/>Laboratory</td><td valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/IMSR_JAX:017320">IMSR_JAX:017320</ext-link></td><td valign="top"/></tr><tr><td valign="top">Genetic reagent (<italic>M. musculus</italic>)</td><td valign="top"><italic>Sst-ires-Cre</italic> (C57BL/6;129S4 strain)</td><td valign="top">The Jackson Laboratory</td><td valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/IMSR_JAX:013044">IMSR_JAX:013044</ext-link></td><td valign="top"/></tr><tr><td valign="top">Genetic reagent (<italic>M. musculus</italic>)</td><td valign="top"><italic>Rosa26-CAG-LSL-tdTomato</italic> (C57BL/6J strain)</td><td valign="top">The Jackson <break/>Laboratory</td><td valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/IMSR_JAX:007914">IMSR_JAX:007914</ext-link></td><td valign="top"/></tr><tr><td valign="top">Antibody</td><td valign="top">Rabbit anti-Munc18-1, polyclonal</td><td valign="top">Abcam, catalog # ab3451</td><td valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_303813">AB_303813</ext-link></td><td valign="top">(1:2000 or 1:5,000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Rabbit anti-Munc18-1, polyclonal</td><td valign="top">Synaptic Systems, catalog # 116002</td><td valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_887736">AB_887736</ext-link></td><td valign="top">(1:2000 or 1:5,000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Rabbit anti-Gapdh, polyclonal</td><td valign="top">Santa Cruz Biotechnology, catalog #sc-25778</td><td valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_10167668">AB_10167668</ext-link></td><td valign="top">(1:300 or 1:1,000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Goat anti-rabbit IgG <break/>conjugated with IRDye 680LT, polyclonal</td><td valign="top">LI-COR Biosciences, catalog # 925–68021</td><td valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2713919">AB_2713919</ext-link></td><td valign="top">(1:20,000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Rabbit anti-Somatostatin, polyclonal</td><td valign="top">Peninsula Laboratories <break/>International, catalog # T4103.0050</td><td valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_518614">AB_518614</ext-link></td><td valign="top">(1:3,000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Mouse anti-Parvalbumin, monoclonal</td><td valign="top">EMD Millipore, catalog # MAB1572</td><td valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2174013">AB_2174013</ext-link></td><td valign="top">(1:1,000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Guinea pig anti-NeuN, polyclonal</td><td valign="top">Sigma Millipore, catalog # ABN90</td><td valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_11205592">AB_11205592</ext-link></td><td valign="top">(1:1,000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Goat anti-guinea pig IgG (H+L) conjugated with <break/>Alexa Flour 488, polyclonal</td><td valign="top">Invitrogen, catalog # A-11073</td><td valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2534117">AB_2534117</ext-link></td><td valign="top">(1:1,000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Goat anti-mouse IgG (H+L) <break/>conjugated with Alexa Flour 555, polyclonal</td><td valign="top">Invitrogen, catalog # A-21424</td><td valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_141780">AB_141780</ext-link></td><td valign="top">(1:1,000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Goat anti-rabbit IgG (H+L) conjugated with Alexa Flour 647, polyclonal</td><td valign="top">Invitrogen, catalog # A-21245</td><td valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_141775">AB_141775</ext-link></td><td valign="top">(1:1,000)</td></tr><tr><td valign="top">Recombinant DNA reagent</td><td valign="top">pAAV-EF1α-DIO-hChR2(H134R)-P2A-EYFP</td><td valign="top">This paper</td><td valign="top">Addgene: 139283</td><td valign="top">This plasmid was used to produce the AAV vector used in <xref ref-type="fig" rid="fig9">Figure 9</xref>.</td></tr><tr><td valign="top">Transfected construct</td><td valign="top">AAV9-EF1α-DIO-hChR2(H134R)-P2A-EYFP</td><td valign="top">This paper, Baylor College of Medicine Gene Vector Core</td><td valign="top">Addgene: 139283</td><td valign="top">This AAV vector was used in <xref ref-type="fig" rid="fig9">Figure 9</xref>.</td></tr><tr><td valign="top">Software, algorithm</td><td valign="top">Axograph X 1.5.4</td><td valign="top">AxoGraph</td><td valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_014284">SCR_014284</ext-link></td><td valign="top"><ext-link ext-link-type="uri" xlink:href="https://axograph.com">https://axograph.com</ext-link></td></tr><tr><td valign="top">Software, algorithm</td><td valign="top">pClamp 10.7</td><td valign="top">Molecular Devices</td><td valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_011323">SCR_011323</ext-link></td><td valign="top"><ext-link ext-link-type="uri" xlink:href="https://www.moleculardevices.com">https://www.moleculardevices.com</ext-link></td></tr><tr><td valign="top">Software, algorithm</td><td valign="top">Image Studio Lite 5.0</td><td valign="top">LI-COR Biosciences</td><td valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_013715">SCR_013715</ext-link></td><td valign="top"><ext-link ext-link-type="uri" xlink:href="https://www.licor.com">https://www.licor.com</ext-link></td></tr><tr><td valign="top">Software, algorithm</td><td valign="top">MATLAB R2015 to R2017</td><td valign="top">MathWorks</td><td valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_001622">SCR_001622</ext-link></td><td valign="top"><ext-link ext-link-type="uri" xlink:href="https://www.mathworks.com">https://www.mathworks.com</ext-link></td></tr><tr><td valign="top">Software, algorithm</td><td valign="top">Prism 6.0, 7.0, and 8.0</td><td valign="top">GraphPad</td><td valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_002798">SCR_002798</ext-link></td><td valign="top"><ext-link ext-link-type="uri" xlink:href="https://www.graphpad.com">https://www.graphpad.com</ext-link></td></tr><tr><td valign="top">Software, algorithm</td><td valign="top">Spyder 3.3.6 with Anaconda</td><td valign="top">Spyder</td><td valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_017585">SCR_017585</ext-link></td><td valign="top"><ext-link ext-link-type="uri" xlink:href="https://www.spyder-ide.org">https://www.spyder-ide.org</ext-link></td></tr><tr><td valign="top">Software, algorithm</td><td valign="top">Sirenia 1.7.2 to 1.8.3</td><td valign="top">Pinnacle Technology</td><td valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_016183">SCR_016183</ext-link></td><td valign="top"><ext-link ext-link-type="uri" xlink:href="https://www.pinnaclet.com">https://www.pinnaclet.com</ext-link></td></tr><tr><td valign="top">Software, algorithm</td><td valign="top">Imaris 9.2</td><td valign="top">Oxford Instruments</td><td valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_007370">SCR_007370</ext-link></td><td valign="top"><ext-link ext-link-type="uri" xlink:href="https://imaris.oxinst.com">https://imaris.oxinst.com</ext-link></td></tr></tbody></table></table-wrap><sec id="s4-1"><title>Mice</title><p><italic>Stxbp1<sup>tm1a(EUCOMM)Hmgu</sup></italic> embryonic stem (ES) cell clones (C57Bl/6N strain) were obtained from the European Conditional Mouse Mutagenesis Program (EUCOMM) and the targeting was confirmed by Southern blots. Two ES cell clones (HEPD0510_5_A09 and HEPD0510_5_B10) were injected into blastocysts to generate chimeric mice. Germline transmission of clone HEPD0510_5_A09 was obtained by crossing chimeric mice to B6(Cg)-<italic>Tyr<sup>c-2J</sup></italic>/J mice (JAX #000058) to establish the KO-first (<italic>tm1a</italic>) line. Heterozygous KO-first mice were crossed to <italic>Rosa26-Flpo</italic> mice (<xref ref-type="bibr" rid="bib63">Raymond and Soriano, 2007</xref>) to remove the trapping cassette in the germline. The resulting offspring were then crossed to <italic>Sox2-Cre</italic> mice (<xref ref-type="bibr" rid="bib31">Hayashi et al., 2002</xref>) to delete exon seven in the germline to generate the KO (<italic>tm1d</italic>) line. Both <italic>Rosa26-Flpo</italic> and <italic>Sox2-Cre</italic> mice were obtained from the Jackson Laboratory (#012930 and 008454, respectively). <italic>Stxbp1</italic> mice were genotyped by PCR using primer sets 5’-<named-content content-type="sequence">TTCCACAGCCCTTTACAGAAAGG</named-content>-3’ and 5’-<named-content content-type="sequence">ATGTGTATGCCTGGACTCACAGGG</named-content>-3’ for WT allele, 5’-<named-content content-type="sequence">TTCCACAGCCCTTTACAGAAAGG</named-content>-3’ and 5’-<named-content content-type="sequence">CAACGGGTTCTTCTGTTAGTCC</named-content>-3’ for KO-first allele, and 5’-<named-content content-type="sequence">TTCCACAGCCCTTTACAGAAAGG</named-content>-3’ and 5’-<named-content content-type="sequence">TGAACTGATGGCGAGCTCAGACC</named-content>-3’ for KO allele.</p><p>Heterozygous <italic>Stxbp1</italic> KO-first and KO mice were crossed to wild type (WT) C57BL/6J mice (JAX #000664) for maintaining both lines on the C57BL/6J background and for generating experimental cohorts. Male BALB/cAnNTac mice were obtained from Taconic (#BALB-M). <italic>Pv-ires-Cre</italic> (<xref ref-type="bibr" rid="bib33">Hippenmeyer et al., 2005</xref>), <italic>Sst-ires-Cre</italic> (<xref ref-type="bibr" rid="bib76">Taniguchi et al., 2011</xref>), and <italic>Rosa26-CAG-LSL-tdTomato</italic> (<xref ref-type="bibr" rid="bib45">Madisen et al., 2010</xref>) mice were obtained from the Jackson Laboratory (#017320, 013044, and 007914, respectively). <italic>Pv-ires-Cre</italic> and <italic>Rosa26-CAG-LSL-tdTomato</italic> mice were maintained on the C57BL/6J background. <italic>Sst-ires-Cre</italic> mice were on a C57BL/6;129S4 background. Heterozygous KO mice were crossed to <italic>Rosa26-CAG-LSL-tdTomato</italic> mice to generate <italic>Stxbp1<sup>tm1d/+</sup>;Rosa26<sup>tdTomato/ tdTomato</sup></italic> mice. <italic>Pv-ires-Cre</italic> and <italic>Sst-ires-Cre</italic> mice were then crossed to <italic>Stxbp1<sup>tm1d/+</sup>;Rosa26<sup>tdTomato/ tdTomato</sup></italic> mice to generate <italic>Stxbp1<sup>tm1d/+</sup>;Rosa26<sup>tdTomato/+</sup>;Pv<sup>Cre/+</sup></italic> or <italic>Stxbp1<sup>+/+</sup>;Rosa26<sup>tdTomato/+</sup>;Pv<sup>Cre/+</sup></italic> and <italic>Stxbp1<sup>tm1d/+</sup>;Rosa26<sup>tdTomato/+</sup>;Sst<sup>Cre/+</sup></italic> or <italic>Stxbp1<sup>+/+</sup>;Rosa26<sup>tdTomato/+</sup>;Sst<sup>Cre/+</sup></italic> mice, respectively. <italic>Pv-ires-Cre</italic> and <italic>Sst-ires-Cre</italic> mice were also crossed to <italic>Stxbp1<sup>tm1d/+</sup></italic> mice to generate <italic>Stxbp1<sup>tm1d/+</sup>;Pv<sup>Cre/+</sup></italic> or <italic>Stxbp1<sup>+/+</sup>;Pv<sup>Cre/+</sup></italic> and <italic>Stxbp1<sup>tm1d/+</sup>;Sst<sup>Cre/+</sup></italic> or <italic>Stxbp1<sup>+/+</sup>;Sst<sup>Cre/+</sup></italic> mice, respectively.</p><p>Mice were housed in an Association for Assessment and Accreditation of Laboratory Animal Care International-certified animal facility on a 14 hr/10 hr light/dark cycle. All procedures to maintain and use mice were approved by the Institutional Animal Care and Use Committee at Baylor College of Medicine.</p></sec><sec id="s4-2"><title>Southern and Western blots</title><p>Southern and Western blot analyses were performed according standard protocols. For Southern blots, genomic DNA was extracted from ES cells and digested with BspHI for the 5’ probe or MfeI for the 3’ probe (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A</xref>). <sup>32</sup>P-labeled probes were used to detect DNA fragments. For Western blots, proteins were extracted from the brains at embryonic day 17.5 or 3 months of age using lysis buffer containing 50 mM Tris-HCl (pH 7.6), 150 mM NaCl, 1 mM EDTA, 1% Triton X-100, 0.5% Na-deoxycholate, 0.1% SDS, and 1 tablet of cOmplete, Mini, EDTA-free Protease Inhibitor Cocktail (Roche) in 10 ml buffer. Stxbp1 was detected by a rabbit antibody against the N terminal residues 58–70 (Abcam, catalog # ab3451, lot # GR79394-18, 1:2000 or 1:5000 dilution) or a rabbit antibody against the C terminal residues 580–594 (Synaptic Systems, catalog # 116002, lot # 116002/15, 1:2000 or 1:5000 dilution). Gapdh was detected by a rabbit antibody (Santa Cruz Biotechnology, catalog # sc-25778, lot # A0515, 1:300 or 1:1000 dilution). Primary antibodies were detected by a goat anti-rabbit antibody conjugated with IRDye 680LT (LI-COR Biosciences, catalog # 925–68021, lot # C40917-01, 1:20,000 dilution). Proteins were visualized and quantified using an Odyssey CLx Imager and Image Studio Lite 5.0 (LI-COR Biosciences).</p></sec><sec id="s4-3"><title>Immunohistochemistry and fluorescent microscopy</title><p>Mice were anesthetized by an intraperitoneal injection of a ketamine and xylazine mix (80 mg/kg and 16 mg/kg, respectively) and transcardially perfused with phosphate buffered saline (PBS, pH 7.4) followed by 4% paraformaldehyde in PBS (pH 7.4). Brains were then post-fixed for 2 hr in 4% paraformaldehyde at 4°C, cryoprotected with 30% sucrose, and sectioned into 50 µm coronal slices using a HM 450 Sliding Microtome (Thermo Scientific). Brain sections were stored in an ethylene glycol:glycerol:PBS solution (1:1:1.3) until use. Sections containing the somatosensory cortex were incubated in blocking solution (0.2% Triton X-100 in PBS with 10% normal goat serum) for 2 hr and then with primary antibodies for 48 hr at 4°C. Primary antibodies were diluted in the blocking solution: rabbit anti-Somatostatin (Peninsula Laboratories International, catalog # T4103.0050, lot # A17908, 1:3000), mouse anti-Parvalbumin (EMD Millipore, catalog # MAB1572, lot # 2982272, 1:1000), and guinea pig anti-NeuN (Sigma Millipore, catalog # ABN90, lot # 3253333, 1:1000). Sections were washed in 0.2% Triton X-100 in PBS and then incubated with the following secondary antibodies diluted 1:1000 in blocking solution for 24 hr at 4°C: goat anti-guinea pig IgG (H+L) conjugated with Alexa Flour 488 (Invitrogen, catalog # A-11073, lot # 1841755), goat anti-mouse IgG (H+L) conjugated with Alexa Flour 555 (Invitrogen, catalog # A-21424, lot # 1588453), goat anti-rabbit IgG (H+L) conjugated with Alexa Flour 647 (Invitrogen, catalog # A-21245, lot # 1623067). Sections were washed in 0.2% Triton X-100 in PBS and mounted in ProLong Diamond Antifade Mountant with DAPI (Invitrogen, catalog # P36962).</p><p>Low magnification images of brain sections were acquired on an Axio Zoom.V16 Fluorescence Stereo Zoom Microscope (Zeiss). High magnification, tile scanned z-stack images of the primary somatosensory cortex were acquired on an Sp8X Confocal Microscope (Leica) using a 20 × oil objective. Three brain sections were imaged and quantified per mouse. Approximately 50 images were acquired per tile scan with a 5% overlap between images for tiling. The z-stack was centered in the middle of the brain section and 10 optical sections were taken at 0.39 μm step. For analysis, the three optical sections in the middle of the z-stack were processed using the ‘Sum Slices’ function in ImageJ (National Institutes of Health) and then the images were cropped to a region of approximately 2 mm<sup>2</sup> spanning all cortical layers. Within this region, each Pv or Sst interneuron was confirmed to be co-labeled with DAPI and NeuN and counted manually. The numbers of NeuN positive cells were estimated using the Surfaces function in Imaris 9.2 (Oxford Instruments) with the following parameters: surface grain size = 0.568 μm, eliminating background of largest sphere = 9 μm diameter, threshold = 30, seed point diameter = 7 μm, seed point quality = 10, and number of voxels &lt; 200. Accuracy of surface detection was verified by manually counting NeuN positive cells in images containing about 200 cells and the error rate was less than 10%.</p></sec><sec id="s4-4"><title>DNA construct, AAV production, and injection</title><p>Plasmid pAAV-EF1α-DIO-hChR2(H134R)-P2A-EYFP was generated by replacing the hChR2(C128A H134R) in pAAV-EF1α-DIO-hChR2(C128A H134R)-P2A-EYFP (<xref ref-type="bibr" rid="bib60">Prakash et al., 2012</xref>) with the hChR2(H134R) from pAAV-EF1α-DIO-hChR2(H134R)-EYFP (Addgene #20298) and was deposited at Addgene (#139283). The recombinant AAV vectors were produced by the Gene Vector Core at Baylor College of Medicine. To express ChR2 in Pv or Sst interneurons, 200 nl of AAV9-EF1α-DIO-hChR2(H134R)-P2A-EYFP vectors (3 × 10<sup>13</sup> genome copies/ml) were injected into the somatosensory cortex of <italic>Stxbp1<sup>tm1d/+</sup>;Pv<sup>Cre/+</sup></italic> and <italic>Stxbp1<sup>+/+</sup>;Pv<sup>Cre/+</sup></italic> or <italic>Stxbp1<sup>tm1d/+</sup>;Sst<sup>Cre/+</sup></italic> and <italic>Stxbp1<sup>+/+</sup>;Sst<sup>Cre/+</sup></italic> mice, respectively, at postnatal day 1–5 as previously described (<xref ref-type="bibr" rid="bib87">Xue et al., 2014</xref>; <xref ref-type="bibr" rid="bib48">Messier et al., 2018</xref>) with an UltraMicroPump III and a Micro4 controller (World Precision Instruments).</p></sec><sec id="s4-5"><title>Behavioral tests</title><p>All behavioral experiments except the tube test were performed and analyzed blind to the genotypes. The numbers of mice needed were estimated based on previous studies using similar behavioral tests. Approximately equal numbers of <italic>Stxbp1</italic> mutant mice and their sex- and age-matched WT littermates of both sexes were tested in parallel in each experiment except the resident-intruder test where only male mice were used. In each cage, two mutant and two WT mice were housed together. Before all behavioral tests, mice were habituated in the behavioral test facility for at least 30 min. The sexes and ages of the tested mice were indicated in the figures.</p><sec id="s4-5-1"><title>Open-field test</title><p>A mouse was placed in the center of a clear, open chamber (40 × 40 × 30 cm) and allowed to freely explore for 30 min in the presence of 700–750 lux illumination and 65 dB background white noise. In each chamber, two layers of light beams (16 for each layer) in the horizontal X and Y directions capture the locomotor activity of the mouse. The horizontal plane was evenly divided into 256 squares (16 × 16), and the center zone is defined as the central 100 squares (10 × 10). The horizontal travel and vertical activity were quantified by either an Open Field Locomotor system or a VersaMax system (OmniTech).</p></sec><sec id="s4-5-2"><title>Rotarod test</title><p>A mouse was placed on an accelerating rotarod apparatus (Ugo Basile). Each trial lasted for a maximum of 5 min, during which the rod accelerated linearly from 4 to 40 revolutions per minute (RPM) or 8 to 80 RPM. The time when the mouse walks on the rod and the latency for the mouse to fall from the rod were recorded for each trial. Mice were tested in four trials per day for two consecutive days or in three trials per day for four consecutive days. There was a 30–60 min resting interval between trials.</p></sec><sec id="s4-5-3"><title>Dowel test</title><p>A mouse was placed in the center of a horizontal dowel (6.5 mm or 9.5 mm diameter) and the latency to fall was measured with a maximal cutoff time of 120 s.</p></sec><sec id="s4-5-4"><title>Inverted screen test</title><p>A mouse was placed onto a wire grid, and the grid was carefully picked up and shaken a couple of times to ensure that the mouse was holding on. The grid was then inverted such that the mouse was hanging upside down from the grid. The latency to fall was measured with a maximal cutoff time of 60 s.</p></sec><sec id="s4-5-5"><title>Wire hang test</title><p>A mouse was suspended by its forepaws on a 1.5 mm wire and the latency to fall was recorded with a maximal cutoff time of 60 s.</p></sec><sec id="s4-5-6"><title>Foot slip test</title><p>A mouse was placed onto an elevated 40 × 25 cm wire grid (1 × 1 cm spacing) and allowed to freely move for 5 min. The number of foot slips was manually counted, and the moving distance was measured through a video camera (ANY-maze, Stoelting). The number of foot slips were normalized by the moving distance for each mouse.</p></sec><sec id="s4-5-7"><title>Vertical pole test</title><p>A mouse was placed head-upward at the top of a vertical threaded metal pole (1.3 cm diameter, 55 cm length). The amount of time for the mouse to turn around and descend to the floor was measured with a maximal cutoff time of 120 s.</p></sec><sec id="s4-5-8"><title>Grip strength</title><p>Forelimb grip strength was measured using a Grip Strength Meter (Columbus Instruments). A mouse was held by the tail and allowed to grasp a trapeze bar with its forepaws. Once the mouse grasped the bar with both paws, the mouse was pulled away from the bar until the bar was released. The digital meter displayed the level of tension exerted on the bar in gram-force (gf).</p></sec><sec id="s4-5-9"><title>Acoustic startle response test</title><p>A mouse was placed in a well-ventilated, clear plastic cylinder and acclimated to the 70 dB background white noise for 5 min. The mouse was then tested with four blocks. Each block consisted of 13 trials, during which each of 13 different levels of sound (70, 74, 78, 82, 86, 90, 94, 98, 102, 106, 110, 114, or 118 dB, 40 ms, inter-trial interval of 15 s on average) was presented in a pseudorandom order. The startle response was recorded for 40 ms after the onset of the sound. The rapid force changes due to the startles were measured by an accelerometer (SR-LAB, San Diego Instruments).</p></sec><sec id="s4-5-10"><title>Pre-pulse inhibition test</title><p>A mouse was placed in a well-ventilated, clear plastic cylinder and acclimated to the 70 dB background noise for 5 min. The mouse was then tested with six blocks. Each block consisted of 8 trials in a pseudorandom order: a ‘no stimulus’ trial (40 ms, only 70 dB background noise present), a test pulse trial (40 ms, 120 dB), three different pre-pulse trials (20 ms, 74, 78, or 82 dB), and three different pre-pulse inhibition trials (a 20-ms, 74, 78, or 82-dB pre-pulse preceding a 40-ms, 120-dB test pulse by 100 milliseconds). The startle response was recorded for 40 ms after the onset of the 120 dB test pulse. The inter-trial interval is 15 s on average. The rapid force changes due to the startles were measured by an accelerometer (SR-LAB, San Diego Instruments). Pre-pulse inhibition of the startle responses was calculated as ‘1 – (pre-pulse inhibition trial/test pulse trial)'.</p></sec><sec id="s4-5-11"><title>Hot plate test</title><p>A mouse was placed on a hot plate (Columbus Instruments) with a constant temperature of 55°C. The latency for the mouse to first respond with either a hind paw lick, hind paw flick, or jump was measured. If the mouse did not respond within 45 s, then the test was terminated, and the latency was considered to be 45 s.</p></sec><sec id="s4-5-12"><title>Novel object recognition test</title><p>A mouse was first habituated in an empty arena (24 × 45 × 20 cm) for 5 min before every trial. The habituated mouse was then placed into the testing arena with two identical objects (i.e., familiar object 1 and familiar object 2) for the first three trials. In the fourth trial, familiar object 1 was replaced with a novel object.. In the fifth trial, the mouse was presented with the two original, identical objects again. Each trial lasted 5 min. The inter-trial interval was 24 hr or 5 min. In the modified version, <italic>Stxbp1<sup>tm1d/+</sup></italic> and WT mice were exposed to the objects for 10 and 5 min during each trial, respectively. The movement of mice was recorded by a video camera placed above the test arena. The amount of time that the mouse interacted with the objects (<italic>T</italic>) was recorded using a wireless keyboard (ANY-maze, Stoelting). The preference index of interaction was calculated as <italic>T<sub>familiar object 1</sub> /(T<sub>familiar object 1</sub> + T<sub>familiar object 2</sub>)</italic> for the first three trials and fifth trial and as <italic>T<sub>novel object</sub>/(T<sub>novel object</sub> + T<sub>familiar object 2</sub>)</italic> for the fourth trial.</p></sec><sec id="s4-5-13"><title>Fear conditioning test</title><p>Pavlovian fear conditioning was conducted in a chamber (30 × 25 × 29 cm) that has a grid floor for delivering electrical shocks (Coulbourn Instruments). A camera above the chamber was used to monitor the mouse. During the 5 min training phase, a mouse was placed in the chamber for 2 min, and then a sound (85 dB, white noise) was turned on for 30 s immediately followed by a mild foot shock (2 s, 0.72 mA). The same sound and foot shock were repeated one more time 2 min after the first foot shock. After the second foot shock, the mouse stayed in the training chamber for 18 s before returning to its home cage. After 1 or 24 hr, the mouse was tested for the contextual and cued fear memories. In the contextual fear test, the mouse was placed in the same training chamber and its freezing behavior was monitored for 5 min without the sound stimulus. The mouse was then returned to its home cage. One to two hours later, the mouse was transferred to the chamber after it has been altered using plexiglass inserts and a different odor to create a new context for the cued fear test. After 3 min in the chamber, the same sound cue that was used in the training phase was turned on for 3 min without foot shocks while the freezing behavior was monitored. The freezing behavior was scored using an automated video-based system (FreezeFrame, Actimetrics). The freezing time (%) during the first 2 min of the training phase (i.e., before the first sound) was subtracted from the freezing time (%) during the contextual fear test. The freezing time (%) during the first 3 min of the cued fear test (i.e., without sound) was subtracted from the freezing time (%) during the last 3 min of the cued fear test (i.e., with sound).</p></sec><sec id="s4-5-14"><title>Y maze spontaneous alternation test</title><p>A mouse was placed in the center of a Y-shaped maze consisting of three walled arms (35 × 5 × 10 cm) and allowed to freely explore the different arms for 10 min. The sequence of the arms that the mouse entered was recorded using a video camera (ANY-maze, Stoelting). The correct choice refers to when the mouse entered an alternate arm after it came out of one arm.</p></sec><sec id="s4-5-15"><title>Elevated plus maze test</title><p>A mouse was placed in the center of an elevated maze consisting of two open arms (25 × 8 cm) and two closed arms with high walls (25 × 8 × 15 cm). The mouse was initially placed facing the open arms and then allowed to freely explore for 10 min in the presence of 700–750 lux illumination and 65 dB background white noise. The mouse activity was recorded using a video camera (ANY-maze, Stoelting).</p></sec><sec id="s4-5-16"><title>Light-dark chamber test</title><p>A mouse was placed in a rectangular light-dark chamber (44 × 21 × 21 cm) and allowed to freely explore for 10 min in the presence of 700–750 lux illumination and 65 dB background white noise. One third of the chamber is made of black plexiglass (dark) and two thirds is made of clear plexiglass (light) with a small opening between the two areas. The movement of the mouse was tracked by the Open Field Locomotor system (OmniTech).</p></sec><sec id="s4-5-17"><title>Hole-board test</title><p>A mouse was placed at the center of a clear chamber (40 × 40 × 30 cm) that contains a black floor with 16 evenly spaced holes (5/8-inch diameter) arranged in a 4 × 4 array. The mouse was allowed to freely explore for 10 min. Its open-field activity above the floorboard and nose pokes into the holes were detected by infrared beams above and below the hole board, respectively, using the VersaMax system (OmniTech).</p></sec><sec id="s4-5-18"><title>Resident-intruder test</title><p>Male test mice (resident mice) were individually caged for 2 weeks before testing. Age-matched male white BALB/cAnNTac mice (Taconic) were group-housed to serve as the intruders. During the test, an intruder was placed into the home cage of a test mouse for 10 min and their behaviors were video recorded. Videos were scored for the number and duration of each attack by the resident mouse regardless the attack was initiated by either the resident or intruder.</p></sec><sec id="s4-5-19"><title>Tube test</title><p>A pair of a mutant mouse and an age- and sex-matched WT mouse that were housed in different home cages were placed into the opposite ends of a clear acrylic, cylindrical tube (3.5 cm diameter). The mouse that retreats backwards first was considered as the loser. The winner was scored as 1 and the loser as 0. Each mutant mouse was tested against three different WT mice and the scores were averaged.</p></sec><sec id="s4-5-20"><title>Three-chamber test</title><p>The apparatus (60.8 × 40.5 × 23 cm) consists of three chambers (left, center, and right) of equal size with 10 × 5 cm openings between the chambers. WT C57BL/6J mice were used as partner mice. A test mouse was placed in the apparatus with a mesh pencil cup in each of the left and right chambers and allowed to freely explore for 10 min. A novel object was then placed under one mesh pencil cup and an age- and sex-matched partner mouse under the other mesh pencil cup. The test mouse was allowed to freely explore for another 10 min. The position of the test mouse was tracked through a video camera (ANY-maze, Stoelting), and the approaches of the test mouse to the object or partner mouse were scored manually using a wireless keyboard. Partner mice were habituated to the mesh pencil cups in the apparatus for 1 hr per day for 2 days prior to testing. A partner mouse was used only in one test per day.</p></sec><sec id="s4-5-21"><title>Partition test</title><p>The partitioned cage is a standard mouse cage (28.5 × 17.5 × 12 cm) divided in half with a clear perforated partition (a hole of 0.6 cm diameter). WT C57BL/6J mice were used as partner mice. A test mouse was housed in one side of the partitioned cage for overnight. In the afternoon before testing, an age- and sex-matched partner mouse was placed in the opposite half of the partitioned cage. On the next day, the time and number of approaches of the test mouse to the partition were scored using a handheld Psion event recorder (Observer, Noldus) in three 5 min tests. The first test measured the approaches with the familiar overnight partner. The second measured the approaches with a novel partner mouse. The third test measured the approaches with the returned original partner mouse.</p></sec><sec id="s4-5-22"><title>Nestlet shredding test</title><p>A mouse was individually housed in its home cage and an autoclaved Nestlet was given to the mouse. The quality of the nest was assessed every 24 hr for three consecutive days.</p></sec><sec id="s4-5-23"><title>Marble burying test</title><p>A clean standard housing cage was filled with approximately 8 cm deep bedding material. 20 marbles were arranged on top of the bedding in a 4 × 5 array. A mouse was placed into this cage and remained undisturbed for 30 min before returning to its home cage. The number of buried marbles (i.e., at least 2/3 of the marble covered by the bedding) was recorded.</p></sec></sec><sec id="s4-6"><title>Video-EEG/EMG</title><p>Mice at 3–4 weeks of age were anesthetized with 1.5–2.5% isoflurane in oxygen, and the body temperature was maintained by a feedback-based DC temperature control system at 37°C. The head was secured in a stereotaxic apparatus and an incision was made along the midline to expose the skull. Craniotomies (approximate diameter of 0.25 mm) were performed with a round bur (0.25 mm diameter) and a high-speed rotary micromotor at coordinates (see below) that were normalized by the distance between Bregma and Lambda (DBL). Perfluoroalkoxy polymer (PFA)-coated silver wire electrodes (127 µm bare diameter, 177.8 µm coated diameter, A-M Systems) were used for grounding, referencing, and recording. A grounding electrode was placed on the right frontal cortex. An EEG reference electrode was placed on the cerebellum. Three EEG electrodes were placed on the left frontal cortex (anterior posterior (AP): 0.42 of DBL, medial lateral (ML): 0.356 of DBL, dorsal ventral (DV): −1.5 mm), left, and right somatosensory cortices (AP: −0.34 of DBL, ML: ±0.653 of DBL, DV: −1.5 mm). An EMG recording and an EMG reference electrode were inserted into the neck muscles. All the electrodes were connected to an adapter that was secured on the skull by dental acrylic. The skin around the wound was sutured and mice were returned to the home cage to recover for at least one week. Before recording, mice were individually habituated in the recording chambers (10-inch diameter of plexiglass cylinder with bedding and access to food and water) for 24 hr. EEG/EMG signals were sampled at 5000 Hz with a 0.5 Hz high-pass filter and synchronous videos were recorded at 30 frames per second from freely moving mice for continuous 72 hr using a 4-channel EEG/EMG tethered system (Pinnacle Technology).</p><p>To detect spike-wave discharges (SWDs), EEG signals of each channel were divided into 10 min segments and each segment was filtered by a third order Butterworth bandpass filter with 0.5–400 Hz cutoffs. The filtered data was divided into 250-ms non-overlapping epochs. EEG signal changes that occurred in the time domain were captured by root mean square (<inline-formula><mml:math id="inf1"><mml:mi>R</mml:mi><mml:mi>M</mml:mi><mml:mi>S</mml:mi><mml:mo>=</mml:mo><mml:msqrt><mml:mrow><mml:mrow><mml:mrow><mml:msubsup><mml:mo>∑</mml:mo><mml:mrow><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mi>n</mml:mi></mml:mrow></mml:msubsup><mml:mrow><mml:msubsup><mml:mrow><mml:mi>s</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msubsup></mml:mrow></mml:mrow></mml:mrow><mml:mo>/</mml:mo><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:mrow></mml:msqrt></mml:math></inline-formula>; <italic>s</italic>, EEG signal; <italic>n</italic> = 1250) and spike density (number of spikes normalized to each epoch). EEG signal changes that occurred in the frequency domain were captured by frequency band ratio (<inline-formula><mml:math id="inf2"><mml:mi>F</mml:mi><mml:mi>B</mml:mi><mml:mi>R</mml:mi><mml:mo>=</mml:mo><mml:mrow><mml:msubsup><mml:mo>∑</mml:mo><mml:mrow><mml:mi>n</mml:mi><mml:mo>=</mml:mo><mml:mi>f</mml:mi><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>n</mml:mi><mml:mo>=</mml:mo><mml:mi>f</mml:mi><mml:mn>2</mml:mn></mml:mrow></mml:msubsup><mml:mrow><mml:mi>A</mml:mi><mml:mi>B</mml:mi><mml:mi>S</mml:mi><mml:mo>(</mml:mo><mml:mi>F</mml:mi><mml:mi>F</mml:mi><mml:mi>T</mml:mi><mml:mfenced separators="|"><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:mfenced><mml:mo>)</mml:mo><mml:mo>/</mml:mo><mml:mrow><mml:msubsup><mml:mo>∑</mml:mo><mml:mrow><mml:mi>n</mml:mi><mml:mo>=</mml:mo><mml:mi>f</mml:mi><mml:mn>3</mml:mn></mml:mrow><mml:mrow><mml:mi>n</mml:mi><mml:mo>=</mml:mo><mml:mi>f</mml:mi><mml:mn>4</mml:mn></mml:mrow></mml:msubsup><mml:mrow><mml:mi>A</mml:mi><mml:mi>B</mml:mi><mml:mi>S</mml:mi><mml:mo>(</mml:mo><mml:mi>F</mml:mi><mml:mi>F</mml:mi><mml:mi>T</mml:mi><mml:mfenced separators="|"><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:mfenced><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:mrow></mml:mrow></mml:math></inline-formula>; <italic>f1</italic> = 100; <italic>f2</italic> = 300; <italic>f3</italic> = 0.5; <italic>f4</italic> = 80) where the power of the upper band (100–300 Hz) was contrasted with that of the lower band (0.5–80 Hz). The above features were computed in MATLAB. An EEG segment that exceeded the thresholds for all of the above features was identified as a SWD candidate. The candidates were further classified by a convolutional neural network in Spyder (Spyder) that was trained with manually labeled EEG segments. The first layer of the network contained 32 filters that returned their matches with 10-ms (kernel size) non-overlapping (stride) candidate segments across the three EEG channels. Successive convolutional layers were stacked sequentially. For every two consecutive convolutional layers, there was a pooling layer that down-sampled the outputs by a factor of 5 to reduce computation. The overall network consisted of two layers of 32 filters, one layer of pooling, two layers of 64 filters, one layer of pooling, two layers of 128 filters, and one layer of pooling. The network was trained through an iterative approach. In each training iteration, the optimizer (Adadelta) updated the weights of the filters and the loss function (binary cross entropy) evaluated how well the network predicted SWDs. This iteration process continued until the loss function was minimized. Methods implemented to reduce overfitting included dropout (i.e., 50% of the neurons were randomly dropped out from calculation for each iteration) and early stopping (i.e., training process was stopped when the loss function on validation set did not decrease for three iterations). The trained neural network removed 99% of the false-positive candidates and the remaining candidates were further confirmed by visual inspection. For each SWD, the duration (the time difference between the first and last peaks) and spike rate were quantified. The SWD cluster was defined as a cluster of 5 or more SWD episodes that occurred with inter-episode-interval of maximal 60 s.</p><p>To identify myoclonic seizures, the EEG/EMG traces and videos were visually inspected to identify sudden jumps and myoclonic jerks. When the mouse suddenly and quickly move the body in less than one second, if one or more limbs leave the cage floor, then this is classified as a sudden jump. If all limbs stay on the cage floor, then this is classified as a myoclonic jerk. The state of the mouse right before the myoclonic seizure was classified as REM sleep, NREM sleep, or awake based on the EEG/EMG.</p></sec><sec id="s4-7"><title>Brain slice electrophysiology</title><p>All electrophysiological experiments were performed and analyzed blind to the genotypes. Mice were anesthetized by an intraperitoneal injection of a ketamine and xylazine mix (80 mg/kg and 16 mg/kg, respectively) and transcardially perfused with cold (0–4°C) slice cutting solution containing 80 mM NaCl, 2.5 mM KCl, 1.3 mM NaH<sub>2</sub>PO<sub>4</sub>, 26 mM NaHCO<sub>3</sub>, 4 mM MgCl<sub>2</sub>, 0.5 mM CaCl<sub>2</sub>, 20 mM D-glucose, 75 mM sucrose and 0.5 mM sodium ascorbate (315 mosmol, pH 7.4, saturated with 95% O<sub>2</sub>/5% CO<sub>2</sub>). Brains were removed and sectioned in the cutting solution with a VT1200S vibratome (Leica) to obtain 300 μm coronal slices. Slices containing primary somatosensory cortex were collected and incubated in a custom-made interface holding chamber saturated with 95% O<sub>2</sub>/5% CO<sub>2</sub> at 34°C for 30 min and then at room temperature for 20 min to 8 hr until they were transferred to the recording chamber.</p><p>Recordings were performed on submerged slices in artificial cerebrospinal fluid (ACSF) containing 119 mM NaCl, 2.5 mM KCl, 1.3 mM NaH<sub>2</sub>PO<sub>4</sub>, 26 mM NaHCO<sub>3</sub>, 1.3 mM MgCl<sub>2</sub>, 2.5 mM CaCl<sub>2</sub>, 20 mM D-glucose and 0.5 mM sodium ascorbate (305 mosmol, pH 7.4, saturated with 95% O<sub>2</sub>/5% CO<sub>2</sub>, perfused at 3 ml/min) at 30–32°C. For whole-cell recordings, we used a K<sup>+</sup>-based pipette solution containing 142 mM K<sup>+</sup>-gluconate, 10 mM HEPES, 1 mM EGTA, 2.5 mM MgCl<sub>2</sub>, 4 mM ATP-Mg, 0.3 mM GTP-Na, 10 mM Na<sub>2</sub>-phosphocreatine (295 mosmol, pH 7.35) or a Cs<sup>+</sup>-based pipette solution containing 121 mM Cs<sup>+</sup>-methanesulfonate, 10 mM HEPES, 10 mM EGTA, 1.5 mM MgCl<sub>2</sub>, 4 mM ATP-Mg, 0.3 mM GTP-Na, 10 mM Na<sub>2</sub>-phosphocreatine, and 2 mM QX314-Cl (295 mosmol, pH 7.35). Membrane potentials were not corrected for liquid junction potential (experimentally measured as 12.5 mV for the K<sup>+</sup>-based pipette solution and 9.5 mV for the Cs<sup>+</sup>-based pipette solution).</p><p>Neurons were visualized with video-assisted infrared differential interference contrast imaging and fluorescent neurons were identified by epifluorescence imaging under a water immersion objective (40×, 0.8 numerical aperture) on an upright SliceScope Pro 1000 microscope (Scientifica) with an infrared IR-1000 CCD camera (DAGE-MTI). Data were acquired at 10 kHz and low-pass filtered at 4 kHz with an Axon Multiclamp 700B amplifier and an Axon Digidata 1550 or 1440 Data Acquisition System under the control of Clampex 10.7 (Molecular Devices). For the photostimulation of ChR2-expressing neurons, blue light was emitted from a collimated light-emitting diode (LED) of 455 nm. The LED was driven by a LED driver (Mightex) under the control of an Axon Digidata 1550 Data Acquisition System and Clampex 10.7. Light was delivered through the reflected light fluorescence illuminator port and the 40 × objective. Data were analyzed offline using Clampfit 10.7 (Molecular Devices) or AxoGraph X (AxoGraph Scientific).</p><p>Neuronal intrinsic excitability was examined with the K<sup>+</sup>-based pipette solution. The resting membrane potential was recorded in the whole-cell current clamp mode within the first minute after break-in. After balancing the bridge, the input resistance was measured by injecting a 500 ms hyperpolarizing current pulse (10–100 pA) to generate a small membrane potential hyperpolarization (2–10 mV) from the resting membrane potential. Depolarizing currents were increased in 5- or 10-pA steps to identify rheobase currents.</p><p>To record unitary connections between inhibitory interneurons and pyramidal neurons, Pv and Sst interneurons were identified by the Cre-dependent expression of tdTomato. Pyramidal neurons were first recorded in whole-cell voltage clamp mode at the reversal potential for excitation (+10 mV) with the Cs<sup>+</sup>-based patch pipette solution. A nearby Pv or Sst interneuron was subsequently recorded in the whole-cell current clamp mode with the K<sup>+</sup>-based patch pipette solution. Action potentials were elicited in Pv or Sst interneurons by a train of 6 depolarizing current steps (2 ms, 1–2 nA) at 10 Hz with 15 s intervals between sweeps. Unitary IPSC (uIPSC) amplitudes were measured from the first IPSCs of the average of 30–50 sweeps. We considered a Pv or Sst interneuron to be connected with a pyramidal neuron when the average uIPSC amplitude was at least three times the baseline standard deviation. Spontaneous EPSCs (sEPSCs) in Pv and Sst interneurons were recorded in whole-cell voltage clamp mode at the reversal potential for inhibition (–70 mV) with the K<sup>+</sup>-based patch pipette solution. To detect sEPSCs, data were digitally low-pass filtered at 2 kHz offline and events were detected by a scaled-template algorithm (AxoGraph X). The parameters of the template are: length, 5 ms; baseline, 1.5 ms; amplitude, –2 pA; rise time, 0.3 ms; and decay time, 0.7 ms. For voltage clamp experiments, only recordings with series resistance below 20 MΩ were included.</p><p>To isolate Pv or Sst interneurons-mediated quantal IPSCs, pyramidal neurons were recorded in whole-cell voltage clamp mode at the reversal potential for excitation (+10 mV) with the Cs<sup>+</sup>-based patch pipette solution in a modified ACSF containing 4 mM MgCl<sub>2</sub> and 0.5 mM SrCl<sub>2</sub> without CaCl<sub>2</sub>. TTX (1 µM), NBQX (10 µM), and CPP (10 µM) were also included in the modified ACSF to block synaptic excitation and reduce overall activity in the slices. Typically, 10–30 sweeps were recorded for each neuron with 40 s intervals between sweeps. During each sweep, mIPSCs were recorded during the 10 s baseline period and the 10 s blue light stimulation period. The light intensity (0.15–7.43 mW/mm<sup>2</sup>) was ramped down to reduce the tonic currents (<xref ref-type="fig" rid="fig9s1">Figure 9—figure supplement 1</xref>). To detect mIPSCs, data were digitally low-pass filtered at 2 kHz offline and events were detected by a scaled-template algorithm (AxoGraph X). The parameters of the template are: length, 20 ms; baseline, 3 ms; amplitude, 2 pA; rise time, 0.6 ms; and decay time, 10 ms. The average amplitude, charge, and decay time constant of quantal IPSCs from ChR2-expressing interneurons were computed as <inline-formula><mml:math id="inf3"><mml:msub><mml:mrow><mml:mi>A</mml:mi></mml:mrow><mml:mrow><mml:mi>q</mml:mi><mml:mi>u</mml:mi><mml:mi>a</mml:mi><mml:mi>n</mml:mi><mml:mi>t</mml:mi><mml:mi>a</mml:mi><mml:mi>l</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:mi>A</mml:mi></mml:mrow><mml:mrow><mml:mi>l</mml:mi><mml:mi>i</mml:mi><mml:mi>g</mml:mi><mml:mi>h</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mrow><mml:mi>f</mml:mi></mml:mrow><mml:mrow><mml:mi>l</mml:mi><mml:mi>i</mml:mi><mml:mi>g</mml:mi><mml:mi>h</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:msub><mml:mo>-</mml:mo><mml:msub><mml:mrow><mml:mi>A</mml:mi></mml:mrow><mml:mrow><mml:mi>b</mml:mi><mml:mi>a</mml:mi><mml:mi>s</mml:mi><mml:mi>e</mml:mi><mml:mi>l</mml:mi><mml:mi>i</mml:mi><mml:mi>n</mml:mi><mml:mi>e</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mrow><mml:mi>f</mml:mi></mml:mrow><mml:mrow><mml:mi>b</mml:mi><mml:mi>a</mml:mi><mml:mi>s</mml:mi><mml:mi>e</mml:mi><mml:mi>l</mml:mi><mml:mi>i</mml:mi><mml:mi>n</mml:mi><mml:mi>e</mml:mi></mml:mrow></mml:msub><mml:mo>)</mml:mo><mml:mo>/</mml:mo><mml:mo>(</mml:mo><mml:msub><mml:mrow><mml:mi>f</mml:mi></mml:mrow><mml:mrow><mml:mi>l</mml:mi><mml:mi>i</mml:mi><mml:mi>g</mml:mi><mml:mi>h</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:msub><mml:mo>-</mml:mo><mml:msub><mml:mrow><mml:mi>f</mml:mi></mml:mrow><mml:mrow><mml:mi>b</mml:mi><mml:mi>a</mml:mi><mml:mi>s</mml:mi><mml:mi>e</mml:mi><mml:mi>l</mml:mi><mml:mi>i</mml:mi><mml:mi>n</mml:mi><mml:mi>e</mml:mi></mml:mrow></mml:msub><mml:mo>)</mml:mo></mml:math></inline-formula>, where <italic>A<sub>quantal</sub></italic>, <italic>A<sub>light</sub></italic>, and <italic>A<sub>baseline</sub></italic> are the amplitude, charge, or decay time constant of quantal IPSCs, mIPSCs during light stimulation period, and mIPSCs during baseline period, respectively; <italic>f<sub>light</sub></italic> and <italic>f<sub>baseline</sub></italic> are the frequency of mIPSCs during light stimulation period and that of mIPSCs during baseline period, respectively. The average traces of quantal IPSCs were computed similarly using the average traces of mIPSCs from the light stimulation period and baseline period. Only recordings with series resistance below 20 MΩ were included. Data were also excluded if blue light did not significantly evoke more mIPSCs than the baseline period (i.e., p&gt;0.05) or totally less than 150 evoked mIPSCs (i.e., the number of mIPSCs during the blue light stimulation period minus the number of mIPSCs during the baseline period) were obtained. The criterion of 150 evoked mIPSCs was chosen because the likelihood to accurately estimate the parameters (i.e., less than 10% error) from 150 events is higher than 95%.</p></sec><sec id="s4-8"><title>Statistics</title><p>All reported sample numbers (<italic>n</italic>) represent independent biological replicates that are the numbers of tested mice or recorded neurons. Statistical analyses were performed with Prism 6, 7, or 8 (GraphPad Software). D’Agostino-Pearson, Shapiro-Wilk, and Kolmogorov-Smirnov tests were used to determine if data were normally distributed. If all data within one experiment passed all three normality tests, then the statistical test that assumes a Gaussian distribution was used. Otherwise, the statistical test that assumes a non-Gaussian distribution was used. All statistical tests were two-tailed with an alpha of 0.05. Gender effect was inspected by two-way or three-way ANOVA. The details of all statistical tests, numbers of replicates, and <italic>P</italic> values were reported in <xref ref-type="supplementary-material" rid="supp3">Supplementary file 3</xref>.</p></sec></sec></body><back><ack id="ack"><title>Acknowledgements</title><p>This article is dedicated to the memory of Caroline DeLuca, who inspired this project. We thank Gabriele Schuster for the ES cell work and blastocyst injection, Corinne Spencer and James Frost for suggestions and discussions, and Shuyun Deng and Kazuhiro Oka at the Baylor College of Medicine Gene Vector Core for recombinant AAV vector production. This work was supported in part by Citizens United for Research in Epilepsy (CURE Epilepsy Award to MX), the National Institutes of Health (R01NS100893 and R01MH117089 to MX, F30MH118804 to CML), American Epilepsy Society (Postdoctoral Research Fellowship to WC), the Eunice Kennedy Shriver National Institute of Child Health and Human Development (U54HD083092 to Baylor College of Medicine Intellectual and Developmental Disabilities Research Center, Neurobehavioral Core), and the In Vivo Neurophysiology Core of Jan and Dan Duncan Neurological Research Institute. CML and JEM are part of the Baylor College of Medicine Medical Scientist Training Program and McNair MD/PhD Student Scholars supported by the McNair Medical Institute at the Robert and Janice McNair Foundation. HYZ is a Howard Hughes Medical Institute investigator. MX is a Caroline DeLuca Scholar.</p></ack><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf2"><p>Senior Editor, eLife</p></fn><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Data curation, Software, Formal analysis, Investigation, Visualization, Methodology, Writing - original draft, Writing - review and editing</p></fn><fn fn-type="con" id="con2"><p>Formal analysis, Investigation, Visualization, Methodology, Writing - original draft</p></fn><fn fn-type="con" id="con3"><p>Data curation, Software, Formal analysis, Investigation, Visualization, Methodology, Writing - original draft</p></fn><fn fn-type="con" id="con4"><p>Investigation, Writing - review and editing</p></fn><fn fn-type="con" id="con5"><p>Formal analysis, Investigation, Visualization, Methodology, Writing - original draft, Writing - review and editing</p></fn><fn fn-type="con" id="con6"><p>Investigation, Writing - review and editing</p></fn><fn fn-type="con" id="con7"><p>Supervision, Investigation, Writing - review and editing</p></fn><fn fn-type="con" id="con8"><p>Formal analysis, Investigation, Writing - review and editing</p></fn><fn fn-type="con" id="con9"><p>Formal analysis, Investigation, Writing - review and editing</p></fn><fn fn-type="con" id="con10"><p>Supervision, Writing - review and editing</p></fn><fn fn-type="con" id="con11"><p>Supervision, Writing - review and editing</p></fn><fn fn-type="con" id="con12"><p>Supervision, Writing - review and editing</p></fn><fn fn-type="con" id="con13"><p>Conceptualization, Formal analysis, Supervision, Funding acquisition, Investigation, Visualization, Methodology, Writing - original draft, Project administration, Writing - review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other" id="fn1"><p>Animal experimentation: This study was performed in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. All procedures to maintain and use mice were approved in the Animal Research Protocol AN-6544 by the Institutional Animal Care and Use Committee at Baylor College of Medicine.</p></fn></fn-group></sec><sec id="s6" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="supp1"><label>Supplementary file 1.</label><caption><title>EEG phenotypes of individual WT and <italic>Stxbp1<sup>tm1d/+</sup></italic> mice.</title><p>The parameters charactering the SWDs, myoclonic jerks, and myoclonic jumps of each WT and <italic>Stxbp1<sup>tm1d/+</sup></italic> mouse are presented in the table.</p></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-48705-supp1-v2.xlsx"/></supplementary-material><supplementary-material id="supp2"><label>Supplementary file 2.</label><caption><title>Phenotypic comparison of human patients and mouse models.</title><p>The phenotyping tests in mouse models (the second column) are grouped based on the clinical features of <italic>STXBP1</italic> encephalopathy (the first column). The results of phenotyping tests from different mouse models and studies are presented in the table.</p></caption><media mime-subtype="docx" mimetype="application" xlink:href="elife-48705-supp2-v2.docx"/></supplementary-material><supplementary-material id="supp3"><label>Supplementary file 3.</label><caption><title>Statistics of experimental results.</title><p>The details of all statistical tests, numbers of replicates, and <italic>P</italic> values are presented for each experiment in the table.</p></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-48705-supp3-v2.xlsx"/></supplementary-material><supplementary-material id="transrepform"><label>Transparent reporting form</label><media mime-subtype="docx" mimetype="application" xlink:href="elife-48705-transrepform-v2.docx"/></supplementary-material></sec><sec id="s7" sec-type="data-availability"><title>Data availability</title><p>All data generated or analyzed during this study are included in the manuscript and supporting files.</p></sec><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Allen</surname> <given-names>AS</given-names></name><name><surname>Berkovic</surname> <given-names>SF</given-names></name><name><surname>Cossette</surname> <given-names>P</given-names></name><name><surname>Delanty</surname> <given-names>N</given-names></name><name><surname>Dlugos</surname> <given-names>D</given-names></name><name><surname>Eichler</surname> <given-names>EE</given-names></name><name><surname>Epstein</surname> <given-names>MP</given-names></name><name><surname>Glauser</surname> <given-names>T</given-names></name><name><surname>Goldstein</surname> <given-names>DB</given-names></name><name><surname>Han</surname> <given-names>Y</given-names></name><name><surname>Heinzen</surname> <given-names>EL</given-names></name><name><surname>Hitomi</surname> <given-names>Y</given-names></name><name><surname>Howell</surname> <given-names>KB</given-names></name><name><surname>Johnson</surname> <given-names>MR</given-names></name><name><surname>Kuzniecky</surname> <given-names>R</given-names></name><name><surname>Lowenstein</surname> <given-names>DH</given-names></name><name><surname>Lu</surname> <given-names>YF</given-names></name><name><surname>Madou</surname> <given-names>MR</given-names></name><name><surname>Marson</surname> <given-names>AG</given-names></name><name><surname>Mefford</surname> <given-names>HC</given-names></name><name><surname>Esmaeeli Nieh</surname> <given-names>S</given-names></name><name><surname>O'Brien</surname> <given-names>TJ</given-names></name><name><surname>Ottman</surname> <given-names>R</given-names></name><name><surname>Petrovski</surname> <given-names>S</given-names></name><name><surname>Poduri</surname> <given-names>A</given-names></name><name><surname>Ruzzo</surname> <given-names>EK</given-names></name><name><surname>Scheffer</surname> <given-names>IE</given-names></name><name><surname>Sherr</surname> <given-names>EH</given-names></name><name><surname>Yuskaitis</surname> <given-names>CJ</given-names></name><name><surname>Abou-Khalil</surname> <given-names>B</given-names></name><name><surname>Alldredge</surname> <given-names>BK</given-names></name><name><surname>Bautista</surname> <given-names>JF</given-names></name><name><surname>Berkovic</surname> <given-names>SF</given-names></name><name><surname>Boro</surname> <given-names>A</given-names></name><name><surname>Cascino</surname> <given-names>GD</given-names></name><name><surname>Consalvo</surname> <given-names>D</given-names></name><name><surname>Crumrine</surname> <given-names>P</given-names></name><name><surname>Devinsky</surname> <given-names>O</given-names></name><name><surname>Dlugos</surname> <given-names>D</given-names></name><name><surname>Epstein</surname> <given-names>MP</given-names></name><name><surname>Fiol</surname> <given-names>M</given-names></name><name><surname>Fountain</surname> <given-names>NB</given-names></name><name><surname>French</surname> <given-names>J</given-names></name><name><surname>Friedman</surname> <given-names>D</given-names></name><name><surname>Geller</surname> <given-names>EB</given-names></name><name><surname>Glauser</surname> <given-names>T</given-names></name><name><surname>Glynn</surname> <given-names>S</given-names></name><name><surname>Haut</surname> <given-names>SR</given-names></name><name><surname>Hayward</surname> <given-names>J</given-names></name><name><surname>Helmers</surname> <given-names>SL</given-names></name><name><surname>Joshi</surname> <given-names>S</given-names></name><name><surname>Kanner</surname> <given-names>A</given-names></name><name><surname>Kirsch</surname> <given-names>HE</given-names></name><name><surname>Knowlton</surname> <given-names>RC</given-names></name><name><surname>Kossoff</surname> <given-names>EH</given-names></name><name><surname>Kuperman</surname> <given-names>R</given-names></name><name><surname>Kuzniecky</surname> <given-names>R</given-names></name><name><surname>Lowenstein</surname> <given-names>DH</given-names></name><name><surname>McGuire</surname> <given-names>SM</given-names></name><name><surname>Motika</surname> <given-names>PV</given-names></name><name><surname>Novotny</surname> <given-names>EJ</given-names></name><name><surname>Ottman</surname> <given-names>R</given-names></name><name><surname>Paolicchi</surname> <given-names>JM</given-names></name><name><surname>Parent</surname> <given-names>JM</given-names></name><name><surname>Park</surname> <given-names>K</given-names></name><name><surname>Poduri</surname> <given-names>A</given-names></name><name><surname>Scheffer</surname> <given-names>IE</given-names></name><name><surname>Shellhaas</surname> <given-names>RA</given-names></name><name><surname>Sherr</surname> <given-names>EH</given-names></name><name><surname>Shih</surname> <given-names>JJ</given-names></name><name><surname>Singh</surname> <given-names>R</given-names></name><name><surname>Sirven</surname> <given-names>J</given-names></name><name><surname>Smith</surname> <given-names>MC</given-names></name><name><surname>Sullivan</surname> <given-names>J</given-names></name><name><surname>Lin Thio</surname> <given-names>L</given-names></name><name><surname>Venkat</surname> <given-names>A</given-names></name><name><surname>Vining</surname> <given-names>EP</given-names></name><name><surname>Von Allmen</surname> <given-names>GK</given-names></name><name><surname>Weisenberg</surname> <given-names>JL</given-names></name><name><surname>Widdess-Walsh</surname> <given-names>P</given-names></name><name><surname>Winawer</surname> <given-names>MR</given-names></name><collab>Epi4K Consortium, Epilepsy Phenome/Genome Project</collab></person-group><year iso-8601-date="2013">2013</year><article-title>De novo mutations in epileptic encephalopathies</article-title><source>Nature</source><volume>501</volume><fpage>217</fpage><lpage>221</lpage><pub-id pub-id-type="doi">10.1038/nature12439</pub-id><pub-id pub-id-type="pmid">23934111</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Antunes</surname> <given-names>M</given-names></name><name><surname>Biala</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>The novel object recognition memory: neurobiology, test procedure, and its modifications</article-title><source>Cognitive Processing</source><volume>13</volume><fpage>93</fpage><lpage>110</lpage><pub-id pub-id-type="doi">10.1007/s10339-011-0430-z</pub-id><pub-id pub-id-type="pmid">22160349</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arain</surname> <given-names>FM</given-names></name><name><surname>Boyd</surname> <given-names>KL</given-names></name><name><surname>Gallagher</surname> <given-names>MJ</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Decreased viability and absence-like epilepsy in mice lacking or deficient in the GABAA receptor α1 subunit</article-title><source>Epilepsia</source><volume>53</volume><fpage>e161</fpage><lpage>e165</lpage><pub-id pub-id-type="doi">10.1111/j.1528-1167.2012.03596.x</pub-id><pub-id pub-id-type="pmid">22812724</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Avanzini</surname> <given-names>G</given-names></name><name><surname>Shibasaki</surname> <given-names>H</given-names></name><name><surname>Rubboli</surname> <given-names>G</given-names></name><name><surname>Canafoglia</surname> <given-names>L</given-names></name><name><surname>Panzica</surname> <given-names>F</given-names></name><name><surname>Franceschetti</surname> <given-names>S</given-names></name><name><surname>Hallett</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Neurophysiology of myoclonus and progressive myoclonus epilepsies</article-title><source>Epileptic Disorders</source><volume>18</volume><fpage>11</fpage><lpage>27</lpage><pub-id pub-id-type="doi">10.1684/epd.2016.0835</pub-id><pub-id pub-id-type="pmid">27702708</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baker</surname> <given-names>K</given-names></name><name><surname>Gordon</surname> <given-names>SL</given-names></name><name><surname>Grozeva</surname> <given-names>D</given-names></name><name><surname>van Kogelenberg</surname> <given-names>M</given-names></name><name><surname>Roberts</surname> <given-names>NY</given-names></name><name><surname>Pike</surname> <given-names>M</given-names></name><name><surname>Blair</surname> <given-names>E</given-names></name><name><surname>Hurles</surname> <given-names>ME</given-names></name><name><surname>Chong</surname> <given-names>WK</given-names></name><name><surname>Baldeweg</surname> <given-names>T</given-names></name><name><surname>Kurian</surname> <given-names>MA</given-names></name><name><surname>Boyd</surname> <given-names>SG</given-names></name><name><surname>Cousin</surname> <given-names>MA</given-names></name><name><surname>Raymond</surname> <given-names>FL</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Identification of a human synaptotagmin-1 mutation that perturbs synaptic vesicle cycling</article-title><source>Journal of Clinical Investigation</source><volume>125</volume><fpage>1670</fpage><lpage>1678</lpage><pub-id pub-id-type="doi">10.1172/JCI79765</pub-id><pub-id pub-id-type="pmid">25705886</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baker</surname> <given-names>K</given-names></name><name><surname>Gordon</surname> <given-names>SL</given-names></name><name><surname>Melland</surname> <given-names>H</given-names></name><name><surname>Bumbak</surname> <given-names>F</given-names></name><name><surname>Scott</surname> <given-names>DJ</given-names></name><name><surname>Jiang</surname> <given-names>TJ</given-names></name><name><surname>Owen</surname> <given-names>D</given-names></name><name><surname>Turner</surname> <given-names>BJ</given-names></name><name><surname>Boyd</surname> <given-names>SG</given-names></name><name><surname>Rossi</surname> <given-names>M</given-names></name><name><surname>Al-Raqad</surname> <given-names>M</given-names></name><name><surname>Elpeleg</surname> <given-names>O</given-names></name><name><surname>Peck</surname> <given-names>D</given-names></name><name><surname>Mancini</surname> <given-names>GMS</given-names></name><name><surname>Wilke</surname> <given-names>M</given-names></name><name><surname>Zollino</surname> <given-names>M</given-names></name><name><surname>Marangi</surname> <given-names>G</given-names></name><name><surname>Weigand</surname> <given-names>H</given-names></name><name><surname>Borggraefe</surname> <given-names>I</given-names></name><name><surname>Haack</surname> <given-names>T</given-names></name><name><surname>Stark</surname> <given-names>Z</given-names></name><name><surname>Sadedin</surname> <given-names>S</given-names></name><name><surname>Tan</surname> <given-names>TY</given-names></name><name><surname>Jiang</surname> <given-names>Y</given-names></name><name><surname>Gibbs</surname> <given-names>RA</given-names></name><name><surname>Ellingwood</surname> <given-names>S</given-names></name><name><surname>Amaral</surname> <given-names>M</given-names></name><name><surname>Kelley</surname> <given-names>W</given-names></name><name><surname>Kurian</surname> <given-names>MA</given-names></name><name><surname>Cousin</surname> <given-names>MA</given-names></name><name><surname>Raymond</surname> <given-names>FL</given-names></name><collab>Broad Center for Mendelian Genomics</collab></person-group><year iso-8601-date="2018">2018</year><article-title>SYT1-associated neurodevelopmental disorder: a case series</article-title><source>Brain</source><volume>141</volume><fpage>2576</fpage><lpage>2591</lpage><pub-id pub-id-type="doi">10.1093/brain/awy209</pub-id><pub-id pub-id-type="pmid">30107533</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bayés</surname> <given-names>A</given-names></name><name><surname>van de Lagemaat</surname> <given-names>LN</given-names></name><name><surname>Collins</surname> <given-names>MO</given-names></name><name><surname>Croning</surname> <given-names>MD</given-names></name><name><surname>Whittle</surname> <given-names>IR</given-names></name><name><surname>Choudhary</surname> <given-names>JS</given-names></name><name><surname>Grant</surname> <given-names>SG</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Characterization of the proteome, diseases and evolution of the human postsynaptic density</article-title><source>Nature Neuroscience</source><volume>14</volume><fpage>19</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.1038/nn.2719</pub-id><pub-id pub-id-type="pmid">21170055</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boutry-Kryza</surname> <given-names>N</given-names></name><name><surname>Labalme</surname> <given-names>A</given-names></name><name><surname>Ville</surname> <given-names>D</given-names></name><name><surname>de Bellescize</surname> <given-names>J</given-names></name><name><surname>Touraine</surname> <given-names>R</given-names></name><name><surname>Prieur</surname> <given-names>F</given-names></name><name><surname>Dimassi</surname> <given-names>S</given-names></name><name><surname>Poulat</surname> <given-names>AL</given-names></name><name><surname>Till</surname> <given-names>M</given-names></name><name><surname>Rossi</surname> <given-names>M</given-names></name><name><surname>Bourel-Ponchel</surname> <given-names>E</given-names></name><name><surname>Delignières</surname> <given-names>A</given-names></name><name><surname>Le Moing</surname> <given-names>AG</given-names></name><name><surname>Rivier</surname> <given-names>C</given-names></name><name><surname>des Portes</surname> <given-names>V</given-names></name><name><surname>Edery</surname> <given-names>P</given-names></name><name><surname>Calender</surname> <given-names>A</given-names></name><name><surname>Sanlaville</surname> <given-names>D</given-names></name><name><surname>Lesca</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Molecular characterization of a cohort of 73 patients with infantile spasms syndrome</article-title><source>European Journal of Medical Genetics</source><volume>58</volume><fpage>51</fpage><lpage>58</lpage><pub-id pub-id-type="doi">10.1016/j.ejmg.2014.11.007</pub-id><pub-id pub-id-type="pmid">25497044</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boyden</surname> <given-names>ES</given-names></name><name><surname>Zhang</surname> <given-names>F</given-names></name><name><surname>Bamberg</surname> <given-names>E</given-names></name><name><surname>Nagel</surname> <given-names>G</given-names></name><name><surname>Deisseroth</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Millisecond-timescale, genetically targeted optical control of neural activity</article-title><source>Nature Neuroscience</source><volume>8</volume><fpage>1263</fpage><lpage>1268</lpage><pub-id pub-id-type="doi">10.1038/nn1525</pub-id><pub-id pub-id-type="pmid">16116447</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Campbell</surname> <given-names>IM</given-names></name><name><surname>Yatsenko</surname> <given-names>SA</given-names></name><name><surname>Hixson</surname> <given-names>P</given-names></name><name><surname>Reimschisel</surname> <given-names>T</given-names></name><name><surname>Thomas</surname> <given-names>M</given-names></name><name><surname>Wilson</surname> <given-names>W</given-names></name><name><surname>Dayal</surname> <given-names>U</given-names></name><name><surname>Wheless</surname> <given-names>JW</given-names></name><name><surname>Crunk</surname> <given-names>A</given-names></name><name><surname>Curry</surname> <given-names>C</given-names></name><name><surname>Parkinson</surname> <given-names>N</given-names></name><name><surname>Fishman</surname> <given-names>L</given-names></name><name><surname>Riviello</surname> <given-names>JJ</given-names></name><name><surname>Nowaczyk</surname> <given-names>MJ</given-names></name><name><surname>Zeesman</surname> <given-names>S</given-names></name><name><surname>Rosenfeld</surname> <given-names>JA</given-names></name><name><surname>Bejjani</surname> <given-names>BA</given-names></name><name><surname>Shaffer</surname> <given-names>LG</given-names></name><name><surname>Cheung</surname> <given-names>SW</given-names></name><name><surname>Lupski</surname> <given-names>JR</given-names></name><name><surname>Stankiewicz</surname> <given-names>P</given-names></name><name><surname>Scaglia</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Novel 9q34.11 gene deletions encompassing combinations of four Mendelian disease genes: STXBP1, SPTAN1, ENG, and TOR1A</article-title><source>Genetics in Medicine</source><volume>14</volume><fpage>868</fpage><lpage>876</lpage><pub-id pub-id-type="doi">10.1038/gim.2012.65</pub-id><pub-id pub-id-type="pmid">22722545</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carvill</surname> <given-names>GL</given-names></name><name><surname>Heavin</surname> <given-names>SB</given-names></name><name><surname>Yendle</surname> <given-names>SC</given-names></name><name><surname>McMahon</surname> <given-names>JM</given-names></name><name><surname>O'Roak</surname> <given-names>BJ</given-names></name><name><surname>Cook</surname> <given-names>J</given-names></name><name><surname>Khan</surname> <given-names>A</given-names></name><name><surname>Dorschner</surname> <given-names>MO</given-names></name><name><surname>Weaver</surname> <given-names>M</given-names></name><name><surname>Calvert</surname> <given-names>S</given-names></name><name><surname>Malone</surname> <given-names>S</given-names></name><name><surname>Wallace</surname> <given-names>G</given-names></name><name><surname>Stanley</surname> <given-names>T</given-names></name><name><surname>Bye</surname> <given-names>AM</given-names></name><name><surname>Bleasel</surname> <given-names>A</given-names></name><name><surname>Howell</surname> <given-names>KB</given-names></name><name><surname>Kivity</surname> <given-names>S</given-names></name><name><surname>Mackay</surname> <given-names>MT</given-names></name><name><surname>Rodriguez-Casero</surname> <given-names>V</given-names></name><name><surname>Webster</surname> <given-names>R</given-names></name><name><surname>Korczyn</surname> <given-names>A</given-names></name><name><surname>Afawi</surname> <given-names>Z</given-names></name><name><surname>Zelnick</surname> <given-names>N</given-names></name><name><surname>Lerman-Sagie</surname> <given-names>T</given-names></name><name><surname>Lev</surname> <given-names>D</given-names></name><name><surname>Møller</surname> <given-names>RS</given-names></name><name><surname>Gill</surname> <given-names>D</given-names></name><name><surname>Andrade</surname> <given-names>DM</given-names></name><name><surname>Freeman</surname> <given-names>JL</given-names></name><name><surname>Sadleir</surname> <given-names>LG</given-names></name><name><surname>Shendure</surname> <given-names>J</given-names></name><name><surname>Berkovic</surname> <given-names>SF</given-names></name><name><surname>Scheffer</surname> <given-names>IE</given-names></name><name><surname>Mefford</surname> <given-names>HC</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Targeted resequencing in epileptic encephalopathies identifies de novo mutations in CHD2 and SYNGAP1</article-title><source>Nature Genetics</source><volume>45</volume><fpage>825</fpage><lpage>830</lpage><pub-id pub-id-type="doi">10.1038/ng.2646</pub-id><pub-id pub-id-type="pmid">23708187</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carvill</surname> <given-names>GL</given-names></name><name><surname>Weckhuysen</surname> <given-names>S</given-names></name><name><surname>McMahon</surname> <given-names>JM</given-names></name><name><surname>Hartmann</surname> <given-names>C</given-names></name><name><surname>Møller</surname> <given-names>RS</given-names></name><name><surname>Hjalgrim</surname> <given-names>H</given-names></name><name><surname>Cook</surname> <given-names>J</given-names></name><name><surname>Geraghty</surname> <given-names>E</given-names></name><name><surname>O'Roak</surname> <given-names>BJ</given-names></name><name><surname>Petrou</surname> <given-names>S</given-names></name><name><surname>Clarke</surname> <given-names>A</given-names></name><name><surname>Gill</surname> <given-names>D</given-names></name><name><surname>Sadleir</surname> <given-names>LG</given-names></name><name><surname>Muhle</surname> <given-names>H</given-names></name><name><surname>von Spiczak</surname> <given-names>S</given-names></name><name><surname>Nikanorova</surname> <given-names>M</given-names></name><name><surname>Hodgson</surname> <given-names>BL</given-names></name><name><surname>Gazina</surname> <given-names>EV</given-names></name><name><surname>Suls</surname> <given-names>A</given-names></name><name><surname>Shendure</surname> <given-names>J</given-names></name><name><surname>Dibbens</surname> <given-names>LM</given-names></name><name><surname>De Jonghe</surname> <given-names>P</given-names></name><name><surname>Helbig</surname> <given-names>I</given-names></name><name><surname>Berkovic</surname> <given-names>SF</given-names></name><name><surname>Scheffer</surname> <given-names>IE</given-names></name><name><surname>Mefford</surname> <given-names>HC</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>GABRA1 and STXBP1: novel genetic causes of dravet syndrome</article-title><source>Neurology</source><volume>82</volume><fpage>1245</fpage><lpage>1253</lpage><pub-id pub-id-type="doi">10.1212/WNL.0000000000000291</pub-id><pub-id pub-id-type="pmid">24623842</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname> <given-names>YF</given-names></name><name><surname>Imam</surname> <given-names>JS</given-names></name><name><surname>Wilkinson</surname> <given-names>MF</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>The nonsense-mediated decay RNA surveillance pathway</article-title><source>Annual Review of Biochemistry</source><volume>76</volume><fpage>51</fpage><lpage>74</lpage><pub-id pub-id-type="doi">10.1146/annurev.biochem.76.050106.093909</pub-id><pub-id pub-id-type="pmid">17352659</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cohen</surname> <given-names>SJ</given-names></name><name><surname>Stackman</surname> <given-names>RW</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Assessing rodent hippocampal involvement in the novel object recognition task a review</article-title><source>Behavioural Brain Research</source><volume>285</volume><fpage>105</fpage><lpage>117</lpage><pub-id pub-id-type="doi">10.1016/j.bbr.2014.08.002</pub-id><pub-id pub-id-type="pmid">25169255</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Contestabile</surname> <given-names>A</given-names></name><name><surname>Magara</surname> <given-names>S</given-names></name><name><surname>Cancedda</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>The GABAergic hypothesis for cognitive disabilities in down syndrome</article-title><source>Frontiers in Cellular Neuroscience</source><volume>11</volume><elocation-id>54</elocation-id><pub-id pub-id-type="doi">10.3389/fncel.2017.00054</pub-id><pub-id pub-id-type="pmid">28326014</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deacon</surname> <given-names>RM</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Digging and marble burying in mice: simple methods for in vivo identification of biological impacts</article-title><source>Nature Protocols</source><volume>1</volume><fpage>122</fpage><lpage>124</lpage><pub-id pub-id-type="doi">10.1038/nprot.2006.20</pub-id><pub-id pub-id-type="pmid">17406223</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><collab>Deciphering Developmental Disorders Study</collab></person-group><year iso-8601-date="2015">2015</year><article-title>Large-scale discovery of novel genetic causes of developmental disorders</article-title><source>Nature</source><volume>519</volume><fpage>223</fpage><lpage>228</lpage><pub-id pub-id-type="doi">10.1038/nature14135</pub-id><pub-id pub-id-type="pmid">25533962</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><collab>Deciphering Developmental Disorders Study</collab></person-group><year iso-8601-date="2017">2017</year><article-title>Prevalence and architecture of de novo mutations in developmental disorders</article-title><source>Nature</source><volume>542</volume><fpage>433</fpage><lpage>438</lpage><pub-id pub-id-type="doi">10.1038/nature21062</pub-id><pub-id pub-id-type="pmid">28135719</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Depaulis</surname> <given-names>A</given-names></name><name><surname>Charpier</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Pathophysiology of absence epilepsy: insights from genetic models</article-title><source>Neuroscience Letters</source><volume>667</volume><fpage>53</fpage><lpage>65</lpage><pub-id pub-id-type="doi">10.1016/j.neulet.2017.02.035</pub-id><pub-id pub-id-type="pmid">28216336</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deprez</surname> <given-names>L</given-names></name><name><surname>Weckhuysen</surname> <given-names>S</given-names></name><name><surname>Holmgren</surname> <given-names>P</given-names></name><name><surname>Suls</surname> <given-names>A</given-names></name><name><surname>Van Dyck</surname> <given-names>T</given-names></name><name><surname>Goossens</surname> <given-names>D</given-names></name><name><surname>Del-Favero</surname> <given-names>J</given-names></name><name><surname>Jansen</surname> <given-names>A</given-names></name><name><surname>Verhaert</surname> <given-names>K</given-names></name><name><surname>Lagae</surname> <given-names>L</given-names></name><name><surname>Jordanova</surname> <given-names>A</given-names></name><name><surname>Van Coster</surname> <given-names>R</given-names></name><name><surname>Yendle</surname> <given-names>S</given-names></name><name><surname>Berkovic</surname> <given-names>SF</given-names></name><name><surname>Scheffer</surname> <given-names>I</given-names></name><name><surname>Ceulemans</surname> <given-names>B</given-names></name><name><surname>De Jonghe</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Clinical spectrum of early-onset epileptic encephalopathies associated with STXBP1 mutations</article-title><source>Neurology</source><volume>75</volume><fpage>1159</fpage><lpage>1165</lpage><pub-id pub-id-type="doi">10.1212/WNL.0b013e3181f4d7bf</pub-id><pub-id pub-id-type="pmid">20876469</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Engel</surname> <given-names>AG</given-names></name><name><surname>Selcen</surname> <given-names>D</given-names></name><name><surname>Shen</surname> <given-names>XM</given-names></name><name><surname>Milone</surname> <given-names>M</given-names></name><name><surname>Harper</surname> <given-names>CM</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Loss of MUNC13-1 function causes microcephaly, cortical hyperexcitability, and fatal myasthenia</article-title><source>Neurology Genetics</source><volume>2</volume><elocation-id>e105</elocation-id><pub-id pub-id-type="doi">10.1212/NXG.0000000000000105</pub-id><pub-id pub-id-type="pmid">27648472</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fukuda</surname> <given-names>H</given-names></name><name><surname>Imagawa</surname> <given-names>E</given-names></name><name><surname>Hamanaka</surname> <given-names>K</given-names></name><name><surname>Fujita</surname> <given-names>A</given-names></name><name><surname>Mitsuhashi</surname> <given-names>S</given-names></name><name><surname>Miyatake</surname> <given-names>S</given-names></name><name><surname>Mizuguchi</surname> <given-names>T</given-names></name><name><surname>Takata</surname> <given-names>A</given-names></name><name><surname>Miyake</surname> <given-names>N</given-names></name><name><surname>Kramer</surname> <given-names>U</given-names></name><name><surname>Matsumoto</surname> <given-names>N</given-names></name><name><surname>Fattal-Valevski</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>A novel missense SNAP25b mutation in two affected siblings from an israeli family showing seizures and cerebellar ataxia</article-title><source>Journal of Human Genetics</source><volume>63</volume><fpage>673</fpage><lpage>676</lpage><pub-id pub-id-type="doi">10.1038/s10038-018-0421-3</pub-id><pub-id pub-id-type="pmid">29491473</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grone</surname> <given-names>BP</given-names></name><name><surname>Marchese</surname> <given-names>M</given-names></name><name><surname>Hamling</surname> <given-names>KR</given-names></name><name><surname>Kumar</surname> <given-names>MG</given-names></name><name><surname>Krasniak</surname> <given-names>CS</given-names></name><name><surname>Sicca</surname> <given-names>F</given-names></name><name><surname>Santorelli</surname> <given-names>FM</given-names></name><name><surname>Patel</surname> <given-names>M</given-names></name><name><surname>Baraban</surname> <given-names>SC</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Epilepsy, behavioral abnormalities, and physiological comorbidities in Syntaxin-Binding protein 1 (STXBP1) Mutant zebrafish</article-title><source>PLOS ONE</source><volume>11</volume><elocation-id>e0151148</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0151148</pub-id><pub-id pub-id-type="pmid">26963117</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guiberson</surname> <given-names>NGL</given-names></name><name><surname>Pineda</surname> <given-names>A</given-names></name><name><surname>Abramov</surname> <given-names>D</given-names></name><name><surname>Kharel</surname> <given-names>P</given-names></name><name><surname>Carnazza</surname> <given-names>KE</given-names></name><name><surname>Wragg</surname> <given-names>RT</given-names></name><name><surname>Dittman</surname> <given-names>JS</given-names></name><name><surname>Burré</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Mechanism-based rescue of Munc18-1 dysfunction in varied encephalopathies by chemical chaperones</article-title><source>Nature Communications</source><volume>9</volume><elocation-id>3986</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-018-06507-4</pub-id><pub-id pub-id-type="pmid">30266908</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hager</surname> <given-names>T</given-names></name><name><surname>Maroteaux</surname> <given-names>G</given-names></name><name><surname>Pont</surname> <given-names>P</given-names></name><name><surname>Julsing</surname> <given-names>J</given-names></name><name><surname>van Vliet</surname> <given-names>R</given-names></name><name><surname>Stiedl</surname> <given-names>O</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Munc18-1 haploinsufficiency results in enhanced anxiety-like behavior as determined by heart rate responses in mice</article-title><source>Behavioural Brain Research</source><volume>260</volume><fpage>44</fpage><lpage>52</lpage><pub-id pub-id-type="doi">10.1016/j.bbr.2013.11.033</pub-id><pub-id pub-id-type="pmid">24304718</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hamada</surname> <given-names>N</given-names></name><name><surname>Iwamoto</surname> <given-names>I</given-names></name><name><surname>Tabata</surname> <given-names>H</given-names></name><name><surname>Nagata</surname> <given-names>KI</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>MUNC18-1 gene abnormalities are involved in neurodevelopmental disorders through defective cortical architecture during brain development</article-title><source>Acta Neuropathologica Communications</source><volume>5</volume><elocation-id>92</elocation-id><pub-id pub-id-type="doi">10.1186/s40478-017-0498-5</pub-id><pub-id pub-id-type="pmid">29191246</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hamdan</surname> <given-names>FF</given-names></name><name><surname>Piton</surname> <given-names>A</given-names></name><name><surname>Gauthier</surname> <given-names>J</given-names></name><name><surname>Lortie</surname> <given-names>A</given-names></name><name><surname>Dubeau</surname> <given-names>F</given-names></name><name><surname>Dobrzeniecka</surname> <given-names>S</given-names></name><name><surname>Spiegelman</surname> <given-names>D</given-names></name><name><surname>Noreau</surname> <given-names>A</given-names></name><name><surname>Pellerin</surname> <given-names>S</given-names></name><name><surname>Côté</surname> <given-names>M</given-names></name><name><surname>Henrion</surname> <given-names>E</given-names></name><name><surname>Fombonne</surname> <given-names>E</given-names></name><name><surname>Mottron</surname> <given-names>L</given-names></name><name><surname>Marineau</surname> <given-names>C</given-names></name><name><surname>Drapeau</surname> <given-names>P</given-names></name><name><surname>Lafrenière</surname> <given-names>RG</given-names></name><name><surname>Lacaille</surname> <given-names>JC</given-names></name><name><surname>Rouleau</surname> <given-names>GA</given-names></name><name><surname>Michaud</surname> <given-names>JL</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>De novo <italic>STXBP1</italic> mutations in mental retardation and nonsyndromic epilepsy</article-title><source>Annals of Neurology</source><volume>65</volume><fpage>748</fpage><lpage>753</lpage><pub-id pub-id-type="doi">10.1002/ana.21625</pub-id><pub-id pub-id-type="pmid">19557857</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hamdan</surname> <given-names>FF</given-names></name><name><surname>Gauthier</surname> <given-names>J</given-names></name><name><surname>Dobrzeniecka</surname> <given-names>S</given-names></name><name><surname>Lortie</surname> <given-names>A</given-names></name><name><surname>Mottron</surname> <given-names>L</given-names></name><name><surname>Vanasse</surname> <given-names>M</given-names></name><name><surname>D'Anjou</surname> <given-names>G</given-names></name><name><surname>Lacaille</surname> <given-names>JC</given-names></name><name><surname>Rouleau</surname> <given-names>GA</given-names></name><name><surname>Michaud</surname> <given-names>JL</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Intellectual disability without epilepsy associated with STXBP1 disruption</article-title><source>European Journal of Human Genetics</source><volume>19</volume><fpage>607</fpage><lpage>609</lpage><pub-id pub-id-type="doi">10.1038/ejhg.2010.183</pub-id><pub-id pub-id-type="pmid">21364700</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hamdan</surname> <given-names>FF</given-names></name><name><surname>Myers</surname> <given-names>CT</given-names></name><name><surname>Cossette</surname> <given-names>P</given-names></name><name><surname>Lemay</surname> <given-names>P</given-names></name><name><surname>Spiegelman</surname> <given-names>D</given-names></name><name><surname>Laporte</surname> <given-names>AD</given-names></name><name><surname>Nassif</surname> <given-names>C</given-names></name><name><surname>Diallo</surname> <given-names>O</given-names></name><name><surname>Monlong</surname> <given-names>J</given-names></name><name><surname>Cadieux-Dion</surname> <given-names>M</given-names></name><name><surname>Dobrzeniecka</surname> <given-names>S</given-names></name><name><surname>Meloche</surname> <given-names>C</given-names></name><name><surname>Retterer</surname> <given-names>K</given-names></name><name><surname>Cho</surname> <given-names>MT</given-names></name><name><surname>Rosenfeld</surname> <given-names>JA</given-names></name><name><surname>Bi</surname> <given-names>W</given-names></name><name><surname>Massicotte</surname> <given-names>C</given-names></name><name><surname>Miguet</surname> <given-names>M</given-names></name><name><surname>Brunga</surname> <given-names>L</given-names></name><name><surname>Regan</surname> <given-names>BM</given-names></name><name><surname>Mo</surname> <given-names>K</given-names></name><name><surname>Tam</surname> <given-names>C</given-names></name><name><surname>Schneider</surname> <given-names>A</given-names></name><name><surname>Hollingsworth</surname> <given-names>G</given-names></name><name><surname>FitzPatrick</surname> <given-names>DR</given-names></name><name><surname>Donaldson</surname> <given-names>A</given-names></name><name><surname>Canham</surname> <given-names>N</given-names></name><name><surname>Blair</surname> <given-names>E</given-names></name><name><surname>Kerr</surname> <given-names>B</given-names></name><name><surname>Fry</surname> <given-names>AE</given-names></name><name><surname>Thomas</surname> <given-names>RH</given-names></name><name><surname>Shelagh</surname> <given-names>J</given-names></name><name><surname>Hurst</surname> <given-names>JA</given-names></name><name><surname>Brittain</surname> <given-names>H</given-names></name><name><surname>Blyth</surname> <given-names>M</given-names></name><name><surname>Lebel</surname> <given-names>RR</given-names></name><name><surname>Gerkes</surname> <given-names>EH</given-names></name><name><surname>Davis-Keppen</surname> <given-names>L</given-names></name><name><surname>Stein</surname> <given-names>Q</given-names></name><name><surname>Chung</surname> <given-names>WK</given-names></name><name><surname>Dorison</surname> <given-names>SJ</given-names></name><name><surname>Benke</surname> <given-names>PJ</given-names></name><name><surname>Fassi</surname> <given-names>E</given-names></name><name><surname>Corsten-Janssen</surname> <given-names>N</given-names></name><name><surname>Kamsteeg</surname> <given-names>EJ</given-names></name><name><surname>Mau-Them</surname> <given-names>FT</given-names></name><name><surname>Bruel</surname> <given-names>AL</given-names></name><name><surname>Verloes</surname> <given-names>A</given-names></name><name><surname>Õunap</surname> <given-names>K</given-names></name><name><surname>Wojcik</surname> <given-names>MH</given-names></name><name><surname>Albert</surname> <given-names>DVF</given-names></name><name><surname>Venkateswaran</surname> <given-names>S</given-names></name><name><surname>Ware</surname> <given-names>T</given-names></name><name><surname>Jones</surname> <given-names>D</given-names></name><name><surname>Liu</surname> <given-names>YC</given-names></name><name><surname>Mohammad</surname> <given-names>SS</given-names></name><name><surname>Bizargity</surname> <given-names>P</given-names></name><name><surname>Bacino</surname> <given-names>CA</given-names></name><name><surname>Leuzzi</surname> <given-names>V</given-names></name><name><surname>Martinelli</surname> <given-names>S</given-names></name><name><surname>Dallapiccola</surname> <given-names>B</given-names></name><name><surname>Tartaglia</surname> <given-names>M</given-names></name><name><surname>Blumkin</surname> <given-names>L</given-names></name><name><surname>Wierenga</surname> <given-names>KJ</given-names></name><name><surname>Purcarin</surname> <given-names>G</given-names></name><name><surname>O'Byrne</surname> <given-names>JJ</given-names></name><name><surname>Stockler</surname> <given-names>S</given-names></name><name><surname>Lehman</surname> <given-names>A</given-names></name><name><surname>Keren</surname> <given-names>B</given-names></name><name><surname>Nougues</surname> <given-names>MC</given-names></name><name><surname>Mignot</surname> <given-names>C</given-names></name><name><surname>Auvin</surname> <given-names>S</given-names></name><name><surname>Nava</surname> <given-names>C</given-names></name><name><surname>Hiatt</surname> <given-names>SM</given-names></name><name><surname>Bebin</surname> <given-names>M</given-names></name><name><surname>Shao</surname> <given-names>Y</given-names></name><name><surname>Scaglia</surname> <given-names>F</given-names></name><name><surname>Lalani</surname> <given-names>SR</given-names></name><name><surname>Frye</surname> <given-names>RE</given-names></name><name><surname>Jarjour</surname> <given-names>IT</given-names></name><name><surname>Jacques</surname> <given-names>S</given-names></name><name><surname>Boucher</surname> <given-names>RM</given-names></name><name><surname>Riou</surname> <given-names>E</given-names></name><name><surname>Srour</surname> <given-names>M</given-names></name><name><surname>Carmant</surname> <given-names>L</given-names></name><name><surname>Lortie</surname> <given-names>A</given-names></name><name><surname>Major</surname> <given-names>P</given-names></name><name><surname>Diadori</surname> <given-names>P</given-names></name><name><surname>Dubeau</surname> <given-names>F</given-names></name><name><surname>D'Anjou</surname> <given-names>G</given-names></name><name><surname>Bourque</surname> <given-names>G</given-names></name><name><surname>Berkovic</surname> <given-names>SF</given-names></name><name><surname>Sadleir</surname> <given-names>LG</given-names></name><name><surname>Campeau</surname> <given-names>PM</given-names></name><name><surname>Kibar</surname> <given-names>Z</given-names></name><name><surname>Lafrenière</surname> <given-names>RG</given-names></name><name><surname>Girard</surname> <given-names>SL</given-names></name><name><surname>Mercimek-Mahmutoglu</surname> <given-names>S</given-names></name><name><surname>Boelman</surname> <given-names>C</given-names></name><name><surname>Rouleau</surname> <given-names>GA</given-names></name><name><surname>Scheffer</surname> <given-names>IE</given-names></name><name><surname>Mefford</surname> <given-names>HC</given-names></name><name><surname>Andrade</surname> <given-names>DM</given-names></name><name><surname>Rossignol</surname> <given-names>E</given-names></name><name><surname>Minassian</surname> <given-names>BA</given-names></name><name><surname>Michaud</surname> <given-names>JL</given-names></name><collab>Deciphering Developmental Disorders Study</collab></person-group><year iso-8601-date="2017">2017</year><article-title>High rate of recurrent de novo mutations in developmental and epileptic encephalopathies</article-title><source>The American Journal of Human Genetics</source><volume>101</volume><fpage>664</fpage><lpage>685</lpage><pub-id pub-id-type="doi">10.1016/j.ajhg.2017.09.008</pub-id><pub-id pub-id-type="pmid">29100083</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harrison</surname> <given-names>SD</given-names></name><name><surname>Broadie</surname> <given-names>K</given-names></name><name><surname>van de Goor</surname> <given-names>J</given-names></name><name><surname>Rubin</surname> <given-names>GM</given-names></name></person-group><year iso-8601-date="1994">1994</year><article-title>Mutations in the <italic>Drosophila</italic> rop gene suggest a function in general secretion and synaptic transmission</article-title><source>Neuron</source><volume>13</volume><fpage>555</fpage><lpage>566</lpage><pub-id pub-id-type="doi">10.1016/0896-6273(94)90025-6</pub-id><pub-id pub-id-type="pmid">7917291</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hayashi</surname> <given-names>S</given-names></name><name><surname>Lewis</surname> <given-names>P</given-names></name><name><surname>Pevny</surname> <given-names>L</given-names></name><name><surname>McMahon</surname> <given-names>AP</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Efficient gene modulation in mouse epiblast using a Sox2Cre transgenic mouse strain</article-title><source>Mechanisms of Development</source><volume>119</volume><fpage>S97</fpage><lpage>S101</lpage><pub-id pub-id-type="doi">10.1016/S0925-4773(03)00099-6</pub-id><pub-id pub-id-type="pmid">14516668</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heeroma</surname> <given-names>JH</given-names></name><name><surname>Roelandse</surname> <given-names>M</given-names></name><name><surname>Wierda</surname> <given-names>K</given-names></name><name><surname>van Aerde</surname> <given-names>KI</given-names></name><name><surname>Toonen</surname> <given-names>RF</given-names></name><name><surname>Hensbroek</surname> <given-names>RA</given-names></name><name><surname>Brussaard</surname> <given-names>A</given-names></name><name><surname>Matus</surname> <given-names>A</given-names></name><name><surname>Verhage</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Trophic support delays but does not prevent cell-intrinsic degeneration of neurons deficient for munc18-1</article-title><source>European Journal of Neuroscience</source><volume>20</volume><fpage>623</fpage><lpage>634</lpage><pub-id pub-id-type="doi">10.1111/j.1460-9568.2004.03503.x</pub-id><pub-id pub-id-type="pmid">15255974</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hippenmeyer</surname> <given-names>S</given-names></name><name><surname>Vrieseling</surname> <given-names>E</given-names></name><name><surname>Sigrist</surname> <given-names>M</given-names></name><name><surname>Portmann</surname> <given-names>T</given-names></name><name><surname>Laengle</surname> <given-names>C</given-names></name><name><surname>Ladle</surname> <given-names>DR</given-names></name><name><surname>Arber</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>A developmental switch in the response of DRG neurons to ETS transcription factor signaling</article-title><source>PLOS Biology</source><volume>3</volume><elocation-id>e159</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pbio.0030159</pub-id><pub-id pub-id-type="pmid">15836427</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoischen</surname> <given-names>A</given-names></name><name><surname>Krumm</surname> <given-names>N</given-names></name><name><surname>Eichler</surname> <given-names>EE</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Prioritization of neurodevelopmental disease genes by discovery of new mutations</article-title><source>Nature Neuroscience</source><volume>17</volume><fpage>764</fpage><lpage>772</lpage><pub-id pub-id-type="doi">10.1038/nn.3703</pub-id><pub-id pub-id-type="pmid">24866042</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ito-Ishida</surname> <given-names>A</given-names></name><name><surname>Ure</surname> <given-names>K</given-names></name><name><surname>Chen</surname> <given-names>H</given-names></name><name><surname>Swann</surname> <given-names>JW</given-names></name><name><surname>Zoghbi</surname> <given-names>HY</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Loss of MeCP2 in Parvalbumin-and Somatostatin-Expressing neurons in mice leads to distinct rett Syndrome-like phenotypes</article-title><source>Neuron</source><volume>88</volume><fpage>651</fpage><lpage>658</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2015.10.029</pub-id><pub-id pub-id-type="pmid">26590342</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kovacevic</surname> <given-names>J</given-names></name><name><surname>Maroteaux</surname> <given-names>G</given-names></name><name><surname>Schut</surname> <given-names>D</given-names></name><name><surname>Loos</surname> <given-names>M</given-names></name><name><surname>Dubey</surname> <given-names>M</given-names></name><name><surname>Pitsch</surname> <given-names>J</given-names></name><name><surname>Remmelink</surname> <given-names>E</given-names></name><name><surname>Koopmans</surname> <given-names>B</given-names></name><name><surname>Crowley</surname> <given-names>J</given-names></name><name><surname>Cornelisse</surname> <given-names>LN</given-names></name><name><surname>Sullivan</surname> <given-names>PF</given-names></name><name><surname>Schoch</surname> <given-names>S</given-names></name><name><surname>Toonen</surname> <given-names>RF</given-names></name><name><surname>Stiedl</surname> <given-names>O</given-names></name><name><surname>Verhage</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Protein instability, Haploinsufficiency, and cortical hyper-excitability underlie STXBP1 encephalopathy</article-title><source>Brain</source><volume>141</volume><fpage>1350</fpage><lpage>1374</lpage><pub-id pub-id-type="doi">10.1093/brain/awy046</pub-id><pub-id pub-id-type="pmid">29538625</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kraushaar</surname> <given-names>U</given-names></name><name><surname>Jonas</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Efficacy and stability of quantal GABA release at a hippocampal interneuron-principal neuron synapse</article-title><source>The Journal of Neuroscience</source><volume>20</volume><fpage>5594</fpage><lpage>5607</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.20-15-05594.2000</pub-id><pub-id pub-id-type="pmid">10908596</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Law</surname> <given-names>C</given-names></name><name><surname>Schaan Profes</surname> <given-names>M</given-names></name><name><surname>Levesque</surname> <given-names>M</given-names></name><name><surname>Kaltschmidt</surname> <given-names>JA</given-names></name><name><surname>Verhage</surname> <given-names>M</given-names></name><name><surname>Kania</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Normal molecular specification and neurodegenerative Disease-Like death of spinal neurons lacking the SNARE-Associated synaptic protein Munc18-1</article-title><source>Journal of Neuroscience</source><volume>36</volume><fpage>561</fpage><lpage>576</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.1964-15.2016</pub-id><pub-id pub-id-type="pmid">26758845</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname> <given-names>E</given-names></name><name><surname>Lee</surname> <given-names>J</given-names></name><name><surname>Kim</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Excitation/Inhibition imbalance in animal models of autism spectrum disorders</article-title><source>Biological Psychiatry</source><volume>81</volume><fpage>838</fpage><lpage>847</lpage><pub-id pub-id-type="doi">10.1016/j.biopsych.2016.05.011</pub-id><pub-id pub-id-type="pmid">27450033</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Letts</surname> <given-names>VA</given-names></name><name><surname>Beyer</surname> <given-names>BJ</given-names></name><name><surname>Frankel</surname> <given-names>WN</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Hidden in plain sight: spike-wave discharges in mouse inbred strains</article-title><source>Genes, Brain and Behavior</source><volume>13</volume><fpage>519</fpage><lpage>526</lpage><pub-id pub-id-type="doi">10.1111/gbb.12142</pub-id><pub-id pub-id-type="pmid">24861780</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>X</given-names></name><name><surname>Gutierrez</surname> <given-names>DV</given-names></name><name><surname>Hanson</surname> <given-names>MG</given-names></name><name><surname>Han</surname> <given-names>J</given-names></name><name><surname>Mark</surname> <given-names>MD</given-names></name><name><surname>Chiel</surname> <given-names>H</given-names></name><name><surname>Hegemann</surname> <given-names>P</given-names></name><name><surname>Landmesser</surname> <given-names>LT</given-names></name><name><surname>Herlitze</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Fast noninvasive activation and inhibition of neural and network activity by vertebrate rhodopsin and green algae channelrhodopsin</article-title><source>PNAS</source><volume>102</volume><fpage>17816</fpage><lpage>17821</lpage><pub-id pub-id-type="doi">10.1073/pnas.0509030102</pub-id><pub-id pub-id-type="pmid">16306259</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lindy</surname> <given-names>AS</given-names></name><name><surname>Stosser</surname> <given-names>MB</given-names></name><name><surname>Butler</surname> <given-names>E</given-names></name><name><surname>Downtain-Pickersgill</surname> <given-names>C</given-names></name><name><surname>Shanmugham</surname> <given-names>A</given-names></name><name><surname>Retterer</surname> <given-names>K</given-names></name><name><surname>Brandt</surname> <given-names>T</given-names></name><name><surname>Richard</surname> <given-names>G</given-names></name><name><surname>McKnight</surname> <given-names>DA</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Diagnostic outcomes for genetic testing of 70 genes in 8565 patients with epilepsy and neurodevelopmental disorders</article-title><source>Epilepsia</source><volume>59</volume><fpage>1062</fpage><lpage>1071</lpage><pub-id pub-id-type="doi">10.1111/epi.14074</pub-id><pub-id pub-id-type="pmid">29655203</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lipstein</surname> <given-names>N</given-names></name><name><surname>Verhoeven-Duif</surname> <given-names>NM</given-names></name><name><surname>Michelassi</surname> <given-names>FE</given-names></name><name><surname>Calloway</surname> <given-names>N</given-names></name><name><surname>van Hasselt</surname> <given-names>PM</given-names></name><name><surname>Pienkowska</surname> <given-names>K</given-names></name><name><surname>van Haaften</surname> <given-names>G</given-names></name><name><surname>van Haelst</surname> <given-names>MM</given-names></name><name><surname>van Empelen</surname> <given-names>R</given-names></name><name><surname>Cuppen</surname> <given-names>I</given-names></name><name><surname>van Teeseling</surname> <given-names>HC</given-names></name><name><surname>Evelein</surname> <given-names>AM</given-names></name><name><surname>Vorstman</surname> <given-names>JA</given-names></name><name><surname>Thoms</surname> <given-names>S</given-names></name><name><surname>Jahn</surname> <given-names>O</given-names></name><name><surname>Duran</surname> <given-names>KJ</given-names></name><name><surname>Monroe</surname> <given-names>GR</given-names></name><name><surname>Ryan</surname> <given-names>TA</given-names></name><name><surname>Taschenberger</surname> <given-names>H</given-names></name><name><surname>Dittman</surname> <given-names>JS</given-names></name><name><surname>Rhee</surname> <given-names>JS</given-names></name><name><surname>Visser</surname> <given-names>G</given-names></name><name><surname>Jans</surname> <given-names>JJ</given-names></name><name><surname>Brose</surname> <given-names>N</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Synaptic UNC13A protein variant causes increased neurotransmission and dyskinetic movement disorder</article-title><source>Journal of Clinical Investigation</source><volume>127</volume><fpage>1005</fpage><lpage>1018</lpage><pub-id pub-id-type="doi">10.1172/JCI90259</pub-id><pub-id pub-id-type="pmid">28192369</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luthi</surname> <given-names>A</given-names></name><name><surname>Di Paolo</surname> <given-names>G</given-names></name><name><surname>Cremona</surname> <given-names>O</given-names></name><name><surname>Daniell</surname> <given-names>L</given-names></name><name><surname>De Camilli</surname> <given-names>P</given-names></name><name><surname>McCormick</surname> <given-names>DA</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Synaptojanin 1 contributes to maintaining the stability of GABAergic transmission in primary cultures of cortical neurons</article-title><source>The Journal of Neuroscience</source><volume>21</volume><fpage>9101</fpage><lpage>9111</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.21-23-09101.2001</pub-id><pub-id pub-id-type="pmid">11717343</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Madisen</surname> <given-names>L</given-names></name><name><surname>Zwingman</surname> <given-names>TA</given-names></name><name><surname>Sunkin</surname> <given-names>SM</given-names></name><name><surname>Oh</surname> <given-names>SW</given-names></name><name><surname>Zariwala</surname> <given-names>HA</given-names></name><name><surname>Gu</surname> <given-names>H</given-names></name><name><surname>Ng</surname> <given-names>LL</given-names></name><name><surname>Palmiter</surname> <given-names>RD</given-names></name><name><surname>Hawrylycz</surname> <given-names>MJ</given-names></name><name><surname>Jones</surname> <given-names>AR</given-names></name><name><surname>Lein</surname> <given-names>ES</given-names></name><name><surname>Zeng</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>A robust and high-throughput cre reporting and characterization system for the whole mouse brain</article-title><source>Nature Neuroscience</source><volume>13</volume><fpage>133</fpage><lpage>140</lpage><pub-id pub-id-type="doi">10.1038/nn.2467</pub-id><pub-id pub-id-type="pmid">20023653</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maheshwari</surname> <given-names>A</given-names></name><name><surname>Noebels</surname> <given-names>JL</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Monogenic models of absence epilepsy: windows into the complex balance between inhibition and excitation in thalamocortical microcircuits</article-title><source>Progress in Brain Research</source><volume>213</volume><fpage>223</fpage><lpage>252</lpage><pub-id pub-id-type="doi">10.1016/B978-0-444-63326-2.00012-0</pub-id><pub-id pub-id-type="pmid">25194492</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marín</surname> <given-names>O</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Interneuron dysfunction in psychiatric disorders</article-title><source>Nature Reviews Neuroscience</source><volume>13</volume><fpage>107</fpage><lpage>120</lpage><pub-id pub-id-type="doi">10.1038/nrn3155</pub-id><pub-id pub-id-type="pmid">22251963</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Messier</surname> <given-names>JE</given-names></name><name><surname>Chen</surname> <given-names>H</given-names></name><name><surname>Cai</surname> <given-names>Z-L</given-names></name><name><surname>Xue</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Targeting light-gated chloride channels to neuronal somatodendritic domain reduces their excitatory effect in the axon</article-title><source>eLife</source><volume>7</volume><elocation-id>e38506</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.38506</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mignot</surname> <given-names>C</given-names></name><name><surname>Moutard</surname> <given-names>ML</given-names></name><name><surname>Trouillard</surname> <given-names>O</given-names></name><name><surname>Gourfinkel-An</surname> <given-names>I</given-names></name><name><surname>Jacquette</surname> <given-names>A</given-names></name><name><surname>Arveiler</surname> <given-names>B</given-names></name><name><surname>Morice-Picard</surname> <given-names>F</given-names></name><name><surname>Lacombe</surname> <given-names>D</given-names></name><name><surname>Chiron</surname> <given-names>C</given-names></name><name><surname>Ville</surname> <given-names>D</given-names></name><name><surname>Charles</surname> <given-names>P</given-names></name><name><surname>LeGuern</surname> <given-names>E</given-names></name><name><surname>Depienne</surname> <given-names>C</given-names></name><name><surname>Héron</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>STXBP1-related encephalopathy presenting as infantile spasms and generalized tremor in three patients</article-title><source>Epilepsia</source><volume>52</volume><fpage>1820</fpage><lpage>1827</lpage><pub-id pub-id-type="doi">10.1111/j.1528-1167.2011.03163.x</pub-id><pub-id pub-id-type="pmid">21762454</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Milh</surname> <given-names>M</given-names></name><name><surname>Villeneuve</surname> <given-names>N</given-names></name><name><surname>Chouchane</surname> <given-names>M</given-names></name><name><surname>Kaminska</surname> <given-names>A</given-names></name><name><surname>Laroche</surname> <given-names>C</given-names></name><name><surname>Barthez</surname> <given-names>MA</given-names></name><name><surname>Gitiaux</surname> <given-names>C</given-names></name><name><surname>Bartoli</surname> <given-names>C</given-names></name><name><surname>Borges-Correia</surname> <given-names>A</given-names></name><name><surname>Cacciagli</surname> <given-names>P</given-names></name><name><surname>Mignon-Ravix</surname> <given-names>C</given-names></name><name><surname>Cuberos</surname> <given-names>H</given-names></name><name><surname>Chabrol</surname> <given-names>B</given-names></name><name><surname>Villard</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Epileptic and nonepileptic features in patients with early onset epileptic encephalopathy and STXBP1 mutations</article-title><source>Epilepsia</source><volume>52</volume><fpage>1828</fpage><lpage>1834</lpage><pub-id pub-id-type="doi">10.1111/j.1528-1167.2011.03181.x</pub-id><pub-id pub-id-type="pmid">21770924</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miyamoto</surname> <given-names>H</given-names></name><name><surname>Shimohata</surname> <given-names>A</given-names></name><name><surname>Abe</surname> <given-names>M</given-names></name><name><surname>Abe</surname> <given-names>T</given-names></name><name><surname>Mazaki</surname> <given-names>E</given-names></name><name><surname>Amano</surname> <given-names>K</given-names></name><name><surname>Suzuki</surname> <given-names>T</given-names></name><name><surname>Tatsukawa</surname> <given-names>T</given-names></name><name><surname>Itohara</surname> <given-names>S</given-names></name><name><surname>Sakimura</surname> <given-names>K</given-names></name><name><surname>Yamakawa</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Potentiation of excitatory synaptic transmission ameliorates aggression in mice with Stxbp1 haploinsufficiency</article-title><source>Human Molecular Genetics</source><volume>26</volume><fpage>4961</fpage><lpage>4974</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddx379</pub-id><pub-id pub-id-type="pmid">29040524</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miyamoto</surname> <given-names>H</given-names></name><name><surname>Tatsukawa</surname> <given-names>T</given-names></name><name><surname>Shimohata</surname> <given-names>A</given-names></name><name><surname>Yamagata</surname> <given-names>T</given-names></name><name><surname>Suzuki</surname> <given-names>T</given-names></name><name><surname>Amano</surname> <given-names>K</given-names></name><name><surname>Mazaki</surname> <given-names>E</given-names></name><name><surname>Raveau</surname> <given-names>M</given-names></name><name><surname>Ogiwara</surname> <given-names>I</given-names></name><name><surname>Oba-Asaka</surname> <given-names>A</given-names></name><name><surname>Hensch</surname> <given-names>TK</given-names></name><name><surname>Itohara</surname> <given-names>S</given-names></name><name><surname>Sakimura</surname> <given-names>K</given-names></name><name><surname>Kobayashi</surname> <given-names>K</given-names></name><name><surname>Kobayashi</surname> <given-names>K</given-names></name><name><surname>Yamakawa</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Impaired cortico-striatal excitatory transmission triggers epilepsy</article-title><source>Nature Communications</source><volume>10</volume><elocation-id>1917</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-019-09954-9</pub-id><pub-id pub-id-type="pmid">31015467</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nagel</surname> <given-names>G</given-names></name><name><surname>Szellas</surname> <given-names>T</given-names></name><name><surname>Huhn</surname> <given-names>W</given-names></name><name><surname>Kateriya</surname> <given-names>S</given-names></name><name><surname>Adeishvili</surname> <given-names>N</given-names></name><name><surname>Berthold</surname> <given-names>P</given-names></name><name><surname>Ollig</surname> <given-names>D</given-names></name><name><surname>Hegemann</surname> <given-names>P</given-names></name><name><surname>Bamberg</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Channelrhodopsin-2, a directly light-gated cation-selective membrane channel</article-title><source>PNAS</source><volume>100</volume><fpage>13940</fpage><lpage>13945</lpage><pub-id pub-id-type="doi">10.1073/pnas.1936192100</pub-id><pub-id pub-id-type="pmid">14615590</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nelson</surname> <given-names>SB</given-names></name><name><surname>Valakh</surname> <given-names>V</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Excitatory/Inhibitory balance and circuit homeostasis in autism spectrum disorders</article-title><source>Neuron</source><volume>87</volume><fpage>684</fpage><lpage>698</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2015.07.033</pub-id><pub-id pub-id-type="pmid">26291155</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ogden</surname> <given-names>KK</given-names></name><name><surname>Ozkan</surname> <given-names>ED</given-names></name><name><surname>Rumbaugh</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Prioritizing the development of mouse models for childhood brain disorders</article-title><source>Neuropharmacology</source><volume>100</volume><fpage>2</fpage><lpage>16</lpage><pub-id pub-id-type="doi">10.1016/j.neuropharm.2015.07.029</pub-id><pub-id pub-id-type="pmid">26231830</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Orock</surname> <given-names>A</given-names></name><name><surname>Logan</surname> <given-names>S</given-names></name><name><surname>Deak</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Munc18-1 haploinsufficiency impairs learning and memory by reduced synaptic vesicular release in a model of ohtahara syndrome</article-title><source>Molecular and Cellular Neuroscience</source><volume>88</volume><fpage>33</fpage><lpage>42</lpage><pub-id pub-id-type="doi">10.1016/j.mcn.2017.12.002</pub-id><pub-id pub-id-type="pmid">29217410</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Otsuka</surname> <given-names>M</given-names></name><name><surname>Oguni</surname> <given-names>H</given-names></name><name><surname>Liang</surname> <given-names>JS</given-names></name><name><surname>Ikeda</surname> <given-names>H</given-names></name><name><surname>Imai</surname> <given-names>K</given-names></name><name><surname>Hirasawa</surname> <given-names>K</given-names></name><name><surname>Imai</surname> <given-names>K</given-names></name><name><surname>Tachikawa</surname> <given-names>E</given-names></name><name><surname>Shimojima</surname> <given-names>K</given-names></name><name><surname>Osawa</surname> <given-names>M</given-names></name><name><surname>Yamamoto</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>STXBP1 mutations cause not only ohtahara syndrome but also west syndrome--result of japanese cohort study</article-title><source>Epilepsia</source><volume>51</volume><fpage>2449</fpage><lpage>2452</lpage><pub-id pub-id-type="doi">10.1111/j.1528-1167.2010.02767.x</pub-id><pub-id pub-id-type="pmid">21204804</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patzke</surname> <given-names>C</given-names></name><name><surname>Han</surname> <given-names>Y</given-names></name><name><surname>Covy</surname> <given-names>J</given-names></name><name><surname>Yi</surname> <given-names>F</given-names></name><name><surname>Maxeiner</surname> <given-names>S</given-names></name><name><surname>Wernig</surname> <given-names>M</given-names></name><name><surname>Südhof</surname> <given-names>TC</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Analysis of conditional heterozygous STXBP1 mutations in human neurons</article-title><source>Journal of Clinical Investigation</source><volume>125</volume><fpage>3560</fpage><lpage>3571</lpage><pub-id pub-id-type="doi">10.1172/JCI78612</pub-id><pub-id pub-id-type="pmid">26280581</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paz</surname> <given-names>JT</given-names></name><name><surname>Huguenard</surname> <given-names>JR</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Microcircuits and their interactions in epilepsy: is the focus out of focus?</article-title><source>Nature Neuroscience</source><volume>18</volume><fpage>351</fpage><lpage>359</lpage><pub-id pub-id-type="doi">10.1038/nn.3950</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prakash</surname> <given-names>R</given-names></name><name><surname>Yizhar</surname> <given-names>O</given-names></name><name><surname>Grewe</surname> <given-names>B</given-names></name><name><surname>Ramakrishnan</surname> <given-names>C</given-names></name><name><surname>Wang</surname> <given-names>N</given-names></name><name><surname>Goshen</surname> <given-names>I</given-names></name><name><surname>Packer</surname> <given-names>AM</given-names></name><name><surname>Peterka</surname> <given-names>DS</given-names></name><name><surname>Yuste</surname> <given-names>R</given-names></name><name><surname>Schnitzer</surname> <given-names>MJ</given-names></name><name><surname>Deisseroth</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Two-photon optogenetic toolbox for fast inhibition, excitation and bistable modulation</article-title><source>Nature Methods</source><volume>9</volume><fpage>1171</fpage><lpage>1179</lpage><pub-id pub-id-type="doi">10.1038/nmeth.2215</pub-id><pub-id pub-id-type="pmid">23169303</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramamoorthi</surname> <given-names>K</given-names></name><name><surname>Lin</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>The contribution of GABAergic dysfunction to neurodevelopmental disorders</article-title><source>Trends in Molecular Medicine</source><volume>17</volume><fpage>452</fpage><lpage>462</lpage><pub-id pub-id-type="doi">10.1016/j.molmed.2011.03.003</pub-id><pub-id pub-id-type="pmid">21514225</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rauch</surname> <given-names>A</given-names></name><name><surname>Wieczorek</surname> <given-names>D</given-names></name><name><surname>Graf</surname> <given-names>E</given-names></name><name><surname>Wieland</surname> <given-names>T</given-names></name><name><surname>Endele</surname> <given-names>S</given-names></name><name><surname>Schwarzmayr</surname> <given-names>T</given-names></name><name><surname>Albrecht</surname> <given-names>B</given-names></name><name><surname>Bartholdi</surname> <given-names>D</given-names></name><name><surname>Beygo</surname> <given-names>J</given-names></name><name><surname>Di Donato</surname> <given-names>N</given-names></name><name><surname>Dufke</surname> <given-names>A</given-names></name><name><surname>Cremer</surname> <given-names>K</given-names></name><name><surname>Hempel</surname> <given-names>M</given-names></name><name><surname>Horn</surname> <given-names>D</given-names></name><name><surname>Hoyer</surname> <given-names>J</given-names></name><name><surname>Joset</surname> <given-names>P</given-names></name><name><surname>Röpke</surname> <given-names>A</given-names></name><name><surname>Moog</surname> <given-names>U</given-names></name><name><surname>Riess</surname> <given-names>A</given-names></name><name><surname>Thiel</surname> <given-names>CT</given-names></name><name><surname>Tzschach</surname> <given-names>A</given-names></name><name><surname>Wiesener</surname> <given-names>A</given-names></name><name><surname>Wohlleber</surname> <given-names>E</given-names></name><name><surname>Zweier</surname> <given-names>C</given-names></name><name><surname>Ekici</surname> <given-names>AB</given-names></name><name><surname>Zink</surname> <given-names>AM</given-names></name><name><surname>Rump</surname> <given-names>A</given-names></name><name><surname>Meisinger</surname> <given-names>C</given-names></name><name><surname>Grallert</surname> <given-names>H</given-names></name><name><surname>Sticht</surname> <given-names>H</given-names></name><name><surname>Schenck</surname> <given-names>A</given-names></name><name><surname>Engels</surname> <given-names>H</given-names></name><name><surname>Rappold</surname> <given-names>G</given-names></name><name><surname>Schröck</surname> <given-names>E</given-names></name><name><surname>Wieacker</surname> <given-names>P</given-names></name><name><surname>Riess</surname> <given-names>O</given-names></name><name><surname>Meitinger</surname> <given-names>T</given-names></name><name><surname>Reis</surname> <given-names>A</given-names></name><name><surname>Strom</surname> <given-names>TM</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Range of genetic mutations associated with severe non-syndromic sporadic intellectual disability: an exome sequencing study</article-title><source>The Lancet</source><volume>380</volume><fpage>1674</fpage><lpage>1682</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(12)61480-9</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raymond</surname> <given-names>CS</given-names></name><name><surname>Soriano</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>High-efficiency FLP and PhiC31 site-specific recombination in mammalian cells</article-title><source>PLOS ONE</source><volume>2</volume><elocation-id>e162</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0000162</pub-id><pub-id pub-id-type="pmid">17225864</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rizo</surname> <given-names>J</given-names></name><name><surname>Xu</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>The synaptic vesicle release machinery</article-title><source>Annual Review of Biophysics</source><volume>44</volume><fpage>339</fpage><lpage>367</lpage><pub-id pub-id-type="doi">10.1146/annurev-biophys-060414-034057</pub-id><pub-id pub-id-type="pmid">26098518</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rohena</surname> <given-names>L</given-names></name><name><surname>Neidich</surname> <given-names>J</given-names></name><name><surname>Truitt Cho</surname> <given-names>M</given-names></name><name><surname>Gonzalez</surname> <given-names>KD</given-names></name><name><surname>Tang</surname> <given-names>S</given-names></name><name><surname>Devinsky</surname> <given-names>O</given-names></name><name><surname>Chung</surname> <given-names>WK</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Mutation in <italic>SNAP25</italic> as a novel genetic cause of epilepsy and intellectual disability</article-title><source>Rare Diseases</source><volume>1</volume><elocation-id>e26314</elocation-id><pub-id pub-id-type="doi">10.4161/rdis.26314</pub-id><pub-id pub-id-type="pmid">25003006</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rubinstein</surname> <given-names>M</given-names></name><name><surname>Han</surname> <given-names>S</given-names></name><name><surname>Tai</surname> <given-names>C</given-names></name><name><surname>Westenbroek</surname> <given-names>RE</given-names></name><name><surname>Hunker</surname> <given-names>A</given-names></name><name><surname>Scheuer</surname> <given-names>T</given-names></name><name><surname>Catterall</surname> <given-names>WA</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Dissecting the phenotypes of dravet syndrome by gene deletion</article-title><source>Brain</source><volume>138</volume><fpage>2219</fpage><lpage>2233</lpage><pub-id pub-id-type="doi">10.1093/brain/awv142</pub-id><pub-id pub-id-type="pmid">26017580</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saitsu</surname> <given-names>H</given-names></name><name><surname>Kato</surname> <given-names>M</given-names></name><name><surname>Mizuguchi</surname> <given-names>T</given-names></name><name><surname>Hamada</surname> <given-names>K</given-names></name><name><surname>Osaka</surname> <given-names>H</given-names></name><name><surname>Tohyama</surname> <given-names>J</given-names></name><name><surname>Uruno</surname> <given-names>K</given-names></name><name><surname>Kumada</surname> <given-names>S</given-names></name><name><surname>Nishiyama</surname> <given-names>K</given-names></name><name><surname>Nishimura</surname> <given-names>A</given-names></name><name><surname>Okada</surname> <given-names>I</given-names></name><name><surname>Yoshimura</surname> <given-names>Y</given-names></name><name><surname>Hirai</surname> <given-names>S</given-names></name><name><surname>Kumada</surname> <given-names>T</given-names></name><name><surname>Hayasaka</surname> <given-names>K</given-names></name><name><surname>Fukuda</surname> <given-names>A</given-names></name><name><surname>Ogata</surname> <given-names>K</given-names></name><name><surname>Matsumoto</surname> <given-names>N</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>De novo mutations in the gene encoding STXBP1 (MUNC18-1) cause early infantile epileptic encephalopathy</article-title><source>Nature Genetics</source><volume>40</volume><fpage>782</fpage><lpage>788</lpage><pub-id pub-id-type="doi">10.1038/ng.150</pub-id><pub-id pub-id-type="pmid">18469812</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saitsu</surname> <given-names>H</given-names></name><name><surname>Kato</surname> <given-names>M</given-names></name><name><surname>Okada</surname> <given-names>I</given-names></name><name><surname>Orii</surname> <given-names>KE</given-names></name><name><surname>Higuchi</surname> <given-names>T</given-names></name><name><surname>Hoshino</surname> <given-names>H</given-names></name><name><surname>Kubota</surname> <given-names>M</given-names></name><name><surname>Arai</surname> <given-names>H</given-names></name><name><surname>Tagawa</surname> <given-names>T</given-names></name><name><surname>Kimura</surname> <given-names>S</given-names></name><name><surname>Sudo</surname> <given-names>A</given-names></name><name><surname>Miyama</surname> <given-names>S</given-names></name><name><surname>Takami</surname> <given-names>Y</given-names></name><name><surname>Watanabe</surname> <given-names>T</given-names></name><name><surname>Nishimura</surname> <given-names>A</given-names></name><name><surname>Nishiyama</surname> <given-names>K</given-names></name><name><surname>Miyake</surname> <given-names>N</given-names></name><name><surname>Wada</surname> <given-names>T</given-names></name><name><surname>Osaka</surname> <given-names>H</given-names></name><name><surname>Kondo</surname> <given-names>N</given-names></name><name><surname>Hayasaka</surname> <given-names>K</given-names></name><name><surname>Matsumoto</surname> <given-names>N</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>STXBP1 mutations in early infantile epileptic encephalopathy with suppression-burst pattern</article-title><source>Epilepsia</source><volume>51</volume><fpage>2397</fpage><lpage>2405</lpage><pub-id pub-id-type="doi">10.1111/j.1528-1167.2010.02728.x</pub-id><pub-id pub-id-type="pmid">20887364</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salpietro</surname> <given-names>V</given-names></name><name><surname>Malintan</surname> <given-names>NT</given-names></name><name><surname>Llano-Rivas</surname> <given-names>I</given-names></name><name><surname>Spaeth</surname> <given-names>CG</given-names></name><name><surname>Efthymiou</surname> <given-names>S</given-names></name><name><surname>Striano</surname> <given-names>P</given-names></name><name><surname>Vandrovcova</surname> <given-names>J</given-names></name><name><surname>Cutrupi</surname> <given-names>MC</given-names></name><name><surname>Chimenz</surname> <given-names>R</given-names></name><name><surname>David</surname> <given-names>E</given-names></name><name><surname>Di Rosa</surname> <given-names>G</given-names></name><name><surname>Marce-Grau</surname> <given-names>A</given-names></name><name><surname>Raspall-Chaure</surname> <given-names>M</given-names></name><name><surname>Martin-Hernandez</surname> <given-names>E</given-names></name><name><surname>Zara</surname> <given-names>F</given-names></name><name><surname>Minetti</surname> <given-names>C</given-names></name><name><surname>Bello</surname> <given-names>OD</given-names></name><name><surname>De Zorzi</surname> <given-names>R</given-names></name><name><surname>Fortuna</surname> <given-names>S</given-names></name><name><surname>Dauber</surname> <given-names>A</given-names></name><name><surname>Alkhawaja</surname> <given-names>M</given-names></name><name><surname>Sultan</surname> <given-names>T</given-names></name><name><surname>Mankad</surname> <given-names>K</given-names></name><name><surname>Vitobello</surname> <given-names>A</given-names></name><name><surname>Thomas</surname> <given-names>Q</given-names></name><name><surname>Mau-Them</surname> <given-names>FT</given-names></name><name><surname>Faivre</surname> <given-names>L</given-names></name><name><surname>Martinez-Azorin</surname> <given-names>F</given-names></name><name><surname>Prada</surname> <given-names>CE</given-names></name><name><surname>Macaya</surname> <given-names>A</given-names></name><name><surname>Kullmann</surname> <given-names>DM</given-names></name><name><surname>Rothman</surname> <given-names>JE</given-names></name><name><surname>Krishnakumar</surname> <given-names>SS</given-names></name><name><surname>Houlden</surname> <given-names>H</given-names></name><collab>Deciphering Developmental Disorders Study, SYNAPS Study Group</collab></person-group><year iso-8601-date="2019">2019</year><article-title>Mutations in the neuronal vesicular SNARE VAMP2 affect synaptic membrane fusion and impair human neurodevelopment</article-title><source>The American Journal of Human Genetics</source><volume>104</volume><fpage>721</fpage><lpage>730</lpage><pub-id pub-id-type="doi">10.1016/j.ajhg.2019.02.016</pub-id><pub-id pub-id-type="pmid">30929742</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schubert</surname> <given-names>J</given-names></name><name><surname>Siekierska</surname> <given-names>A</given-names></name><name><surname>Langlois</surname> <given-names>M</given-names></name><name><surname>May</surname> <given-names>P</given-names></name><name><surname>Huneau</surname> <given-names>C</given-names></name><name><surname>Becker</surname> <given-names>F</given-names></name><name><surname>Muhle</surname> <given-names>H</given-names></name><name><surname>Suls</surname> <given-names>A</given-names></name><name><surname>Lemke</surname> <given-names>JR</given-names></name><name><surname>de Kovel</surname> <given-names>CG</given-names></name><name><surname>Thiele</surname> <given-names>H</given-names></name><name><surname>Konrad</surname> <given-names>K</given-names></name><name><surname>Kawalia</surname> <given-names>A</given-names></name><name><surname>Toliat</surname> <given-names>MR</given-names></name><name><surname>Sander</surname> <given-names>T</given-names></name><name><surname>Rüschendorf</surname> <given-names>F</given-names></name><name><surname>Caliebe</surname> <given-names>A</given-names></name><name><surname>Nagel</surname> <given-names>I</given-names></name><name><surname>Kohl</surname> <given-names>B</given-names></name><name><surname>Kecskés</surname> <given-names>A</given-names></name><name><surname>Jacmin</surname> <given-names>M</given-names></name><name><surname>Hardies</surname> <given-names>K</given-names></name><name><surname>Weckhuysen</surname> <given-names>S</given-names></name><name><surname>Riesch</surname> <given-names>E</given-names></name><name><surname>Dorn</surname> <given-names>T</given-names></name><name><surname>Brilstra</surname> <given-names>EH</given-names></name><name><surname>Baulac</surname> <given-names>S</given-names></name><name><surname>Møller</surname> <given-names>RS</given-names></name><name><surname>Hjalgrim</surname> <given-names>H</given-names></name><name><surname>Koeleman</surname> <given-names>BP</given-names></name><name><surname>Jurkat-Rott</surname> <given-names>K</given-names></name><name><surname>Lehman-Horn</surname> <given-names>F</given-names></name><name><surname>Roach</surname> <given-names>JC</given-names></name><name><surname>Glusman</surname> <given-names>G</given-names></name><name><surname>Hood</surname> <given-names>L</given-names></name><name><surname>Galas</surname> <given-names>DJ</given-names></name><name><surname>Martin</surname> <given-names>B</given-names></name><name><surname>de Witte</surname> <given-names>PA</given-names></name><name><surname>Biskup</surname> <given-names>S</given-names></name><name><surname>De Jonghe</surname> <given-names>P</given-names></name><name><surname>Helbig</surname> <given-names>I</given-names></name><name><surname>Balling</surname> <given-names>R</given-names></name><name><surname>Nürnberg</surname> <given-names>P</given-names></name><name><surname>Crawford</surname> <given-names>AD</given-names></name><name><surname>Esguerra</surname> <given-names>CV</given-names></name><name><surname>Weber</surname> <given-names>YG</given-names></name><name><surname>Lerche</surname> <given-names>H</given-names></name><collab>EuroEPINOMICS RES Consortium</collab></person-group><year iso-8601-date="2014">2014</year><article-title>Mutations in STX1B, encoding a presynaptic protein, cause fever-associated epilepsy syndromes</article-title><source>Nature Genetics</source><volume>46</volume><fpage>1327</fpage><lpage>1332</lpage><pub-id pub-id-type="doi">10.1038/ng.3130</pub-id><pub-id pub-id-type="pmid">25362483</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shen</surname> <given-names>XM</given-names></name><name><surname>Selcen</surname> <given-names>D</given-names></name><name><surname>Brengman</surname> <given-names>J</given-names></name><name><surname>Engel</surname> <given-names>AG</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Mutant SNAP25B causes Myasthenia, cortical hyperexcitability, ataxia, and intellectual disability</article-title><source>Neurology</source><volume>83</volume><fpage>2247</fpage><lpage>2255</lpage><pub-id pub-id-type="doi">10.1212/WNL.0000000000001079</pub-id><pub-id pub-id-type="pmid">25381298</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Skarnes</surname> <given-names>WC</given-names></name><name><surname>Rosen</surname> <given-names>B</given-names></name><name><surname>West</surname> <given-names>AP</given-names></name><name><surname>Koutsourakis</surname> <given-names>M</given-names></name><name><surname>Bushell</surname> <given-names>W</given-names></name><name><surname>Iyer</surname> <given-names>V</given-names></name><name><surname>Mujica</surname> <given-names>AO</given-names></name><name><surname>Thomas</surname> <given-names>M</given-names></name><name><surname>Harrow</surname> <given-names>J</given-names></name><name><surname>Cox</surname> <given-names>T</given-names></name><name><surname>Jackson</surname> <given-names>D</given-names></name><name><surname>Severin</surname> <given-names>J</given-names></name><name><surname>Biggs</surname> <given-names>P</given-names></name><name><surname>Fu</surname> <given-names>J</given-names></name><name><surname>Nefedov</surname> <given-names>M</given-names></name><name><surname>de Jong</surname> <given-names>PJ</given-names></name><name><surname>Stewart</surname> <given-names>AF</given-names></name><name><surname>Bradley</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>A conditional knockout resource for the genome-wide study of mouse gene function</article-title><source>Nature</source><volume>474</volume><fpage>337</fpage><lpage>342</lpage><pub-id pub-id-type="doi">10.1038/nature10163</pub-id><pub-id pub-id-type="pmid">21677750</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stamberger</surname> <given-names>H</given-names></name><name><surname>Nikanorova</surname> <given-names>M</given-names></name><name><surname>Willemsen</surname> <given-names>MH</given-names></name><name><surname>Accorsi</surname> <given-names>P</given-names></name><name><surname>Angriman</surname> <given-names>M</given-names></name><name><surname>Baier</surname> <given-names>H</given-names></name><name><surname>Benkel-Herrenbrueck</surname> <given-names>I</given-names></name><name><surname>Benoit</surname> <given-names>V</given-names></name><name><surname>Budetta</surname> <given-names>M</given-names></name><name><surname>Caliebe</surname> <given-names>A</given-names></name><name><surname>Cantalupo</surname> <given-names>G</given-names></name><name><surname>Capovilla</surname> <given-names>G</given-names></name><name><surname>Casara</surname> <given-names>G</given-names></name><name><surname>Courage</surname> <given-names>C</given-names></name><name><surname>Deprez</surname> <given-names>M</given-names></name><name><surname>Destrée</surname> <given-names>A</given-names></name><name><surname>Dilena</surname> <given-names>R</given-names></name><name><surname>Erasmus</surname> <given-names>CE</given-names></name><name><surname>Fannemel</surname> <given-names>M</given-names></name><name><surname>Fjær</surname> <given-names>R</given-names></name><name><surname>Giordano</surname> <given-names>L</given-names></name><name><surname>Helbig</surname> <given-names>KL</given-names></name><name><surname>Heyne</surname> <given-names>HO</given-names></name><name><surname>Klepper</surname> <given-names>J</given-names></name><name><surname>Kluger</surname> <given-names>GJ</given-names></name><name><surname>Lederer</surname> <given-names>D</given-names></name><name><surname>Lodi</surname> <given-names>M</given-names></name><name><surname>Maier</surname> <given-names>O</given-names></name><name><surname>Merkenschlager</surname> <given-names>A</given-names></name><name><surname>Michelberger</surname> <given-names>N</given-names></name><name><surname>Minetti</surname> <given-names>C</given-names></name><name><surname>Muhle</surname> <given-names>H</given-names></name><name><surname>Phalin</surname> <given-names>J</given-names></name><name><surname>Ramsey</surname> <given-names>K</given-names></name><name><surname>Romeo</surname> <given-names>A</given-names></name><name><surname>Schallner</surname> <given-names>J</given-names></name><name><surname>Schanze</surname> <given-names>I</given-names></name><name><surname>Shinawi</surname> <given-names>M</given-names></name><name><surname>Sleegers</surname> <given-names>K</given-names></name><name><surname>Sterbova</surname> <given-names>K</given-names></name><name><surname>Syrbe</surname> <given-names>S</given-names></name><name><surname>Traverso</surname> <given-names>M</given-names></name><name><surname>Tzschach</surname> <given-names>A</given-names></name><name><surname>Uldall</surname> <given-names>P</given-names></name><name><surname>Van Coster</surname> <given-names>R</given-names></name><name><surname>Verhelst</surname> <given-names>H</given-names></name><name><surname>Viri</surname> <given-names>M</given-names></name><name><surname>Winter</surname> <given-names>S</given-names></name><name><surname>Wolff</surname> <given-names>M</given-names></name><name><surname>Zenker</surname> <given-names>M</given-names></name><name><surname>Zoccante</surname> <given-names>L</given-names></name><name><surname>De Jonghe</surname> <given-names>P</given-names></name><name><surname>Helbig</surname> <given-names>I</given-names></name><name><surname>Striano</surname> <given-names>P</given-names></name><name><surname>Lemke</surname> <given-names>JR</given-names></name><name><surname>Møller</surname> <given-names>RS</given-names></name><name><surname>Weckhuysen</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>STXBP1 encephalopathy: a neurodevelopmental disorder including epilepsy</article-title><source>Neurology</source><volume>86</volume><fpage>954</fpage><lpage>962</lpage><pub-id pub-id-type="doi">10.1212/WNL.0000000000002457</pub-id><pub-id pub-id-type="pmid">26865513</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stessman</surname> <given-names>HA</given-names></name><name><surname>Xiong</surname> <given-names>B</given-names></name><name><surname>Coe</surname> <given-names>BP</given-names></name><name><surname>Wang</surname> <given-names>T</given-names></name><name><surname>Hoekzema</surname> <given-names>K</given-names></name><name><surname>Fenckova</surname> <given-names>M</given-names></name><name><surname>Kvarnung</surname> <given-names>M</given-names></name><name><surname>Gerdts</surname> <given-names>J</given-names></name><name><surname>Trinh</surname> <given-names>S</given-names></name><name><surname>Cosemans</surname> <given-names>N</given-names></name><name><surname>Vives</surname> <given-names>L</given-names></name><name><surname>Lin</surname> <given-names>J</given-names></name><name><surname>Turner</surname> <given-names>TN</given-names></name><name><surname>Santen</surname> <given-names>G</given-names></name><name><surname>Ruivenkamp</surname> <given-names>C</given-names></name><name><surname>Kriek</surname> <given-names>M</given-names></name><name><surname>van Haeringen</surname> <given-names>A</given-names></name><name><surname>Aten</surname> <given-names>E</given-names></name><name><surname>Friend</surname> <given-names>K</given-names></name><name><surname>Liebelt</surname> <given-names>J</given-names></name><name><surname>Barnett</surname> <given-names>C</given-names></name><name><surname>Haan</surname> <given-names>E</given-names></name><name><surname>Shaw</surname> <given-names>M</given-names></name><name><surname>Gecz</surname> <given-names>J</given-names></name><name><surname>Anderlid</surname> <given-names>BM</given-names></name><name><surname>Nordgren</surname> <given-names>A</given-names></name><name><surname>Lindstrand</surname> <given-names>A</given-names></name><name><surname>Schwartz</surname> <given-names>C</given-names></name><name><surname>Kooy</surname> <given-names>RF</given-names></name><name><surname>Vandeweyer</surname> <given-names>G</given-names></name><name><surname>Helsmoortel</surname> <given-names>C</given-names></name><name><surname>Romano</surname> <given-names>C</given-names></name><name><surname>Alberti</surname> <given-names>A</given-names></name><name><surname>Vinci</surname> <given-names>M</given-names></name><name><surname>Avola</surname> <given-names>E</given-names></name><name><surname>Giusto</surname> <given-names>S</given-names></name><name><surname>Courchesne</surname> <given-names>E</given-names></name><name><surname>Pramparo</surname> <given-names>T</given-names></name><name><surname>Pierce</surname> <given-names>K</given-names></name><name><surname>Nalabolu</surname> <given-names>S</given-names></name><name><surname>Amaral</surname> <given-names>DG</given-names></name><name><surname>Scheffer</surname> <given-names>IE</given-names></name><name><surname>Delatycki</surname> <given-names>MB</given-names></name><name><surname>Lockhart</surname> <given-names>PJ</given-names></name><name><surname>Hormozdiari</surname> <given-names>F</given-names></name><name><surname>Harich</surname> <given-names>B</given-names></name><name><surname>Castells-Nobau</surname> <given-names>A</given-names></name><name><surname>Xia</surname> <given-names>K</given-names></name><name><surname>Peeters</surname> <given-names>H</given-names></name><name><surname>Nordenskjöld</surname> <given-names>M</given-names></name><name><surname>Schenck</surname> <given-names>A</given-names></name><name><surname>Bernier</surname> <given-names>RA</given-names></name><name><surname>Eichler</surname> <given-names>EE</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Targeted sequencing identifies 91 neurodevelopmental-disorder risk genes with autism and developmental-disability biases</article-title><source>Nature Genetics</source><volume>49</volume><fpage>515</fpage><lpage>526</lpage><pub-id pub-id-type="doi">10.1038/ng.3792</pub-id><pub-id pub-id-type="pmid">28191889</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suri</surname> <given-names>M</given-names></name><name><surname>Evers</surname> <given-names>JMG</given-names></name><name><surname>Laskowski</surname> <given-names>RA</given-names></name><name><surname>O'Brien</surname> <given-names>S</given-names></name><name><surname>Baker</surname> <given-names>K</given-names></name><name><surname>Clayton-Smith</surname> <given-names>J</given-names></name><name><surname>Dabir</surname> <given-names>T</given-names></name><name><surname>Josifova</surname> <given-names>D</given-names></name><name><surname>Joss</surname> <given-names>S</given-names></name><name><surname>Kerr</surname> <given-names>B</given-names></name><name><surname>Kraus</surname> <given-names>A</given-names></name><name><surname>McEntagart</surname> <given-names>M</given-names></name><name><surname>Morton</surname> <given-names>J</given-names></name><name><surname>Smith</surname> <given-names>A</given-names></name><name><surname>Splitt</surname> <given-names>M</given-names></name><name><surname>Thornton</surname> <given-names>JM</given-names></name><name><surname>Wright</surname> <given-names>CF</given-names></name><collab>DDD Study</collab></person-group><year iso-8601-date="2017">2017</year><article-title>Protein structure and phenotypic analysis of pathogenic and population missense variants in <italic>STXBP1</italic></article-title><source>Molecular Genetics &amp; Genomic Medicine</source><volume>5</volume><fpage>495</fpage><lpage>507</lpage><pub-id pub-id-type="doi">10.1002/mgg3.304</pub-id><pub-id pub-id-type="pmid">28944233</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taniguchi</surname> <given-names>H</given-names></name><name><surname>He</surname> <given-names>M</given-names></name><name><surname>Wu</surname> <given-names>P</given-names></name><name><surname>Kim</surname> <given-names>S</given-names></name><name><surname>Paik</surname> <given-names>R</given-names></name><name><surname>Sugino</surname> <given-names>K</given-names></name><name><surname>Kvitsiani</surname> <given-names>D</given-names></name><name><surname>Kvitsani</surname> <given-names>D</given-names></name><name><surname>Fu</surname> <given-names>Y</given-names></name><name><surname>Lu</surname> <given-names>J</given-names></name><name><surname>Lin</surname> <given-names>Y</given-names></name><name><surname>Miyoshi</surname> <given-names>G</given-names></name><name><surname>Shima</surname> <given-names>Y</given-names></name><name><surname>Fishell</surname> <given-names>G</given-names></name><name><surname>Nelson</surname> <given-names>SB</given-names></name><name><surname>Huang</surname> <given-names>ZJ</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>A resource of cre driver lines for genetic targeting of GABAergic neurons in cerebral cortex</article-title><source>Neuron</source><volume>71</volume><fpage>995</fpage><lpage>1013</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2011.07.026</pub-id><pub-id pub-id-type="pmid">21943598</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Testa</surname> <given-names>G</given-names></name><name><surname>Schaft</surname> <given-names>J</given-names></name><name><surname>van der Hoeven</surname> <given-names>F</given-names></name><name><surname>Glaser</surname> <given-names>S</given-names></name><name><surname>Anastassiadis</surname> <given-names>K</given-names></name><name><surname>Zhang</surname> <given-names>Y</given-names></name><name><surname>Hermann</surname> <given-names>T</given-names></name><name><surname>Stremmel</surname> <given-names>W</given-names></name><name><surname>Stewart</surname> <given-names>AF</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>A reliable lacZ expression reporter cassette for multipurpose, knockout-first alleles</article-title><source>Genesis</source><volume>38</volume><fpage>151</fpage><lpage>158</lpage><pub-id pub-id-type="doi">10.1002/gene.20012</pub-id><pub-id pub-id-type="pmid">15048813</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thomas</surname> <given-names>A</given-names></name><name><surname>Burant</surname> <given-names>A</given-names></name><name><surname>Bui</surname> <given-names>N</given-names></name><name><surname>Graham</surname> <given-names>D</given-names></name><name><surname>Yuva-Paylor</surname> <given-names>LA</given-names></name><name><surname>Paylor</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Marble burying reflects a repetitive and perseverative behavior more than novelty-induced anxiety</article-title><source>Psychopharmacology</source><volume>204</volume><fpage>361</fpage><lpage>373</lpage><pub-id pub-id-type="doi">10.1007/s00213-009-1466-y</pub-id><pub-id pub-id-type="pmid">19189082</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Toonen</surname> <given-names>RF</given-names></name><name><surname>Wierda</surname> <given-names>K</given-names></name><name><surname>Sons</surname> <given-names>MS</given-names></name><name><surname>de Wit</surname> <given-names>H</given-names></name><name><surname>Cornelisse</surname> <given-names>LN</given-names></name><name><surname>Brussaard</surname> <given-names>A</given-names></name><name><surname>Plomp</surname> <given-names>JJ</given-names></name><name><surname>Verhage</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Munc18-1 expression levels control synapse recovery by regulating readily releasable pool size</article-title><source>PNAS</source><volume>103</volume><fpage>18332</fpage><lpage>18337</lpage><pub-id pub-id-type="doi">10.1073/pnas.0608507103</pub-id><pub-id pub-id-type="pmid">17110441</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Varoqueaux</surname> <given-names>F</given-names></name><name><surname>Sigler</surname> <given-names>A</given-names></name><name><surname>Rhee</surname> <given-names>JS</given-names></name><name><surname>Brose</surname> <given-names>N</given-names></name><name><surname>Enk</surname> <given-names>C</given-names></name><name><surname>Reim</surname> <given-names>K</given-names></name><name><surname>Rosenmund</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Total arrest of spontaneous and evoked synaptic transmission but normal synaptogenesis in the absence of Munc13-mediated vesicle priming</article-title><source>PNAS</source><volume>99</volume><fpage>9037</fpage><lpage>9042</lpage><pub-id pub-id-type="doi">10.1073/pnas.122623799</pub-id><pub-id pub-id-type="pmid">12070347</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verhage</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Synaptic assembly of the brain in the absence of neurotransmitter secretion</article-title><source>Science</source><volume>287</volume><fpage>864</fpage><lpage>869</lpage><pub-id pub-id-type="doi">10.1126/science.287.5454.864</pub-id></element-citation></ref><ref id="bib82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weckhuysen</surname> <given-names>S</given-names></name><name><surname>Holmgren</surname> <given-names>P</given-names></name><name><surname>Hendrickx</surname> <given-names>R</given-names></name><name><surname>Jansen</surname> <given-names>AC</given-names></name><name><surname>Hasaerts</surname> <given-names>D</given-names></name><name><surname>Dielman</surname> <given-names>C</given-names></name><name><surname>de Bellescize</surname> <given-names>J</given-names></name><name><surname>Boutry-Kryza</surname> <given-names>N</given-names></name><name><surname>Lesca</surname> <given-names>G</given-names></name><name><surname>Von Spiczak</surname> <given-names>S</given-names></name><name><surname>Helbig</surname> <given-names>I</given-names></name><name><surname>Gill</surname> <given-names>D</given-names></name><name><surname>Yendle</surname> <given-names>S</given-names></name><name><surname>Møller</surname> <given-names>RS</given-names></name><name><surname>Klitten</surname> <given-names>L</given-names></name><name><surname>Korff</surname> <given-names>C</given-names></name><name><surname>Godfraind</surname> <given-names>C</given-names></name><name><surname>Van Rijckevorsel</surname> <given-names>K</given-names></name><name><surname>De Jonghe</surname> <given-names>P</given-names></name><name><surname>Hjalgrim</surname> <given-names>H</given-names></name><name><surname>Scheffer</surname> <given-names>IE</given-names></name><name><surname>Suls</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Reduction of seizure frequency after epilepsy surgery in a patient with <italic>STXBP1</italic> encephalopathy and clinical description of six novel mutation carriers</article-title><source>Epilepsia</source><volume>54</volume><fpage>e74</fpage><lpage>e80</lpage><pub-id pub-id-type="doi">10.1111/epi.12124</pub-id><pub-id pub-id-type="pmid">23409955</pub-id></element-citation></ref><ref id="bib83"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weimer</surname> <given-names>RM</given-names></name><name><surname>Richmond</surname> <given-names>JE</given-names></name><name><surname>Davis</surname> <given-names>WS</given-names></name><name><surname>Hadwiger</surname> <given-names>G</given-names></name><name><surname>Nonet</surname> <given-names>ML</given-names></name><name><surname>Jorgensen</surname> <given-names>EM</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Defects in synaptic vesicle docking in unc-18 mutants</article-title><source>Nature Neuroscience</source><volume>6</volume><fpage>1023</fpage><lpage>1030</lpage><pub-id pub-id-type="doi">10.1038/nn1118</pub-id><pub-id pub-id-type="pmid">12973353</pub-id></element-citation></ref><ref id="bib84"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wolking</surname> <given-names>S</given-names></name><name><surname>May</surname> <given-names>P</given-names></name><name><surname>Mei</surname> <given-names>D</given-names></name><name><surname>Møller</surname> <given-names>RS</given-names></name><name><surname>Balestrini</surname> <given-names>S</given-names></name><name><surname>Helbig</surname> <given-names>KL</given-names></name><name><surname>Altuzarra</surname> <given-names>CD</given-names></name><name><surname>Chatron</surname> <given-names>N</given-names></name><name><surname>Kaiwar</surname> <given-names>C</given-names></name><name><surname>Stöhr</surname> <given-names>K</given-names></name><name><surname>Widdess-Walsh</surname> <given-names>P</given-names></name><name><surname>Mendelsohn</surname> <given-names>BA</given-names></name><name><surname>Numis</surname> <given-names>A</given-names></name><name><surname>Cilio</surname> <given-names>MR</given-names></name><name><surname>Van Paesschen</surname> <given-names>W</given-names></name><name><surname>Svendsen</surname> <given-names>LL</given-names></name><name><surname>Oates</surname> <given-names>S</given-names></name><name><surname>Hughes</surname> <given-names>E</given-names></name><name><surname>Goyal</surname> <given-names>S</given-names></name><name><surname>Brown</surname> <given-names>K</given-names></name><name><surname>Sifuentes Saenz</surname> <given-names>M</given-names></name><name><surname>Dorn</surname> <given-names>T</given-names></name><name><surname>Muhle</surname> <given-names>H</given-names></name><name><surname>Pagnamenta</surname> <given-names>AT</given-names></name><name><surname>Vavoulis</surname> <given-names>DV</given-names></name><name><surname>Knight</surname> <given-names>SJL</given-names></name><name><surname>Taylor</surname> <given-names>JC</given-names></name><name><surname>Canevini</surname> <given-names>MP</given-names></name><name><surname>Darra</surname> <given-names>F</given-names></name><name><surname>Gavrilova</surname> <given-names>RH</given-names></name><name><surname>Powis</surname> <given-names>Z</given-names></name><name><surname>Tang</surname> <given-names>S</given-names></name><name><surname>Marquetand</surname> <given-names>J</given-names></name><name><surname>Armstrong</surname> <given-names>M</given-names></name><name><surname>McHale</surname> <given-names>D</given-names></name><name><surname>Klee</surname> <given-names>EW</given-names></name><name><surname>Kluger</surname> <given-names>GJ</given-names></name><name><surname>Lowenstein</surname> <given-names>DH</given-names></name><name><surname>Weckhuysen</surname> <given-names>S</given-names></name><name><surname>Pal</surname> <given-names>DK</given-names></name><name><surname>Helbig</surname> <given-names>I</given-names></name><name><surname>Guerrini</surname> <given-names>R</given-names></name><name><surname>Thomas</surname> <given-names>RH</given-names></name><name><surname>Rees</surname> <given-names>MI</given-names></name><name><surname>Lesca</surname> <given-names>G</given-names></name><name><surname>Sisodiya</surname> <given-names>SM</given-names></name><name><surname>Weber</surname> <given-names>YG</given-names></name><name><surname>Lal</surname> <given-names>D</given-names></name><name><surname>Marini</surname> <given-names>C</given-names></name><name><surname>Lerche</surname> <given-names>H</given-names></name><name><surname>Schubert</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Clinical spectrum of <italic>STX1B</italic>-related epileptic disorders</article-title><source>Neurology</source><volume>92</volume><fpage>e1238</fpage><lpage>e1249</lpage><pub-id pub-id-type="doi">10.1212/WNL.0000000000007089</pub-id><pub-id pub-id-type="pmid">30737342</pub-id></element-citation></ref><ref id="bib85"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wolmarans</surname> <given-names>deW</given-names></name><name><surname>Stein</surname> <given-names>DJ</given-names></name><name><surname>Harvey</surname> <given-names>BH</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Of mice and marbles: novel perspectives on burying behavior as a screening test for psychiatric illness</article-title><source>Cognitive, Affective, &amp; Behavioral Neuroscience</source><volume>16</volume><fpage>551</fpage><lpage>560</lpage><pub-id pub-id-type="doi">10.3758/s13415-016-0413-8</pub-id><pub-id pub-id-type="pmid">26920212</pub-id></element-citation></ref><ref id="bib86"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname> <given-names>MN</given-names></name><name><surname>Littleton</surname> <given-names>JT</given-names></name><name><surname>Bhat</surname> <given-names>MA</given-names></name><name><surname>Prokop</surname> <given-names>A</given-names></name><name><surname>Bellen</surname> <given-names>HJ</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>ROP, the <italic>Drosophila </italic>Sec1 homolog, interacts with syntaxin and regulates neurotransmitter release in a dosage-dependent manner</article-title><source>The EMBO Journal</source><volume>17</volume><fpage>127</fpage><lpage>139</lpage><pub-id pub-id-type="doi">10.1093/emboj/17.1.127</pub-id><pub-id pub-id-type="pmid">9427747</pub-id></element-citation></ref><ref id="bib87"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xue</surname> <given-names>M</given-names></name><name><surname>Atallah</surname> <given-names>BV</given-names></name><name><surname>Scanziani</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Equalizing excitation-inhibition ratios across visual cortical neurons</article-title><source>Nature</source><volume>511</volume><fpage>596</fpage><lpage>600</lpage><pub-id pub-id-type="doi">10.1038/nature13321</pub-id><pub-id pub-id-type="pmid">25043046</pub-id></element-citation></ref><ref id="bib88"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname> <given-names>X</given-names></name><name><surname>Need</surname> <given-names>AC</given-names></name><name><surname>Petrovski</surname> <given-names>S</given-names></name><name><surname>Goldstein</surname> <given-names>DB</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>One gene, many neuropsychiatric disorders: lessons from mendelian diseases</article-title><source>Nature Neuroscience</source><volume>17</volume><fpage>773</fpage><lpage>781</lpage><pub-id pub-id-type="doi">10.1038/nn.3713</pub-id><pub-id pub-id-type="pmid">24866043</pub-id></element-citation></ref></ref-list></back><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.48705.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group><contrib contrib-type="editor"><name><surname>Monteggia</surname><given-names>Lisa M</given-names></name><role>Reviewing Editor</role><aff><institution>Vanderbilt University</institution><country>United States</country></aff></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name><surname>Missler</surname><given-names>Markus</given-names> </name><role>Reviewer</role><aff><institution/></aff></contrib></contrib-group></front-stub><body><boxed-text><p>In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.</p></boxed-text><p><bold>Acceptance summary:</bold></p><p>The manuscript by Chen and colleagues characterizes a mouse model of Munc18 haploinsufficiency and presents electrophysiological analysis of inhibitory interneuron function in these mutants that gives rise to the behavioral phenotypes. Deficiencies in synaptic vesicle fusion machinery is being increasingly recognized as key targets for several neurological and neurodevelopmental disorders. The current study provides mechanistic insight into how Munc18, a key component of synaptic vesicle fusion machinery, haploinsufficiency may lead to disease phenotypes.</p><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;<italic>Stxbp1</italic> haploinsufficiency impairs cortical inhibition and mediates key neurological features of <italic>STXBP1</italic> encephalopathy&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by three peer reviewers, one of whom is a member of our Board of Reviewing Editors, and the evaluation has been overseen by Catherine Dulac as the Senior Editor. The following individual involved in review of your submission has agreed to reveal their identity: Markus Missler (Reviewer #3).</p><p>The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.</p><p>Summary:</p><p>In this study, the authors present an extensive behavioral analysis of <italic>STXBP1</italic> (also called munc-18) haploinsufficiency in mice. While this type of analysis has been previously performed by other groups, the current manuscript presents a systematic evaluation of the phenotypes as well as a potential link to alterations in inhibitory neurotransmission in the somatosensory cortex.</p><p>Essential revisions:</p><p>There are a number of issues that require further attention. Overall, the authors' main claim to novelty is based on the fact that they present more consistent and robust behavioral phenotypes than previous studies that include epileptiform activities, cognitive deficits etc. However, circuit based analysis of synaptic transmission that may uncover the mechanisms underlying these phenotypes is rather cursory. Therefore, this analysis should be expanded as indicated below to address several open questions raised by the findings.</p><p>1) The authors should specifically justify and expand the aspect of this work that sets it apart from earlier studies (e.g. Kovacevic et al., 2018; Miyamoto et al., 2019) that address the very same questions.</p><p>2) The authors primarily focus on inhibitory neurotransmission by indicating that &quot;…a decrease in excitatory transmission is unlikely adequate to explain how <italic>Stxbp1</italic> haploinsufficiency in vivo leads to cortical hyperexcitability&quot;. The logic behind this strong statement is unclear. A decrease in excitatory drive onto inhibitory interneurons, in the least, could contribute to such as phenotype. In this regard, the authors should complement their analysis of GABAergic transmission with analysis of excitatory inputs interneurons expressing Parvalbumin or Somatostatin.</p><p>3) The analysis focuses on a reduction in GABAergic neurotransmission originating from cortical inhibitory interneurons expressing Parvalbumin and Somatostatin. While Parvalbumin neurons show a reduction in unitary response amplitudes (no changes in short term plasticity) Somatostatin neurons show a reduction in connectivity. The authors do not present any detailed analysis of these phenotypes. For instance, these effects could easily be postsynaptic and the absence of any in depth analysis complicates a straightforward interpretation. Are there any changes in Sr2+ driven asynchronous events driven by the two inputs? Any differences in spontaneous mIPSCs? These additional parameters will help to strengthen the arguments.</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.48705.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential revisions:</p><p>There are a number of issues that require further attention. Overall, the authors' main claim to novelty is based on the fact that they present more consistent and robust behavioral phenotypes than previous studies that include epileptiform activities, cognitive deficits etc. However, circuit based analysis of synaptic transmission that may uncover the mechanisms underlying these phenotypes is rather cursory. Therefore, this analysis should be expanded as indicated below to address several open questions raised by the findings.</p><p>1) The authors should specifically justify and expand the aspect of this work that sets it apart from earlier studies (e.g. Kovacevic et al., 2018; Miyamoto et al., 2019) that address the very same questions.</p></disp-quote><p>Previous studies (Miyamoto et al., 2017; Kovačević et al., 2018; Orock et al., 2018) characterized the phenotypes of three lines of <italic>Stxbp1</italic> heterozygous knockout mice. Compared to the current study, previous characterization was limited in scope, used relatively smaller cohorts of mice, and reported some inconsistent results. Here we present a more comprehensive neurological and behavioral study of two new <italic>Stxbp1</italic> haploinsufficiency models and report consistent and robust phenotypes. We feel that these new models are construct and face valid models of <italic>STXBP1</italic> encephalopathy and will be useful for the community to study the disease pathogenesis and explore therapeutic strategies. Furthermore, we report distinct deficits of GABAergic synaptic transmission from two main classes of cortical interneurons. These points are now elaborated in the Introduction and Discussion.</p><disp-quote content-type="editor-comment"><p>2) The authors primarily focus on inhibitory neurotransmission by indicating that &quot;…a decrease in excitatory transmission is unlikely adequate to explain how Stxbp1 haploinsufficiency in vivo leads to cortical hyperexcitability&quot;. The logic behind this strong statement is unclear. A decrease in excitatory drive onto inhibitory interneurons, in the least, could contribute to such as phenotype. In this regard, the authors should complement their analysis of GABAergic transmission with analysis of excitatory inputs interneurons expressing Parvalbumin or Somatostatin.</p></disp-quote><p>We agree with the reviewers that a reduction of the excitatory inputs onto inhibitory interneurons could lead to cortical hyperexcitability. Thus, we recorded the spontaneous excitatory postsynaptic currents (sEPSCs) in both Pv and Sst interneurons, but did not observe any significant changes of either amplitude or frequency in the mutant mice, suggesting that the excitatory drive onto interneurons is normal in <italic>Stxbp1</italic> haploinsufficient mice. These results are now presented in Figure 8—figure supplement 2.</p><disp-quote content-type="editor-comment"><p>3) The analysis focuses on a reduction in GABAergic neurotransmission originating from cortical inhibitory interneurons expressing Parvalbumin and Somatostatin. While Parvalbumin neurons show a reduction in unitary response amplitudes (no changes in short term plasticity) Somatostatin neurons show a reduction in connectivity. The authors do not present any detailed analysis of these phenotypes. For instance, these effects could easily be postsynaptic and the absence of any in depth analysis complicates a straightforward interpretation. Are there any changes in Sr2+ driven asynchronous events driven by the two inputs? Any differences in spontaneous mIPSCs? These additional parameters will help to strengthen the arguments.</p></disp-quote><p>We agree with the reviewers that it is crucial to understand if the synaptic transmission deficit of Pv synapses is due to a postsynaptic mechanism. To address this question, we developed a new optogenetic method to isolate quantal IPSCs mediated by the GABA release specifically from Pv or Sst interneurons. We used ChR2 to enhance asynchronous exocytosis of synaptic vesicles from Pv or Sst interneurons in the presence of TTX and Sr<sup>2+</sup>, and then mathematically subtracted the mIPSCs recorded during the baseline period (i.e., before blue light stimulation) from those recorded during blue light stimulation to obtain the average amplitude, charge, and decay time constant of Pv or Sst interneuron-mediated quantal IPSCs. These experiments showed that none of these properties are different between WT and mutant mice, indicating that <italic>Stxbp1</italic> haploinsufficiency does not affect the postsynaptic properties of inhibitory transmission. The results are now presented in Figure 9.</p><p>These results indicate that the reduction in the strength of Pv synapses is most likely due to a decrease in the number of readily releasable vesicles or release probability given the role of <italic>Stxbp1</italic> in synaptic vesicle priming and fusion (Rizo and Xu, 2015) and the fact that the quantal amplitude and connectivity are unaltered in <italic>Stxbp1<sup>tm1d/+</sup></italic> mice. Although the short-term synaptic depression is unaltered in <italic>Stxbp1<sup>tm1d/+</sup></italic> mice, a change in release probability is still possible because at the Pv interneuron synapses the short-term synaptic plasticity during a short train of action potentials, which was used in this study, is not sensitive to the release probability (Kraushaar and Jonas, 2000; Luthi et al., 2001).</p></body></sub-article></article>